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ABSTRACT 
The role of systems biology in the interpretation and analysis of important biological 
events is gaining rapid acceptance in a number of biological fields. Here a 
computational systems approach was applied to investigate the production and 
regulation of Escherichia coli’s (E. coli) outer membrane. The outer membrane 
comprises of phospholipids in the inner leaflet, and lipopolysaccharides (LPS) in the 
outer leaflet. LPS is an endotoxin that elicits a strong immune response from humans 
and its biosynthesis is in part, regulated via degradation of LpxC and WaaA enzymes by 
the protease FtsH. Despite a substantial amount of research conducted on LPS 
synthesis, there is remarkably little information on its regulation.  
The model of the outer membrane synthesis was completed in two phases; firstly a 
model of lipid A (representing the LPS pathway) was constructed followed by an 
integrated pathway model which incorporated fatty acids biosynthesis pathway 
(representing phospholipid production). The parameters used to construct the model 
were derived from published datasets where available, and estimated when necessary 
prior to model fitting. Model validation was carried out using a combination of 
published datasets alongside subsequent experimental data from this research. 
Model findings suggested that the FtsH-mediated LpxC degradation signal arises from 
levels of lipid A disaccharide, the substrate for LpxK. This was subsequently validated 
experimentally using an lpxK overexpression system. Analysis of the integrated model 
further refined this mechanism indicating the catalytic activity of LpxK appears to be 
dependent on the concentration of unsaturated fatty acids. This is biologically important 
because it assists in maintaining LPS/phospholipids homeostasis. 
Further crosstalk between the fatty acids and lipid A biosynthetic pathways was 
revealed by experimental observations that LpxC is additionally regulated by an 
ii 
 
unidentified protease whose activity is independent of lipid A disaccharide 
concentration, but could be induced in vitro by palmitic acid. The biological relevance 
of this acute mechanism is not obvious; however, experiments aimed at causing abrupt 
damage to the cell wall or membrane (by antimicrobials) suggest that under conditions 
which directly damage membrane structure, LPS regulation via this unidentified 
protease may be crucial.  
Computational analysis into the regulation of WaaA suggested that its proteolytic 
regulation does not affect the LPS synthetic rate. Subsequent experimental analysis 
provided evidence that WaaA regulation is aimed at controlling the quality of LPS 
synthesized by preventing glycosylation of undesirable lipid acceptors. Overexpression 
of waaA resulted in increased levels of 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) 
sugar whereas, levels of heptose were not elevated in comparison to non-overexpressed 
cells. This implies that an uncontrolled production of WaaA does not increase LPS level 
but rather re-glycosylates lipid A precursors. This is the first time experimental data has 
been produced attempting to explain the regulation of WaaA. 
Computation of flux coefficient indicates that LpxC is the rate-limiting step when 
pathway regulation is ignored, but LpxK becomes the limiting step if feedback 
regulation is included as it is in vivo. Thus, in contrast to LpxC, LpxK may represent a 
more appropriate target for novel drug development. Overall, the findings of this work 
provide novel insights into the complex biogenesis of the E. coli outer membrane. 
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In 1976, the first complete genome sequence of an organism was published which in 
essence, opened up a new era for the biological sciences (Fiers et al, 1976).  For the first 
time in human history, scientists could observe and analyse the complete nucleotide 
sequence of an organism and from this, determine and annotate the various genes which 
are present. These genome sets, of course, represent the blueprints which are 
responsible for producing a living organism. However, this data on its own is incapable 
of predicting or simulating an organism’s behaviour. A major challenge of this century 
is to understand how the products of these genomes interact and form sophisticated 
biochemical networks which in turn produce a living organism. To accomplish this, 
much more data is required; in particular, precise information relating to each gene 
product. Most of this functional information is acquired through classical methods 
including in vitro experiments, cell culture analysis, and animal model studies (van Riel, 
2006). Fortunately, a substantial amount of this data is available particularly for the 
prokaryotes, of which Escherichia coli is the best studied. Therefore, where sufficient 
information exists, the gene products can be assembled into specific groups carrying out 
specific tasks such as glucose metabolism, lipids biosynthesis or DNA synthesis. This 
results in the construction of metabolic pathways and also enables organisms to be 
studied as a ‘whole’ entity. Such an approach is commonly regarded as the “systems 
biology approach” (Ideker et al., 2001). 
 
1.1  SYSTEMS BIOLOGY AND ITS APPLICATION 
Despite the acknowledgment and rapid acceptance of its importance in current-day 
biological interpretations, there is still no universally accepted definition for the term 
“systems biology” (Chuang et al., 2010). This thus gives an insight into the complexity 
of this relatively new area of discipline.  
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The mode and manner in which systems biology is viewed, perceived or defined differs 
amongst systems biology practitioners. However, O’Malley and Dupre (2005) are of the 
opinion that current definitions lack a precise explanation as to what constitutes a 
‘system’. Perhaps, until a clear and coherent definition of a ‘system’ exists, the 
definition of “systems biology” will remain ambiguous. Nevertheless, all proposed 
definitions centre around a fundamental understanding of biological systems based on 
individual modular components (Likic et al., 2010). The word ‘system’ in the context of 
“systems biology” depends largely on the research problem at hand, objectives of the 
study, and the methodological choices employed in its analysis (Likic et al., 2010).  
During the late 20th century, biological studies were greatly influenced by the so called 
‘reductionist’ approach which generally involved the creation of information regarding 
individual cellular components, their chemical composition, and most times, their 
biological functions (Palsson, 2006). Over the past decade, this process has been rapidly 
enhanced by the advent of genomics, largely resulting from the completion of the 
Human Genome Project (HGP) (Lander et al., 2001). Furthermore, the emergence of 
’omics technologies such as transcriptomics, proteomics, and metabolomics has also 
accelerated this process (Schena et al., 1995; Oliver et al., 1998; Fiehn, 2001; Patterson 
and Aebersold 2003). All aforementioned processes lead to the generation of a large 
array of data which enables cells to be viewed as systems. This is important because as 
informative as individual modular components may be, they only provide basic 
information such as the molecular and chemical constituents that make up cells, and 
when cells decide to utilize these components (Palsson, 2006). It is now generally 
accepted amongst biologists that the integrative exploration of multiple gene functions 
is important in the understanding of actual cellular behaviour. For instance, p53, 
sometimes referred to as the ‘guardian of the genome’ (Kitano, 2002) is a human 
protein of 393 amino acids that function as a tumour suppressor due to its positioning 
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within a network of transcriptional factors. However, its functional role as a tumour 
suppressor is reliant on the activities of other proteins. In particular, p53 alteration 
patterns such as phosphorylation, dephoshporylation, and action of proteases, lead to the 
activation, inhibition, and degradation of p53 protein respectively (Kitano, 2002). The 
resultant modification pattern to a large extent determines the selectivity of its target 
which highlights the complexity of this individual component. In other words, neither 
p53 nor other components of the network function as a tumour suppressor 
independently; instead, it is dependent on the collective state of the network. Therefore, 
in this scenario, cellular behaviour would be better characterized if studied as a system. 
Integrative systems approaches also reveal complex and unexpected behaviours in what 
were originally assumed to be simple organisms. The bacterium Mycoplasma 
pneumoniae whose genome is relatively small, encoding for just 689 proteins lack most 
regulatory and transcriptional factors (Yus et al., 2009). Yet, a co-ordinated and highly 
complex transcriptional response has been observed (Guell et al., 2009). Despite its 
small genome, there is a substantial level of communication between various cellular 
components in which the proteome exhibits extensive reuse of functional components 
(Kuhner et al., 2009). According to Likic et al. (2010), these observations do not 
indicate that M. pneumoniae is an unusual organism, rather they highlight and reveal 
potentially unknown regulatory machineries that operate across the transcriptome, 
proteome, and metabolome level. This only becomes obvious when studied as a 
‘system’. 
 
1.2  THE ROLE OF BIOINFORMATICS IN SYSTEMS BIOLOGY 
It is practically unrealistic to interrogate the combined role of every individual 
component of a cell on observed cellular behaviour using the conventional 
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biochemical/experimental techniques (Breitling, 2010). However, these individual 
components can be assembled, analysed and used to predict cellular function using 
computational approaches (Breitling, 2010). As a result, bioinformatics has unarguably 
become an indispensable tool in systems biology (Kitano, 2002; May, 2004) and this is 
evidenced in a number of studies. In a number of modelling studies investigating yeast 
metabolism, a clear and coherent picture of the dynamic cellular behaviour becomes 
apparent only after mathematical modelling had been applied partly due to the 
complexity of the network (Tyson et al., 2001; Chen et al., 2004). The use of 
mathematical models also proved invaluable in the study of an E. coli inducible genetic 
switch by Roberts et al. (2011) in which the authors were able to interpret cellular 
behaviour in response to the presence of sugar in the external environment, and 
furthermore, elucidate the role of intracellular molecular crowding on sugar uptake. 
More recently, a whole-cell computational model of Mycoplasma genitalium has been 
developed which also has provided novel insights into previously unobserved cellular 
behaviours (Karr et al., 2012). 
In addition to producing novel findings, computational models are also being explored 
to represent our current understanding as regards biological entities. This entails 
replicating known biological behaviours using in silico models. Under these 
circumstances, model reliability is improved when models are capable of reproducing as 
many experimental data as possible. A reliable model thus enhances its predictive 
properties. Thus, computational or mathematical models also represent “concise 
summaries of our current knowledge of respective systems” (Likic et al., 2010). 
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1.3  CONSTRUCTION OF IN SILICO MODELS 
Generally, the construction of metabolic models follows four principal steps (Palsson, 
2006). Firstly, the individual components that would be involved in the process are 
specified. These individual components could be enzymes which catalyse reactions in 
the pathway, transcription and regulatory proteins, or substrate molecules. Secondly, the 
interactions between these individual components are enumerated which invariably 
results in the construction of the network. In this regard, detailed information are 
obtained from the literature regarding the relationship between these individual 
components. Subsequently, a ‘pseudo’ network or algorithm is constructed based on 
such information. Thirdly, the constructed metabolic networks are represented 
mathematically and their properties analysed, resulting in a computational model. 
Finally, the models are used to interpret and analyse known biological events, and also 
to predict potential experimental outcomes. 
In a broad sense, there are two modelling approaches being adopted in biological 
systems analysis (Smallbone et al., 2007). These are constraint-based modelling (Beard 
et al., 2002; Covert et al., 2003; Price et al., 2006; Kim et al., 2008) and kinetic 
modelling (Smallbone et al., 2007; Resat et al., 2009). Constraint-based modelling 
employs physiochemical constraints which include mass balance, energy balance, and 
flux limitations in the exploration of cellular behaviours (Smallbone et al., 2007). In 
most cases, the basic biochemical architecture of metabolic pathways are known to 
some extent; hence, the stoichiometries of such a network can be inferred (Kim et al., 
2008; Orth et al., 2010). Furthermore, when there is sufficient information about the 
network such as the reaction rate, the reaction flux through the network can be 
constrained (Orth et al., 2010). The major advantage of constraint-based modelling 
approach lies in the minimal amount of biological data required to make quantitative 
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inference about the biochemical network (Smallbone et al., 2007). However, this 
approach does not provide a detailed picture of the network such as concentration of 
metabolites and regulatory patterns (Smallbone et al., 2007).  
In contrast, kinetic models are well detailed and they provide in-depth information 
about the system. Kinetic modelling aims to fully characterize how changes in a 
modular component (such as metabolites and enzymes) alter the local reaction rates 
(Smallbone et al., 2007). This approach usually involves a considerable amount of 
biological information to parameterize the model. As a result, kinetic models are 
computationally more expensive than constraint-based models. Obtaining the required 
parameters could be time-consuming and, in some cases, practically impossible to 
determine experimentally (Covert et al., 2003). Since such parameters are required for 
the model, they are sometimes inferred or deduced from the available information. Such 
assumptions on the other hand, can result in biological interpretations that are highly 
speculative.  
 
1.3.1  Modelling biological systems using kinetic approaches 
Biological systems are typically modelled kinetically by using either deterministic 
methods, or stochastic methods, or a hybrid of both (Wilkinson, 2009; Lachor et al., 
2011). The choice of methodology utilized is dependent on a number of factors as 
discussed below. 
 
 1.3.1.1  Deterministic kinetic models 
The conventional approach to modelling chemical kinetics is to assume that the 
participating components (i.e. reactants) are present in high amounts, and have a level 
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measured on a continuous scale such as in units of concentration or particle numbers 
(Wilkinson, 2009). The deterministic approach is based on the hypothesis that since the 
population sizes of the reacting components are large, such models can be defined by 
the average population size (i.e. mean) of the reacting components (Szekely and 
Burrage, 2014). In addition, the changes in the concentration of the reacting species are 
assumed to occur in a continuous and predictable process (Wilkinson, 2009).  
Deterministic models are particularly useful in the description of the evolution of bio-
molecular populations (Lachor et al., 2011). The reaction rates in these models are 
specified using equations that usually assume mass action kinetics or conventional 
enzyme kinetic laws such as Michaelis-Menten kinetics (Cornish-Bowden, 2004; 
Wilkinson, 2009). Under simplistic circumstances, deterministic models are relatively 
easy to use, and come at a low computational cost (Meng et al., 2004). 
On the other hand, there are certain limitations to the use of deterministic approaches in 
the study of biological systems. Firstly, it is inaccurate for systems that contain low 
level of reacting species. If the cellular concentrations of reacting species are low, 
representing this phenomenon by its ‘population mean’ can lead to erroneous model 
predictions, or may even alter the qualitative properties of the model (Lachor et al., 
2011). Secondly, when the behaviours of biological systems are being analysed for 
parameters close to diverging/branching points (for instance, in evolution studies), 
restriction to average values can again, as above, result in bypassing important features 
that are inherent to the system (Lachor et al., 2011). Finally, deterministic models 
ignore noise and heterogeneity which are intrinsic components of certain biological 
events (Szekely and Burrage, 2014).        
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 1.3.1.2  Stochastic kinetic models 
Stochastic models are typically used to study the effects of random fluctuations in the 
numbers of reacting species on biological systems behaviour (Gillespie, 2007). As 
mentioned above, deterministic models may fail to capture cellular behaviours that arise 
from stochastic events or noise in the system. However, real biological systems will 
unarguably be influenced by factors that are not fully understood to biologists or 
impractical to model explicitly (Ditlevsen and Samson, 2013). For instance, it is well 
documented that a number of essential biochemical processes involve some element of 
randomness such as promoter binding events, mRNA transcription and degradation, 
protein translation and degradation, and protein-protein interactions (Ideker et al., 
2001). Ignoring these effects during modelling may affect the analysis of the biological 
system under investigation. These random events can be accounted for by utilizing 
stochastic approaches.  
A stochastic approach treats the precise number of molecules in the system as a discrete 
quantity. The ‘state’ which describes how many molecules of each type are present in 
the system changes discretely (Gibson and Mjolsness, 1999) and such changes are 
probabilistic. Specifically, the rate constants in stochastic equations represent the 
probability of a discrete event occurring per unit time (Gibson and Mjolsness, 1999). A 
popular approach used in modelling the dynamics of biological systems is the Markov 
jump process (Cox and Miller, 1977). In this case, an algorithm called the “stochastic 
simulation algorithm” (popularly referred to as Gillespie algorithm (Gillespie, 1977)), is 
used to generate ‘runs’ or ‘exact realizations’ of the Markov jump process (Gillespie, 
1977). Starting from the initial state of the system, the algorithm produces time course 
trajectories over a given time period (Wilkinson, 2009). The ‘runs’ or ‘realizations’ are 
random; thus, they vary for each simulation. This variability over several runs 
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subsequently represents a benchmark for interpreting noise in the biological system 
being studied. 
On the other hand, the computational cost of including stochasticity in models is high 
especially when analysing complex systems. Thus, the choice of modelling approach is 
dependent on the importance of noise and heterogeneity on the biological event being 
studied. In other words, a researcher would often compromise between computational 
time cost of the project, and the accuracy of the expected output (Lachor et al., 2011). 
Nevertheless, when heterogeneity isn’t particularly necessary, deterministic models 
would suffice. 
 
1.4  TOOLS FOR SYSTEMS BIOLOGY ANALYSIS 
The development and maintenance of modelling/software tools pose some significant 
challenges in systems analysis. In most cases, a specific tool is aimed at addressing only 
a specific need of systems biology. The specific need may include the development of 
data repositories, development of software tools for simulation and analysis, or creation 
of tools for the visualization of the systems component of biochemical networks (Likic 
et al., 2010). As a result, biological systems analysis usually involves a combination of 
different bioinformatics tools. 
In the early 2000s, the necessity for an effective platform for the exchange and 
distribution of quantitative systems biology models was recognized, and subsequently 
resulted in the development of the Systems Biology Mark-up Language (SBML) 
(Hucka et al., 2003). SBML is a free, open, XML-based format for representing reaction 
networks of biological systems. Currently, the SBML format is adopted in over 180 
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software tools which is testament to its importance (Likic et al. 2010). A good example 
is the COPASI software (Hoops et al., 2006; Mendes et al., 2009). 
 The COPASI software is one of the most common modelling tools used in metabolic 
pathway analysis (as at 2015, the first publication describing COPASI has been cited 
1145 times which implies an average citation rate of 127 per year). COPASI is an 
independent, user-friendly, and widely accepted simulator of models encoded in SBML. 
It can be used to describe models based on ordinary differential equations (ODE), 
stochastic approaches, or a combination of both (i.e. hybrid). Furthermore, COPASI 
provide tools for the visual analysis of simulation results, and also tools for conducting 
post-simulation analyses such as metabolic control analyses (MCA) (Mendes et al., 
2009). 
It has been acknowledged that modelling certain biological events by ignoring spatial 
localization (such as with COPASI) may be inadequate. This is because a number of 
cellular processes depend on intracellular location and collisions of the individual 
reacting molecules (Andrews et al., 2010). For example, during cell signalling, signals 
are transmitted across substantial distance of length and across multiple intracellular 
membrane compartments (Andrews et al., 2010). In this regard, software tools have 
been developed which incorporate spatial effect into simulations. These include MCell 
(Stiles et al., 1996), Smoldyn (Andrews et al., 2010), and MesoRD (Fange et al., 2012). 
The importance of spatial localization in biological models was recently buttressed in 
Roberts et al. (2011). In the study, the authors observed that intracellular molecular 
crowding greatly influences the uptake of sugar from the environment and subsequent 
activation of the lac expression system.       
In order to run computational simulations, input parameters are usually required. In the 
case of COPASI for instance, such input parameters could be enzyme turnover rate, 
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Michaelis-Menten constant (Km), drug inhibition constant etc. Consequently, databases 
which incorporate biological information and parameters have been developed. A good 
example is the BRENDA database which represents a fairly comprehensive collection 
of enzyme and metabolic information (such as Km values and turnover rates) obtained 
from the experimental literature (Schomburg et al., 2004). 
 
1.5  THE APPLICATION OF SYSTEMS BIOLOGY IN THE STUDY OF 
GRAM-NEGATIVE BACTERIA  
A significant number of clinically relevant bacterial infections are caused by a group of 
bacteria known as ‘Gram-negatives’ (Quinn, 1998; Gaynes et al., 2005; Paterson, 2006; 
Kumarasamy et al., 2010). In particular, four of the most frequent hospital-acquired 
infections may be caused by this group of bacteria (Gaynes et al., 2005). These are 
bloodstream infection, urinary tract infection, surgical site infection, and pneumonia. 
The rise in the incidence of antibiotic-resistant strains of bacteria especially amongst 
Gram-negatives has limited the scope of treatment of these common infections (Poole, 
2001; Paterson, 2006). It is estimated that in the United States, approximately 2 million 
people become infected with bacteria that are resistant to antibiotics resulting in at least 
23,000 deaths yearly (Centre for Disease Control, 2015a). Similarly, there has been 
significant increases in cases of multi-drug resistant bacterial infection in the United 
Kingdom (UK). For instance, between the years 2003 and 2009, the cases of bacterial 
resistance to carbapenems (often regarded as the antibiotic of last resort (Papp-Wallace 
et al., 2011)) in the UK, has increased by approximately 14 folds (Kumarasamy et al., 
2010). Therefore, a proactive approach is required in tackling what has been regarded as 
one of the “world’s most pressing public health problems” (Centre for Disease Control, 
2015b). 
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In a broader sense, there are primarily two ways at tackling the problem of bacterial 
resistance (Bush et al., 2011). Firstly, by enlightening patients on the importance of 
adhering to prescribed antibiotics regimen, and in addition, encouraging health 
practitioners to minimize the prescription of antibiotics. However, there are instances 
whereby the use of antibiotics are indispensable such as under surgical settings. 
Secondly, the development of new classes of antibiotics, especially those aimed at novel 
metabolic pathways. The importance of the latter option is readily acknowledged by 
both health researchers and governments (Bush et al., 2011; Centre for Disease Control, 
2015b). Therefore, there is a need to drive the development of novel antibiotics aimed at 
novel drug targets. An example of a biochemical pathway that would represent a 
suitable drug target is that which is involved in the synthesis of the outer membrane 
found in Gram-negatives. This is because the outer membrane is of importance to the 
survival of the bacteria and the enzymes involved in its biosynthesis have no orthologs 
in humans. Although, often underestimated, one of the difficulties in novel 
antimicrobial design is identifying the appropriate enzyme target within a pathway. This 
is important because bacteria tend to devise ways to counteract external perturbations 
when certain enzymes are being inhibited thereby resulting in a quick development to 
resistance (Brinster et al., 2009). In order to elucidate suitable drug targets within 
pathways, it is essential to study, understand, investigate, and analyse the physiology 
and metabolism of these bacteria in the context of the specific pathway in question. As 
mentioned above, such detailed integrative analyses are only obtainable when a 
computational systems approach is employed. Furthermore, because the outer 
membrane of Gram-negatives is quite complex and consists of series of biosynthetic 
and regulatory machineries, development of a computational model of this pathway also 
represents a key step towards the creation of a whole-cell model. 
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1.6  THE OUTER MEMBRANE OF GRAM-NEGATIVE BACTERIA    
The outer membrane of Gram-negative bacteria is composed of LPS in the outer leaflet, 
and phospholipids in the inner leaflet (Nikaido, 2003) (Fig. 1.1). Studies investigating 
bacterial membrane synthesis have been conducted primarily on E. coli (Raetz, 1978; 
Heath et al., 2002). This is partly because E. coli cells can be grown easily in the 
laboratory and can also be readily manipulated by the investigator (Heath et al., 2002). 
Perhaps, more importantly, their complete genome sequence is available (Blattner et al., 
1997) and thus, suitable for genetic manipulation (Heath et al., 2002). Additionally, the 
outer membrane system of E. coli is structurally similar to those of some other Gram-
negatives (Silhavy et al., 2010). For these reasons, E. coli represents a suitable model 
organism for the study of outer membrane in Gram-negatives. 
The outer membrane is an attractive drug target for a number of reasons. Firstly, it is 
decorated with a potent endotoxin (called lipid A) which plays a significant role in 
bacterial pathogenicity and immune evasion (Walker et al., 2004). Secondly, it acts as a 
physical barrier protecting the cell from chemical attack, and represents a significant 
obstacle for the effective delivery of numerous antimicrobial agents (Nikaido, 1996; 
Delcour, 2009). Being in direct contact with the environment, the outer membrane is a 
dynamic system continuously adapting its composition in response to chemical or 
physical pressures (Taneja et al., 1979). Because surrounding conditions can vary 
rapidly, acute or fine control mechanisms aimed at optimising membrane composition 
are of importance for bacterial adaption and survival (Zhang and Rock, 2008).  
. 
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Figure 1.1 Structure of E. coli outer membrane. The bacterial cytoplasm is 
surrounded by a cell envelope which consists of an inner membrane (IM), periplasm, 
and outer membrane (OM). LPS occupy the outer leaflet of the OM while the inner 
leaflet comprises of phospholipids. The peptidoglycan layer is localized in the 
periplasmic space. 
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1.6.1  Lipopolysaccharide   
LPS is a glycolipid that forms the major component of the outer leaflet and occurs with 
approximately 1 million copies in E. coli cells, covering about 75% of the cell surface 
area (Raetz et al; 2009; Whitfield and Trent, 2014). LPS helps stabilize these 
membranes, protects them from chemical attack, and promotes cell adhesion to various 
surfaces (Walker et al., 2004). LPS comprises three components: lipid A, core 
oligosaccharide (core OS), and O-antigen (Fig. 1.2A) (Raetz and Whitfield, 2002; Raetz 
et al., 2009). The lipid A component includes six hydrophobic acyl chains that reside in 
the outer leaflet of the bacterial outer membrane. These are connected together by a 
glucosamine and phosphate head group. In the majority of Gram-negative bacteria, 
including E. coli, this head group connects to a pair of 3-deoxy-D-manno-oct-2-ulosonic 
acid (Kdo) sugar residues (Raetz et al., 2009). These Kdo residues connect to several 
additional sugar residues, and sometimes also to phosphate, 
pyrophosphorylethanolamine, or phosphorylcholine residues, which together form the 
core OS (Raetz and Whitfield, 2002). This core then connects to the O-antigen, which is 
a long polysaccharide that varies widely between different bacterial species and 
different strains within each species (Raetz and Whitfield, 2002). 
LPS elicits a strong immune response in humans and other animals being detectable at 
picomolar levels by the innate immune system’s Toll-like receptor 4 (TLR4) protein 
(Raetz et al., 2009). In macrophages, the resulting activation of TLR4 by LPS 
stimulates the production of different inflammatory molecules, and drives the synthesis 
of co-stimulatory metabolites required for the adaptive immune response (Raetz and 
Whitfield, 2002). In mononuclear and endothelial cells, the presence of LPS stimulates 
tissue factor production (Drake et al., 1993). Such stimulation events are normal, and 
are in fact, important in local infection (Raetz and Whitfield, 2002). However, when 
LPS drives the overproduction of these mediating and clotting factors (such as under 
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Figure 1.2. Structure of LPS and lipid A. (A) Figure was obtained from Whitfield and 
Trent (2014) with permission. LPS is comprised of lipid A, core OS, and O-antigen. 
The core OS can further be divided into inner and outer core OS. The number of 
polysaccharide repeats present in the O-antigen region is widely diverse and varies from 
strain to strain. (B) Structure of lipid A. The top two sugars are Kdo groups, which are 
part of the core OS, while the remainder of the structure represents the hexa-acylated 
lipid A moiety. 
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severe sepsis), they can destroy blood vessels, cause disseminated intravascular 
coagulation, and potentially result in organ failure (Parillo, 1993; Reatz and Whitfield, 
2002). These attributes have made the study of LPS important to the fields of 
bacteriology and drug discovery (Raetz and Whitfield, 2002; Raetz et al., 2007; Raetz et 
al; 2009; Wang and Quinn, 2010; Whitfield and Trent, 2014). 
 
1.6.1.1  Lipid A   
Of the three structural components of LPS, the lipid A moiety (Fig. 1.2B) is of 
particular interest because it is the only component that is essential for cell viability and 
is highly conserved (Raetz and Whitfield, 2002). In addition, the endotoxin component 
of LPS resides in the lipid A moeity. These also make its biosynthesis pathway an 
attractive target for new antibiotics (Onishi et al., 1996; Jackman et al., 2000). For these 
reasons also, this research would focus on the lipid A moiety of LPS. 
The biosynthesis of E. coli lipid A proceeds through nine-enzyme catalysed steps (Fig. 
1.3; Table 1.1) (Raetz et al., 2009). Of these, the first seven enzymes (LpxA, LpxC, 
LpxD, LpxH, LpxB, LpxK, and WaaA) are essential for growth under optimum 
conditions (Raetz et al., 2009). Three of these essential enzymes are of interest due to 
certain characteristics. LpxA possesses a highly unfavourable equilibrium constant 
(Anderson et al., 1993) which indicates the proceeding enzyme LpxC catalyses the 
pathway committed step. In addition, lipid A production is regulated in part through 
proteolysis of LpxC and WaaA proteins (Ogura et al., 1999; Katz and Ron, 2008). The 
biosynthesis and regulatory processes of lipid A are described in great detail in Chapter 
2.  
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Figure 1.3. Biosynthesis of E. coli lipid A. Biosynthesis of lipid A commences by the 
acylation of UDP-N-acetylglucosamine (UDP-GlcNAc) with an acyl chain derived from 
β-hydroxymyristoyl-ACP (3-OH-C14-ACP) catalysed by LpxA. This first reaction step 
is highly unfavourable. Subsequent steps are conducted by LpxC, LpxD, LpxH, LpxB, 
LpxK, WaaA (also known as KdtA), LpxL, and LpxM (Figure obtained from Raetz et 
al. (2009) with permission). 
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1.6.1.2  Core oligosaccharides (core OS) 
The core OS can be divided into inner core OS and outer core OS (Fig. 1.2A). The inner 
core OS connects directly to the lipid A component. Although the lipid A moiety of 
LPS is highly conserved, the core OS exhibit some degree of variation albeit within the 
outer core (Wang and Quinn, 2010). This highlights an important role of inner core OS 
in outer membrane stability (Whitifield and Trent, 2014). Whilst the inner core OS 
typically consists of Kdo and L-glycero-D-manno-heptose (Wang and Quinn, 2010), the 
outer core can consist of a variety of sugars such as galactose and glucose. The diverse 
nature of the core OS is understandable given that it is exposed to the environment in 
most E. coli strains (i.e. strains lacking O-antigen), and thus, exposed to selective 
pressures of the host responses and environmental stress (Raetz and Whitfield, 2002). 
Biosynthesis of the core OS occurs at the cytoplasmic surface of the inner membrane 
and is conducted by membrane-associated gylcosyltransferases which utilizes 
nucleotide sugars as donors. This process is usually prompt and efficient which suggests 
that the glycosyltransferases function as a co-ordinated complex (Wang and Quinn, 
2010). 
After attachment of the core OS to the lipid A moiety, the core OS-lipid A complex is 
flipped by MsbA protein from the inner surface to the outer surface of the inner 
membrane (Fig. 1.4). An inactivation of MsbA results in the accumulation of precursor 
molecules of LPS in the inner membrane (Rees et al., 2009) which indicates that MsbA 
plays a crucial role in LPS assembly. However, suppressor mutations in the yhjD gene 
has been observed to functionally replace MsbA under extreme conditions (Mamat et 
al., 2008).  
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Figure 1.4. Assembly and transport of LPS in E. coli. MsbA flips the core OS-lipid A 
complex from the cytoplasmic face of the inner membrane to the outer surface of the 
inner membrane. Likewise, the O-antigen oligosaccharides are assembled and flipped 
from the inner surface to the outer surface of the inner membrane by the transporter 
Wzx. Polymerization subsequently occurs by Wzy and Wzz enzymes. The core OS-
lipid A is then ligated with the polymerized O-antigen by WaaL. The nascent LPS is 
then shuttled to the periplasmic face of the outer membrane by LptA, LptB, LptC, LptF 
and LptG. Lastly, the outer membrane proteins LptD and LptE exports the LPS to the 
outer membrane (Figure obtained from Wang and Quinn (2010) with permission). 
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1.6.1.3  O-antigen   
Most of the laboratory strains of E. coli such as K-12 lack the O-antigen moiety; 
nevertheless, O-antigen is present in virulent strains of E. coli and they help confer 
resistance to antibiotics (DebRoy et al., 2011; Band and Weiss, 2015). The level of 
diversity in the O-antigen region is remarkable. Over 60 monosaccharides and 30 non-
carbohydrate components have been elucidated (Raetz and Whitfield, 2002).  
The O-antigen region is synthesized by glycosyltransferase enzymes in the cytoplasmic 
surface of the inner membrane similarly to core OS (Wang and Quinn, 2010). The rfb 
gene cluster encodes for enzymes which produce sugar-nucleotide precursors that are 
unique to O-antigen (Raetz and Whitfield, 2002; Wang and Quinn, 2010). The protein 
Wzx flips the O-antigen from the cytoplasmic face to the outer surface of the inner 
membrane in a similar pattern to that of core OS-lipid A with MsbA (Fig. 1.4) (Wang 
and Quinn, 2010).  
 
1.6.1.4  LPS assembly and transport 
Since LPS is localized within the outer membrane and its individual components are 
synthesized in the inner membrane, LPS must be assembled and subsequently 
transported to the outer surface. The core OS-lipid A complex together with the 
synthesized O-antigen are exported to the periplasmic face of the inner membrane 
where O-antigen is further polymerized by Wzy and Wzz (Wang and Quinn, 2010) and 
subsequently attached to the core OS-lipid A by the ligase WaaL (Abeyranthe et al., 
2005) (Fig. 1.4). The resulting structure is referred to as a “nascent LPS”.  
Transportation of nascent LPS from the periplasmic face of the inner membrane to the 
inner leaflet of the outer membrane is performed by LptA, LptB, LptC, LptF, and LptG 
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proteins (Ruiz et al., 2008; Sperandeo et al., 2007; Sperandeo et al., 2008). Subsequent 
translocation to the outer leaflet of the outer membrane are conducted by LptD and LptE 
(Bos et al., 2004; Wu et al., 2006; Ma et al., 2008) (Fig. 1.4). Table 1.1 lists the 
enzymes involved in lipid A biosynthesis and LPS transport.  
 
1.6.1.5  Structural modification of lipid A component of LPS 
Some Gram-negative bacteria such as E. coli have evolved mechanisms to modify either 
the hydrophobic acyl chain region or hydrophilic disaccharide region of lipid A (Raetz 
et al., 2007). Such modification assists the bacterium in evading recognition by the 
innate immune system, or to resist cationic antimicrobial peptides (CAMPs) synthesized 
by the host immune machinery (Whitfield and Trent, 2014). 
A palmitate group obtained from phospholipids can be added to lipid A by the enzyme 
PagP resulting in a hepta-acylated structure (Hwang et al., 2004). This modified form of 
lipid A is believed to play a major role in resistance to some CAMPs (Wang and Quinn, 
2010). On the other hand, PagL is a lipase that removes 3-O-linked acyl group from 
lipid A (Rutten et al., 2006). However, this play no role in resistance to CAMPs 
(Kawasaki et al., 2004). Furthermore, the phosphate region on the hydrophilic region 
can be modified or removed. This structural modification is important because the E. 
coli lipid A usually contains 2 phosphate groups resulting in a negatively charged 
molecule which facilitate binding to positively charged CAMPs (Wang and Quinn, 
2010). Common modification patterns involve the addition of amine-containing 
residues such as phosphoethanolamine and α-L-Ara4N which enable bacteria cells 
develop resistance to polymyxin B and CAMPs (Trent et al., 2001; Lee et al., 2004).    
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Table 1.1: Enzymes involved in lipid A biosynthesis and LPS transport in E. coli 
 
Enzyme    Function 
Lipid A biosynthesis 
LpxA  fatty acylation of UDP-GlcNAc using β-hydroxymyristoyl-ACP as donor 
LpxC catalyses the committed step in lipid A synthesis by deacetylation of the product of 
LpxA.  
LpxD  adds a second acyl-chain using β-hydroxymyristoyl-ACP as donor  
LpxH  cleaves the pyrophosphate linkage from the reaction product of LpxD to form lipid X 
  
LpxB  condenses the product of LpxD with lipid X to produce lipid A disaccharide  
LpxK  phosphorylates lipid A disaccharide to form lipid IVA  
WaaA  incorporates two Kdo residues to lipid IVA resulting in the formation of Kdo-lipid IVA 
  
LpxL  adds a laurate acyl chain to Kdo-lipid IVA.  
LpxM  adds a myristoyl group resulting in a hexa-acylated mature lipid A (Kdo-lipid A).  
 
LPS transport 
MsbA  exports core OS-lipid A from the cytoplasmic to periplasmic face of inner membrane 
Wzx  exports O-antigen to the periplasmic face of inner membrane similarly to MsbA 
LptA  periplasmic protein required for LPS transport across the periplasm  
LptB  cytoplasmic protein required for LPS transport across the periplasm 
LptC  also required for LPS transport across the periplasm 
LptD  outer membrane protein required for LPS incorporation in the outer leaflet of outer  
membrane 
LptE  lipoprotein required for LPS assembly in the outer leaflet of outer membrane 
LptF  required for LPS transport across the periplasm 
LptG  required for LPS transport across the periplasm 
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1.6.2  Phospholipids 
Phospholipids make up of about 10% of the dry weight of the cell, and are a major and 
essential component of the bacterial outer membrane (Heath et al., 2002). The 
biosynthesis of a single mole of lipid typically involves 32 moles of adenosine 
triphosphate (ATP) (Heath et al., 2002). Therefore, the cell invests substantial resources 
in the production of phospholipids. Its biosynthesis involves a series of cytosolic and 
membrane-bound enzymes that differ from those found in mammals (Heath and Rock, 
2004; Janßen et al., 2014). For this reason also, these enzymes are an attractive target 
for novel antimicrobial design (Zhang et al., 2006).   
Each phospholipid molecule consists of a glycerol moiety, a phosphate group, and two 
fatty acids (except for cardiolipins) (Fig. 1.5). E. coli possesses only three types of 
phospholipids in its membrane; phosphatidylethanolamine (PE) which comprises the 
bulk (about 75%), phosphatidylglycerol (PG), and cardiolipin (CL) which represents 15 
- 20% and 5 - 10% respectively (Heath et al., 2002).  
The steps involved in the synthesis of phospholipids can be broadly divided into three 
stages (Heath et al., 2002). These are, (i) initiation of fatty acid biosynthesis; (ii) fatty 
acid elongation; and (iii) phospholipid synthesis. 
 
1.6.2.1  Initiation of fatty acid biosynthesis 
The fatty acids most commonly found in E. coli membranes are palmitic acid (C16:0), 
palmitoleic acid (C16:1), and cis-vaccenic acid (C18:1) (Raetz, 1978). However, other 
fatty acid species can be present in significant numbers depending on the E. coli strain 
being studied, and environmental conditions (Raetz, 1978). The fatty acids notation 
presented in parenthesis above describes the carbon-length of the fatty acid, and the  
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Figure 1.5. Structure of phospholipid. A schematic representation of a phospholipid 
molecule (PE in this case) with two acyl chains, a glycerol group and a phosphate 
group. Most times, the phosphate group is attached to a simple organic molecule.  
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presence or absence of a double bond. For instance, C16:1 indicates that the fatty acid 
consists of 16 carbons and also contains a double bond (i.e. unsaturated fatty acid 
(UFA)). 
A schematic representation of fatty acids biosynthesis in E. coli is presented in Fig. 1.6. 
One of the key features of fatty acid biosynthesis is the presence of a small protein 
called “acyl carrier protein” (ACP) produced by the acpP gene (Heath et al., 2002). It is 
one of the most abundant proteins found in E. coli comprising of about 60,000 copies 
per cell (Heath et al., 2002). The intermediate acyl chain involved in fatty acid synthesis 
is attached to ACP via a thioester linkage (Majerus et al., 1965). An overproduction of 
ACP is generally toxic to the bacterial cell due the resulting high copies of apo-ACP 
(i.e. ACP not bound to an acyl group) (Keating et al., 1995). Presumably, high levels of 
apo-ACP results in elevated levels of long-chain acyl-ACPs which inhibits cell growth 
(Keating et al., 1995). However, apo-ACP are usually present at low copies in the cell 
(Ishihama et al., 2008).  
The first committed step in de novo fatty acid biosynthesis is catalysed by acetyl-CoA 
carboxylase (Janßen et al., 2014) (Fig. 1.6). Acetyl-CoA carboxylase consists of four 
subunits which form a highly unstable complex (AccABCD); although this complex can 
be purified as two sub-complexes (Cronan and Waldrop, 2002; Choi-Rhee and Cronan, 
2003). The reaction requires ATP and two molecules of acetyl-CoA to produce 
malonyl-CoA. Malonyl-CoA in E. coli cells are consumed exclusively in the 
biosynthesis of fatty acids (Heath et al., 2002). In addition to the requirement for ATP, 
each protein subunit must be produced in proportionate amounts. Thus, it is 
unsurprising that acetyl-CoA carboxylase is regulated at the level of transcription (Li 
and Cronan, 1993; James and Cronan, 2004). Furthermore, acyl-acyl carrier protein 
(acyl-ACP) inhibits the carboxylase activity apparently to prevent an accumulation of  
28 
 
 
 
 
 
 
Figure 1.6. Schematic representation of phospholipids biosynthesis in E. coli. Fatty 
acids biosynthesis commences with the condensation of two molecules of acetyl-CoA to 
produce malonyl-CoA which is subsequently converted to malonyl-ACP by FabD. 
Malonyl-ACP is then condensed with acetyl-CoA by FabH to initiate fatty acids 
biosynthesis cycle. The role of FabH is solely restricted to fatty acids initiation step. 
The product of FabH is catalysed by FabG, FabZ/FabA, and FabI to complete a cycle. 
The next cycle begins with the condensation of malonyl-ACP with the growing acyl-
chain which is catalysed by FabB/FabF. 
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excess acyl-ACPs that may not be required for fatty acid synthesis (Davis and Cronan, 
2001). 
Malonyl-CoA is converted to malonyl-ACP (3-carbon atom) by malonyl-CoA:ACP 
transacylase (FabD) (Fig. 1.6). FabD is specific for malonyl-CoA and is incapable of 
utilizing acetyl-CoA (Janßen et al., 2014). Deletion of the fabD gene is lethal to the cell 
(Zhang and Cronan, 1998) whereas, overexpression of fabD results in decreased amount 
of palmitoleic acid (C16:1) and elevated levels of cis-vaccenic acid (C18:1) (Magnuson 
et al., 1992). A possible explanation for this observation is that overexpressing fabD 
would enable malonyl-ACP which has a regulatory effect on FabF to accumulate, and 
thus, increase the activity of FabF (Magnuson et al., 1992). This is because the 
elongation of palmitoleic acid to cis-vaccenic acid is performed exclusively by FabF 
(Garwin et al., 1980a).  
The malonyl-ACP produced is condensed with acyl-ACPs for fatty acid elongation by 
the 3-ketoacyl-ACP synthases (Fig. 1.6) (Janßen et al., 2014). There are three 3-
ketoacyl-ACP synthases in E. coli; FabB, FabF, and FabH (KASI, KASII, and KASIII) 
and they are all functionally distinctive (Heath et al., 2002; Janßen et al., 2014). The 
initial condensation of malonyl-ACP requires acetyl-CoA (2-carbon atom) and this 
reaction is performed solely by FabH (Heath and Rock, 1996a) (Fig. 1.6). Further 
condensation reactions are conducted exclusively by FabB and FabF which involves the 
addition of 2-carbon atoms derived from malonyl-ACP to the growing acyl-chain to 
produce a ketoester (Janßen et al., 2014). The catalytic activities of FabH towards 
acetyl-CoA and propionyl-CoA (3-carbon atoms) are similar and hence, reactions with 
the latter substrate results in the formation of fatty acids with an uneven number of 
carbon atoms (Heath and Rock, 1996a).  
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 1.6.2.2  Fatty acids elongation 
The resulting ketoesters produced by 3-ketoacyl-ACP synthases are reduced by an 
NADPH-dependent 3-ketoacyl ACP reductase (FabG) (Toomey and Wakil, 1966). The 
FabG product is further dehydrated by β-hydroxyacyl-ACP dehydratase (FabA and 
FabZ) (Heath and Rock, 1996b). The final step in the elongation cycle is conducted by 
enoyl-ACP reductase (FabI) which catalyses the reduction of reaction products of FabA 
and FabZ to form an acyl-ACP (Heath and Rock, 1995). This acyl-ACP in turn, serves 
as substrate for another condensation reaction with malonyl-ACP (Fig. 1.6). In addition 
to its dehydratase role, FabA possesses an isomerase catalytic activity which is involved 
in the first step of UFAs synthesis (Janßen et al., 2014). 
A detailed description of the fatty acid elongation pathway is presented in Chapter 3. 
 
 1.6.2.3  Phospholipids synthesis 
Usually, when the growing acyl-ACP chain reaches 16 or 18 carbons, they serve as 
substrates for the synthesis of phospholipids (Heath et al., 2002). As an alternative, 
exogenous fatty acids can be utilized in the synthesis of phospholipids following 
esterification to CoA (co-enzyme A) (Janßen et al., 2014). Table 1.2 lists the enzymes 
involved in fatty acids and phospholipids synthesis. 
Phospholipids synthesis using acyl-ACP can occur via two different routes (Janßen et 
al., 2014). Firstly, the long acyl-ACPs can be activated with an inorganic phosphate 
molecule to produce an acyl-phosphate under the influence of the enzyme PlsX. This 
acyl-phosphate is then added to a glycerol-3-molecule by the enzyme PlsY (Janßen et 
al., 2014). Alternatively, and secondly, the acyl-ACP can be condensed directly with 
glycerol-3-phosphate to produce acylglycerol-3-phosphate by the action of PlsB (Fig. 
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1.6) (Janßen et al., 2014). The activity of PlsB is inhibited in the presence of elevated 
(p)ppGpp which occurs under stringent conditions (Heath et al., 1994). Despite the 
presence of two routes leading to phospholipids production (i.e. PlsX/PlsY or PlsB), one 
synthetic route cannot compensate for the complete loss of the other (Yoshimura et al., 
2007). However, overexpression of plsX and plsY does not increase the catalytic activity 
of the reaction step (Larson et al., 1984). Next, an acyl chain is attached to acylglycerol-
3-phosphate resulting in the formation of diacylglycerol-3-phosphate in a reaction 
catalysed by PlsC (Janßen et al., 2014). The product of the PlsC reaction is catalysed by 
the enzyme CdsA to produce cytosine diphosphate diacylglycerol (CDP diacylglycerol) 
(Fig. 1.6) (Janßen et al., 2014). This then acts as substrate for the formation of the 
various forms of phospholipids found in E. coli (i.e. PE, PG, and CL).  
A serine residue can be condensed with CDP diacylglycerol by PssA and subsequently 
decarboxylated by Psd leading to the production of PE. Cells deficient in PE production 
are only viable when the culture medium is supplemented with divalent metal ions and 
are characterized with disruptions in permeases activity, electron transport, and motility 
(Heath et al., 2002). Alternatively, PgsA condenses glycerol phosphate with CDP 
diacylglycerol and the reaction product is dephosphorylated by either PgpA, PgpB, or 
PgpC resulting in the formation of PG (Icho and Raetz, 1983; Funk et al., 1992). A 
triple mutant of pgpA, pgpB, and pgpC is non-viable; however, cells are viable at low 
temperatures with one of each functional gene (Lu et al., 2011). PG is essential for the 
translocation of proteins across the membrane and is also required for channel activity 
of bacterial colicins (Heath et al., 2002). Furthermore, cell division proteins depend on 
PG for their activities (Erez et al., 2010). On the other hand, CL is formed by the 
condensation of two molecules of PG by the action of CL synthases. CL has been found 
to accumulate in cells at the stationary growth phase and it is required for prolonged 
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bacteria survival (Heath et al., 2002). Expectedly, E. coli mutants deficient in the 
production of CL lose viability at the stationary phase (Heath et al., 2002).   
 
1.6.2.4  Fatty acids degradation 
When exogenous fatty acids are present in the growth medium, they can be utilized in 
the synthesis of membrane phospholipids by PlsB and PlsC (Janßen et al., 2014). 
Alternatively, they can act as the sole carbon source for growth (Nunn and Simons, 
1978). The intake of fatty acids containing 10 or more carbons from the environment 
requires a transporter protein known as FadL (Kumar and Black, 1991) while shorter 
chain fatty acids are presumed to diffuse through the membrane (Maloy et al., 1981). 
Fatty acids bound to FadL are transported into the periplasmic space and thereafter 
enters the cytosol in the form of acyl-CoA through the action of FadD (Fig. 1.7) 
(Weimar et al., 2002). The esterification of free fatty acids to CoA is crucial because 
accumulation of free fatty acids in the cytosol are toxic to the cell (Lennen et al., 2011). 
Additionally, FadD is capable of utilizing fatty acids that are cleaved from membrane 
lipids in which the resultant acyl-CoA is consumed via the β-oxidation pathway (Fig. 
1.7) (Janßen et al., 2014). 
In simplistic terms, β-oxidation is a process whereby fatty acids (i.e. acyl CoA) are 
degraded to generate acetyl-CoA (i.e. carbon source). The β-oxidation process occurs 
through repeated cycles involving a gradual reduction of acyl-CoAs in which a single 
unit of acetyl-CoA is produced per cycle (Fig. 1.7). In other words, it is essentially the 
reverse process of fatty acids biosynthesis (Heath et al., 2002). Whilst β-oxidation 
utilizes fatty acids bound to CoA, fatty acids biosynthesis involves acyl-ACPs as 
substrates (Heath et al., 2002). Acyl-CoA is oxidized by FadE to enoyl-CoA and 
subsequently hydrated by FadB to produce a 3-hydroxyacyl-CoA, and further oxidized 
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again by FadB to form a 3-ketoacyl-CoA (Janßen et al., 2014). The final step in the 
cycle is catalysed by FadA in which case, acetyl-CoA is released from acyl-CoA 
(Feigenbaum and Schulz, 1975).  
 
1.6.2.5  Regulation of fatty acids biosynthesis 
Due to the high energy requirement involved in the production of fatty acids, some of 
the biosynthesis enzymes are regulated at the transcriptional or post-translational level 
as discussed below (Janßen et al., 2014). 
Although FadR is a known repressor of enzymes involved in the β-oxidation cycle 
under high levels of intracellular acyl-CoAs (Fujita et al., 2007), its role in fatty acids 
synthesis became apparent when it was discovered that FadR also activates the 
transcription of fabA and fabB genes (Nunn et al., 1983). The activation by FadR is 
intended to increase the rate of UFAs synthesis (Feng and Cronan, 2012) which 
indicates that FabA and FabB are key enzymes in UFAs production (discussed in more 
detail in Chapter 3). However, the homologous overexpression of fadR in E. coli can 
increase both saturated fatty acids (SFAs) and UFAs (Zhang et al., 2012). More 
recently, FadR has been identified as an activator of fabH, fabD, and fabG transcription 
in the absence of long chain fatty acids (My et al., 2013). This implies that in addition 
to its role at boosting UFAs levels, FadR also plays a crucial role at initiating fatty acids 
biosynthesis.  
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Figure 1.7. Fatty acids degradation in E. coli. Long chain exogenous fatty acids are 
transported across the outer membrane into the periplasmic space by FadL, and 
subsequently converted to an acyl-CoA by FadD prior to being translocated to the 
cytoplasm. Further reaction steps by FadE, FadB, and FadA completes a cycle in the β-
oxidation process with the release of acetyl-CoA (Figure obtained and modified from 
Janßen et al. (2014) with permission).    
 
 
 
 
 
35 
 
Table 1.2: Enzymes involved in fatty acids and phospholipids biosynthesis in E. 
coli 
Enzyme   Function       
Fatty acids biosynthesis 
AccABCD the AccABCD complex directs acetyl-CoA towards fatty acids synthesis 
FabD  catalyses the transfer of the malonyl-moiety to ACP  
FabH  it is involved only in the first cycle of fatty acids synthesis and catalyses the formation  
of ketoacyl-ACP by condensation of fatty acetyl-CoA with malonyl-ACP.  
FabB  condenses fatty acyl-ACP with malonyl-ACP to form ketoacyl-ACP 
FabF  condenses fatty acyl-ACP with malonyl-ACP to form ketoacyl-ACP 
FabG  catalyses the reduction of ketoacyl-ACP to hydroxyacyl-ACP 
FabA  possesses dual function. It dehydrates hydroxyacyl-ACP to produce an enoyl-ACP. It  
also isomerizes 10-carbon enoyl-ACP which represents the first step in UFAs synthesis 
FabZ  dehydration of hydroxyacyl-ACP to produce an enoyl-ACP. 
FabI  reduces an enoyl-ACP to complete a cycle in fatty acids biosynthesis  
 
Phospholipids biosynthesis 
PlsX  catalyses the conversion of acyl-ACP to an acyl-phosphate 
PlsY  addition of acyl-phosphate to glycerol-3-phosphate (G3P) to form acylglycerol-3- 
phosphate 
PlsB  direct condensation of acyl-ACP with G3P to produce acylglycerol-3-phosphate 
PlsC  condensation acyl-ACP with acylglyerol-3-phosphate to produce diacylglycerol-3- 
phosphate 
CdsA  catalyses the conversion of diacylglycerol-3-phosphate to CDP-diacylglycerol  
PssA  catalyses the condensation of CDP-diacylglycerol to produce phosphatidylserine 
Psd  decarboxylates phosphatidylserine to form phosphatidylethanolamine (PE)  
PgsA  condenses glycerol-phosphate with CDP-diacylglycerol to form  
phosphatidylglycerolphosphate 
PgpABC PgpA, PgpB and PgpC dephosphorylates phosphatidylglycerophosphate to produce  
phosphatidylglycerol (PG) 
ClsA  condenses to PG molecules to produce cardiolipin (CL) 
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Furthermore, fabA and fabB are under the regulation of FabR which represses gene 
transcription (Feng and Cronan, 2011). Both unsaturated and saturated acyl substrates 
can bind to FabR; however, only FabR bound to saturated acyl substrates promotes gene 
repression (Zhu et al., 2009). Thus, it has been suggested that FabR senses the ratio of 
SFAs and UFAs and accordingly, regulates the expression of fabA and fabB in order to 
balance the SFAs and UFAs moiety (Zhu et al., 2009). 
The catalytic activities of FabH, FabI are further inhibited by long chain intracellular 
acyl-ACPs (Heath and Rock, 1996a; Heath and Rock, 1996c). The inhibitory effect of 
long chain acyl-ACPs on other fatty acids biosynthetic enzymes has not been 
investigated; therefore, there is a possibility that more fatty acid enzymes may be 
regulated at the substrate level as well. Furthermore, long chain acyl-CoA induces a 
strong inhibitory effect on FabI (Bergler et al., 1996). This mode of regulation enables 
the cell to conserve energy required for the synthesis of fatty acids under conditions in 
which cells can obtain membrane precursor molecules from the external environment 
(Janßen et al., 2014). 
 
 1.6.2.6.  Structural modification of membrane phospholipids 
During stationary growth phase, fatty acids that are present in membrane phospholipids 
can be converted to cyclopropane derivatives by the action of CFA synthase (also 
known as CdfA) (Heath et al., 2002). The cyclopropane derivatives are obtained as a 
result of methylenation of UFAs (Taylor and Cronan, 1979). E. coli mutant strains with 
deficient CFA synthase activity are more susceptible to freeze-thaw cycles and acid-
shock (Grogan and Cronan, 1986; Chang and Cronan, 1999). Thus, it has been 
suggested that the cyclopropane derivatives help to protect the reactive double bond 
from adverse reactions during stationary growth phase (Heath et al., 2002). However, 
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such mutants do not exhibit observable phenotypic defects under a wide range of 
conditions (Taylor and Cronan, 1976). 
 
1.7  SCOPE OF RESEARCH  
Despite a large of amount of research being carried out on either LPS or phospholipids 
synthesis, very little information exists regarding the behaviour of the integrated system. 
This would appear valuable as the synthesis of these molecules have to be synchronised 
in order to ensure a proper balance of membrane components are maintained. The 
studies of the bacterial outer membrane so far have mainly focused on individual 
components of enzymic reactions primarily due to the complex architecture of its 
biosynthesis. In order to investigate the ‘combined’ role of these individual components 
during membrane biogenesis, a whole ‘systems’ approach is essential. 
 Furthermore, available research on the E. coli outer membrane has received remarkably 
little quantitative analysis, which is essential for testing the internal consistency of 
models and for investigating pathway regulatory mechanisms. In one modelling study, 
Kenanov et al. (2010) investigated the elementary flux modes (unbranched paths 
through the metabolic chemical reaction network, not including regulatory interactions) 
for the biosynthesis of all E. coli lipids. Since their model does not include regulatory 
interactions, a large and essential gap still exists in the understanding of the biosynthesis 
and regulation of the bacterial membrane. 
This research aims to build a reasonably large and complex model of the E. coli outer 
membrane which will address a sizeable fraction of the E. coli metabolic reactions. 
Such a model could substantiate the proposed mechanism for the outer membrane 
synthesis as well as providing new insights into this complex and important microbial 
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pathway. Further expansion of the model will eventually lead to a whole-cell model. In 
addition, the findings could prove invaluable towards the identification of suitable 
therapeutic agents.  
The specific questions to be addressed and aims of this research are highlighted in detail 
at the commencement of each Chapter. However, the proposed objectives of this study 
can broadly be divided into two; (i) developing a computational kinetic model of the E. 
coli outer membrane, and (ii) testing the model findings experimentally. 
The development of the model would entail the integrative analysis of published 
datasets, and estimating relevant parameters when necessary. The constructed model 
would subsequently be used to interrogate the regulatory machinery involved in outer 
membrane biosynthesis, which thus far, is poorly understood. The predictive power of 
the model would be examined to provide insight into this complex and sophisticated 
network. 
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Chapter  2 
A complete pathway model for lipid A biosynthesis in 
E. coli 
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2.1  OVERVIEW 
E.coli LPS is comprised of three components; lipid A, core OS, and O-antigen. Of 
these, the lipid A moiety is the only essential component and it is highly conserved 
across the Gram-negatives. Because the core OS and O-antigen are dispensable and 
absent in some strains of E. coli (Raetz and Whitfield, 2002), studies investigating lipid 
A biosynthesis can be used as an indirect indicator of LPS synthesis.  
Biochemical studies of the lipid A pathway have proved difficult for a number of 
reasons. Firstly, some of the reactions occur within the cytoplasm whilst subsequent 
steps occur within the membrane (Raetz and Whitfield, 2002). Secondly, a number of 
these enzymes have been difficult to purify (Garrett et al., 1997) presumably due to 
stability problems and finally, the substrates and products of some of these reactions are 
difficult to assay for (Belunis and Raetz, 1992). Therefore, an in silico metabolic model 
of this pathway would prove extremely useful for a complete understanding of both the 
synthesis and regulation of lipid A.      
A number of studies have investigated the biosynthesis and regulatory processes 
involved in the production of lipid A (Raetz and Whitfield, 2002; Reatz et al., 2009). 
However, there remains a number of unresolved issues which require investigation. The 
first reaction step catalysed by LpxA is characterized with a highly unfavourable 
equilibrium constant in vitro (Anderson et al., 1993). Such large unfavourable 
thermodynamics exist for other enzymes such as creatine kinase which solve the 
energetics by either coupling the reaction to an energetically favourable one or by 
interacting directly with subsequent proteins (Shih and Whitesides, 1977). However, 
there is no evidence of either of these mechanisms occurring for LpxA and to date, there 
have been no studies aimed at examining the impact of this unfavourable reaction in 
context of subsequent lipid A metabolism. Furthermore, the pathway is regulated in 
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part, through the proteolytic degradation of an essential enzyme LpxC by the protease 
FtsH (Ogura et al., 1999; Fuhrer et al., 2006). Yet, the regulatory feedback source 
remains unknown. In addition to LpxC regulation, WaaA is also degraded by FtsH and 
the rationale for this regulation is poorly understood (Katz and Ron, 2008). 
This chapter aims to develop a complete computational model for lipid A biosynthesis. 
The model is specific to E. coli because this organism has been the subject of most lipid 
A research. However, the lipid A biosynthesis pathway is well conserved across Gram-
negative bacteria (Raetz and Whitfield, 2002), so the model may be applicable to other 
Gram-negative bacteria. 
 
2.2  MODEL CONSTRUCTION/ARCHITECTURE 
2.2.1  Lipid A biosynthesis pathway 
E. coli lipid A (or Kdo2-lipid A) biosynthesis proceeds through nine enzyme-catalysed 
steps, which are sometimes referred to as the Raetz pathway (Wang and Quinn, 2010; 
Whitfield and Trent, 2014) (Fig. 2.1). All of these enzymes are constitutively expressed 
under optimum conditions (Raetz and Whitfield, 2002).  
Lipid A biosynthesis begins with the UDP-N-acetylglucosamine (UDP-GlcNAc) and β-
hydroxymyristoyl-ACP substrates. Both substrates are consumed in other metabolic 
pathways as well (Yokoyama et al., 2008): UDP-GlcNAc is a substrate in 
peptidoglycan synthesis (Mengin-Lecreulx et al., 1983; Anderson et al., 1987) and β-
hydroxymyristoyl-ACP is a precursor for phospholipid metabolism (Mohan et al., 1994; 
Heath and Rock, 1996b; Gronow and Brade, 2001). 
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Figure 2.1. Model of the E. coli Kdo2-lipid A biosynthesis pathway. The figure 
herein is displayed on the next page. Enzymes and metabolites are displayed with three 
text styles: upright bold indicates that these concentrations are fixed, upright plain 
indicates that these concentrations vary, and italics indicates that these species are not 
included in the model explicitly. Black arrows with barbed heads represent chemical 
reactions in which reactants are converted to products. Red arrows with closed heads 
represent enzymatic influences on chemical reaction rates, and red arrows with T-bar 
heads represent inhibitory influences. Variables represent model parameters. Numbers 
next to black arrows for bi-substrate reactions indicate which substrate is designated 
number 1 and number 2. 
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The initial three steps of the lipid A pathway occur in the cytoplasm. First, LpxA 
acylates UDP-GlcNAc with β-hydroxymyristoyl-ACP. This reaction has an 
unfavourable equilibrium constant of 0.01 in vitro (Anderson et al., 1993), suggesting 
that the reaction products are not committed to proceed on through the lipid A pathway 
but may instead revert back into the pathway as substrates. The product is then 
deacetylated by LpxC in an essentially irreversible reaction, making this the first 
committed pathway step (Anderson et al., 1988; Young et al., 1995; Sorensen et al., 
1996; Barb and Zhou, 2008). For this and other reasons, LpxC is likely to be a primary 
biosynthesis control point (Anderson et al., 1993) and has been of interest as a drug 
target. The third pathway enzyme, LpxD incorporates a second hydroxymyristate 
moiety onto the lipid A precursor (Kelly et al., 1993; Bartling and Raetz, 2008). LpxD 
is similar to LpxA in that they are acyltransferases and consume the same β-
hydroxymyristoyl-ACP substrate (Bartling and Raetz, 2008). Both LpxD reaction 
products inhibit the LpxD reaction, acting as either competitive or non-competitive 
inhibitors against each substrate (Bartling and Raetz, 2008). This was simplified in the 
model by only including non-competitive inhibition by UDP-2,3-bis(β-
hydroxymyristoyl)-D-glucosamine. Ignoring inhibition by ACP had minimal effect on 
the results because its concentration was fixed. 
The fourth and fifth lipid A biosynthesis steps are catalysed by the peripheral membrane 
proteins LpxH (Babinski et al., 2002) and LpxB (Radika and Raetz, 1988). LpxH 
cleaves most of the UDP moiety to leave just a single phosphate on the remaining lipid 
portion, which is called lipid X. Then, LpxB combines lipid X with the preceding lipid 
metabolite, UDP-2,3-bis(β-hydroxymyristoyl)-D-glucosamine, to form lipid A 
disaccharide (Radika and Raetz, 1988). 
45 
 
The remaining four steps of lipid A biosynthesis are catalysed by integral membrane 
enzymes. LpxK is a kinase that phosphorylates lipid A disaccharide to produce lipid 
IVA (Ray and Raetz, 1987; Garrett et al., 1997). Remarkably, Lipid IVA has been 
reported to be an endotoxin agonist in mouse cells and an endotoxin antagonist in 
human cells (Golenbock et al., 1991). Next, WaaA (previously called KdtA), 
sequentially transfers two Kdo sugar residues to lipid IVA to produce Kdo2-lipid IVA 
(Brozek et al., 1989; Clementz and Raetz, 1991; Belunis and Raetz, 1992). WaaA has 
low substrate specificity, with the result that Kdo2-lipid A can act as an inhibitor for this 
reaction (Belunis and Raetz, 1992), or as another possible WaaA substrate (Brozek et 
al., 1989; Belunis and Raetz, 1992); in the latter case, the reaction produces “alternate 
lipid A”, which the model defines as having more than 2 Kdo sugar residues. In 
addition, the WaaA reaction has been discovered to be reversible, based on the finding 
that in vitro combinations of the reaction products (enzyme, cytidine monophosphate 
(CMP), and Kdo2-lipid IVA) led to detectible concentrations of the Kdo-lipid IVA 
intermediate (Belunis and Raetz, 1992). However, the authors only observed trace 
quantities of lipid IVA even after prolonged incubations, thus, the forward reaction is 
likely to be strongly thermodynamically favourable, in which case, the in vivo back-
reaction rate is probably negligible. For this reason, the model treats WaaA catalysis as 
being irreversible. Finally, the “late acyltransferases,” LpxL (Clementz et al., 1996) and 
LpxM (Brozek and Raetz, 1990; Clementz et al., 1997), incorporate lauroyl and 
myristoyl chains to the Kdo2-lipid IVA, thus giving the final Kdo2-lipid A product six 
acyl chains. Cells are still viable without LpxM, or without LpxL and with 
overexpressed LpxM (Vorachek-Warren et al., 2002a). In cold-adapted E. coli, the 
LpxL function is replaced by LpxP, which incorporates a palmitoleate instead of the 
laurate, presumably as a way of adjusting membrane fluidity (Vorachek-Warren et al., 
2002b). 
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After synthesis, Kdo2-lipid A is joined to core OS and then flipped from the inner leaflet 
of the inner membrane to the outer leaflet of the inner membrane by MsbA, an ABC 
transporter (Zhou et al., 1998; Whitfield and Trent, 2014). Next, several enzymes add 
the O-antigen to form LPS, and then transport the LPS to the outer leaflet of the outer 
membrane (Wang and Quinn, 2010). 
 
2.2.2  Lipid A biosynthesis regulation 
Lipid A synthesis is regulated, at least in part, through controlled degradation of LpxC 
(Ogura et al., 1999; Fuhrer et al., 2006; Fuhrer et al., 2007) and WaaA (Katz and Ron, 
2008), both performed by FtsH. FtsH is an integral membrane AAA-type 
metalloprotease that degrades a wide variety of proteins. These include heat shock 
transcription factor RpoH (σ32), phage λ proteins CII and CIII, and many misfolded 
proteins (Narberhaus et al., 2009; Langklotz et al., 2012). FtsH is an essential protein 
due to its role in regulating LpxC (Ogura et al., 1999; Jayasekera et al., 2000). Lipid A 
biosynthesis regulation is less well established than is the synthetic pathway, so these 
aspects of the model are described in great detail. 
The model assumes that FtsH can reversibly convert between an inactive state, an active 
state for degrading LpxC, and a different active state for degrading WaaA (denoted 
FtsH, FtsH*LpxC, and FtsH*WaaA, respectively). This assumption of substrate-specific 
FtsH activation is supported by several findings: (i) FtsH degradation of RpoH and λ 
CII is substrate-specific, accomplished through separate adapter proteins (Ito and 
Akiyama, 2005; Langklotz et al., 2012), (ii) neither increased nor decreased FtsH 
degradation of LpxC have a significant effect on the intracellular concentration of RpoH 
(Ogura et al., 1999) or the activity of WaaA (Sorensen et al., 1996), and (iii) LpxC is 
degraded more slowly at higher temperatures whereas WaaA is degraded more rapidly 
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at higher temperatures (Katz and Ron, 2008; Schakermann et al., 2013). Substrate-
specific activation of FtsH for LpxC may occur through YciM acting as an LpxC 
adapter protein (Mahalakshmi et al., 2014). 
The model also assumes that the regulatory signal that directs FtsH degradation of LpxC 
arises from the concentration of lipid A disaccharide. Again, this is based on several 
findings. Firstly, E. coli strains that have decreased LpxA, LpxC, or LpxD function, 
whether through temperature-sensitive mutants or chemical inhibition, exhibit decreased 
lipid A content and reduced LpxC degradation (Galloway and Raetz, 1990; Anderson et 
al., 1993; Onishi et al., 1996; Sorensen et al., 1996). These suggest that the feedback 
source is downstream of LpxD. Secondly, chemically inhibiting CMP-Kdo production 
(Goldman et al., 1987) blocks the lipid A biosynthesis pathway at the WaaA point. This 
was found to cause lipid IVA accumulation but did not affect LpxC activity (Sorensen et 
al., 1996). This suggests that the feedback source is upstream of lipid IVA. Three 
metabolites fit these two criteria, UDP-2,3-bis(β-hydroxymyristoyl)-D-glucosamine, 
lipid X, and lipid A disaccharide. Of these, UDP-2,3-bis(β-hydroxymyristoyl)-D-
glucosamine was already regulated by product inhibition (Bartling and Raetz, 2008), 
which makes its concentration a poor indicator of pathway flux and hence a poor 
candidate. Preliminary simulations that represented ftsH knock-out mutants, and hence 
did not include FtsH regulation, exhibited lipid A disaccharide accumulation (Fig. 2.2). 
This suggested that the feedback source for FtsH-mediated LpxC degradation is lipid A 
disaccharide. 
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Figure 2.2. Lipid A disaccharide accumulation in an in silico ftsH mutant. Bars 
represent intracellular counts of lipid X and lipid A disaccharide at the end of a single 
cell generation (30 min) from preliminary model results. The model used the scheme 
presented in Fig. 2.1 and parameters listed in Table 2.1, with the exceptions: the FtsH 
count was set to zero, the LpxC and WaaA counts were set to their steady-state levels in 
the absence of FtsH degradation (1540 and 978, respectively and described below), and 
all metabolites were started with zero molecules. Although not displayed here, the lipid 
X count had stabilised at a constant level, while the lipid A disaccharide count was 
increasing at a constant rate of 924 molecules/s. 
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Finally, the model assumes that the regulatory signal for FtsH degradation of WaaA 
arises from Kdo2-lipid A that is inside the inner membrane. The model utilized Kdo2-
lipid A rather than its precursors because the two enzymes downstream of WaaA, which 
are LpxL and LpxM, are non-essential (Vorachek-Warren et al., 2002a), making their 
substrates unlikely activators. Also, Kdo2-lipid A was chosen before it has been 
transported to the outer membrane, rather than afterwards, because bacterial cells are 
known to regulate excess lipid A in their outer membrane by shedding it into the 
environment (Mattsby-Baltzer et al., 1991). 
Other regulatory signals impinge upon the lipid A biosynthesis pathway as well but are 
outside of the scope of this chapter. In particular, modifications to the FabZ and FabI 
enzyme levels, used for phospholipid synthesis, have been reported to affect the 
concentration of LpxC and hence affect the rate of lipid A production (this was 
investigated and reported in Chapter 3 and the findings therein only supplements the 
results presented in this chapter) (Mohan et al., 1994; Ogura et al., 1999; Zeng et al., 
2013). Thus, by assuming that FabZ and FabI are maintained at wild-type conditions, 
and that there are no feedback processes from the lipid A pathway that affect the FabZ 
or FabI regions of the phospholipid pathway, the model can legitimately ignore these 
additional regulatory signals in this chapter. 
 
2.3  MODEL ASSUMPTIONS, EQUATIONS AND PARAMETERS 
The interactions of individual substrates and enzymes for a single E. coli cell were 
modelled at steady state based on Michaelis-Menten and mass action kinetics. It was 
assumed that the volume of a cell is 6.7×10-16 litres (Cayley et al., 1991) (thus 1 
molecule represents 2.5 nM, 1000 molecules represents 2.5 µM, and 106 molecules 
represents 2.5 mM). Unless specified otherwise, the model assumes a 30 minute (1800 
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s) doubling time, which is the experimental value in rich media (Plank and Harvey, 
1979; Mackie, 2013). For the most part, the model did not account for protein synthesis, 
protein degradation, or cell volume growth during a cell generation. These 
approximations are legitimate because metabolic enzyme concentrations for constitutive 
enzymes likely remain constant over the course of the cell cycle. Table 2.1 lists all 
model parameters, along with the relevant data sources. 
 
2.3.1  Substrate concentrations 
Lipid A metabolism was investigated with either excess or limiting concentrations of 
the UDP-GlcNAc, β-hydroxymyristoyl-ACP, and CMP-Kdo substrates. The 
stoichiometric ratios of these substrates to lipid A are 2:1, 4:1, and 2:1, respectively, due 
to consumption of multiple copies and/or lipid dimerization by LpxB. The first two of 
these substrates are also precursors for other biosynthetic pathways (Mengin-Lecreulx et 
al., 1983; Anderson et al., 1987; Heath and Rock, 1996b; Yokoyama et al., 2008), so 
their relative concentrations are controlled by factors outside of the model simulations. 
To this regard, their levels were kept constant at 2 million molecules (5 mM) throughout 
most simulations, which led to substrate saturation conditions. Additionally, the ACP 
level was fixed to 1024 molecules, based on proteomic results (Ishihama et al., 2008). 
 
2.3.2  Enzyme abundance 
The LpxA, LpxD, WaaA, MsbA, and FtsH protein copy numbers used for simulations 
were derived from mass spectrometry proteomic data collected on E. coli cytosolic 
fractions (Ishihama et al., 2008). Several of these are integral membrane proteins, so 
their experimental protein counts are likely to be lower limits for their true counts in a 
cell.  
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Table 2.1: Abundance and kinetic parameters used in the lipid A biosynthesis 
model. 
Species Location 
Abundance 
(molec./cell) 
Km or 
Km1 (mM) 
Km2 
(mM) 
kcat 
(s-1) 
Notes and other 
Parameters 
UDP-GlcNAc 2,000,000a excess concentration 
β-hydroxymyristoyl-ACP 2,000,000a excess concentration 
CMP-Kdo 2,000,000a excess concentration 
ACP 1024b actual concentration 
LpxA  cyto. 664b 0.82f 0.0016m 7.17f  
   0.82 0.0016 717 back reaction 
LpxC cyto. 385 0.00019 g  3.3l 
ktranslate = 0.148 s-1 
kdegrade = 9.62×10-5 s-1 
LpxD cyto. 453b 0.0025h 0.0032h 23h Ki = 0.0094 mMh 
LpxH p.m. 177c 0.0617c  47 Ki = 0.015 mM 
LpxB p.m. 384d 0.287d 0.381d 129  
LpxK i.m. 432 0.04i  2.1  
WaaA i.m. 153b 0.088j 0.052j 16.7 
Ki = 0.0317 mM 
ktranslate = 0.176 s-1 
kdegrade = 1.8×10-4 s-1 
   0.088j 0.052j 1.9 substrate is Kdo2-lipid A 
LpxL i.m. 928e 0.015k  131k  
LpxM i.m. 3720 0.00275  0.6  
MsbA i.m. 206b 0.021  166  
FtsH i.m. 579b     
FtsH*LpxC i.m. - kFtsH = 2.0 mM-1s-1  
kactive = 0.14 mM-1s-1 
kinactive = 0.1 s-1 
FtsH*WaaA i.m. - kFtsH = 6.8 mM-1s-1  
kactive = 32.3 mM-1s-1 
kinactive = 0.1 s-1 
These values are for E. coli cells in rich media. Location abbreviations are: cyto. for 
cytoplasm, p.m. for peripheral membrane, and i.m. for integral membrane (locations are 
not part of the model). Data estimation methods are presented in the main text. Data are 
from: (a) substrate molecules (b) Ishihama et al. (2008), (c) Babinski et al. (2002), (d) 
Metzger and Raetz (2009), (e) Clementz et al. (1996), (f) Wyckoff and Raetz (1999), (g) 
Hernick et al. (2005), (h) Bartling and Raetz (2008), (i) Fig. 5 in Ray and Raetz (1987), 
(j) Belunis and Raetz (1992), (k) Six et al. (2008), (l) Jackman et al. (1999), (m) 
Anderson et al. (1993). Parameters that do not have citations are discussed in the main 
text. 
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The same proteomic data source from Ishihama et al. (2008) was initially used for the 
copy number of LpxM, another integral membrane protein, but then had to be increased 
by 20-fold as described below. The LpxC, LpxH, and LpxB protein counts were 
calculated from protein purification data (Hyland et al., 1997; Babinski et al., 2002; 
Metzger and Raetz, 2009) along with the assumption that an average E. coli cytoplasm 
contains approximately 1.9 million protein molecules (Sundararaj et al., 2004). For 
instance, when lpxC gene from Pseudomonas aeruginosa was cloned via a plasmid 
vector in an E. coli host (Hyland et al., 1997), it was reported to be overexpressed 
between 900 and 1000 fold representing 3.7 mg (14% yield) of 130 mg of total protein 
in membrane-free crude lysate. By assuming that the protein was expressed 950 folds, 
this indicates that LpxC comprise of about 0.02% of cytoplasmic proteins given that 
there are about 1.9 million proteins present in the cytoplasm of E. coli (Sundararaj et al., 
2004). Similarly, the LpxL protein count was calculated from protein purification 
experiments (Clementz et al., 1996) and the estimate that an E. coli membrane contains 
580,000 proteins (Sundararaj et al., 2004). 
The LpxK protein count was estimated using information about MsbA. These proteins 
are co-transcribed (Garrett et al., 1998) implying that their transcripts are synthesized at 
similar rates. Thus, differences in their expression rates depend on the relative stability 
of their transcripts and on the translation rates for individual proteins. The MsbA and 
LpxK transcript half-lives have been reported as 3.2 min and 3.8 min respectively 
(Bernstein et al., 2002) from which their mean lifetimes were calculated as 277 s and 
329 s. Given that the average translation rate is 20 amino acids per second (Alberts et 
al., 2002), and that they comprise 582 (Karow and Georgopoulos, 1993) and 328 amino 
acids respectively (Garrett et al., 1997), it should take about 29 s and 16 s for their 
translations. This means that about 9.6 MsbA proteins and 20 LpxK proteins are 
translated over the lifetimes of their respective mRNAs. Thus, LpxK is likely to be 
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synthesized about 2.1 times faster than MsbA. Both LpxK and MsbA are membrane 
proteins, so it was assumed that they had similar degradation rates (Akiyama, 2009). 
This meant that the synthesis rate ratio also represented the protein concentration ratio. 
MsbA has an abundance of about 206 molecules per E. coli cell (Ishihama et al., 2008), 
from which it was calculated that the LpxK abundance is about 432 molecules. 
 
2.3.3  Enzyme kinetics 
All pathway reactions were modelled using single-substrate or bi-substrate Michaelis-
Menten mechanisms. In most cases, reversibility of reactions were ignored. This can 
lead to misleading results in metabolic models because it ignores feedback effects that 
arise from product inhibition and hence can prevent models from attaining a steady-state 
(Fell, 1971; Fell and Sauro, 1985). However, it was legitimate here because the model 
included regulatory feedbacks that extend over most of the pathway length. These are 
alternative ways to enable models attain steady-state and, in fact, are typically more 
effective than reversible reactions (Cornish-Bowden and Cardenas, 2001). Also, most of 
the lipid A reactions are likely to be nearly irreversible, due to either favourable 
energetics or much more abundant substrates than products (e.g. the phosphorylation 
reaction catalysed by LpxK is effectively irreversible because ATP is abundant in cells 
whereas ADP is not). 
Single-substrate Michaelis-Menten kinetics were employed for the LpxC, LpxK, LpxL, 
LpxM, and MsbA steps. Here, the metabolite flux is 
 
d P[ ]
dt
= -
d S[ ]
dt
=
kcat E[ ] S[ ]
Km + S[ ]
  (1) 
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where [S] is the substrate concentration, [P] is the product concentration, [E] is the total 
enzyme concentration, kcat is the enzyme catalytic rate constant, and Km is the Michaelis 
constant. Most of these kcat and Km values have been published using data from in vitro 
experiments (Table 2.1), although some of them had to be estimated. (i) The specific 
activity of LpxK in crude E. coli membrane extract was estimated to be 22 
nmol/min/mg in a plasmid-containing strain but 7-fold lower in wild type (Garrett et al., 
1998). There are about 432 LpxK molecules per cell and E. coli membranes include 
about 580,000 individual proteins (Sundararaj et al., 2004) so, the LpxK purity in crude 
membrane is about 0.074%. Thus, the pure wild-type specific activity is about 4 
µmol/min/mg, from which kcat is about 2.1 s
-1. Furthermore, the LpxK Km value was 
derived as 40 µM from Fig. 5 in Ray and Raetz (1987). Although Km estimations from 
crude samples are prone to inaccuracies when the substrate can be catalysed by other 
enzymes in the lysates, there is no evidence of such competition for the LpxK substrate. 
(ii) The LpxM catalytic rate constant, kcat, was estimated as 0.6 s
-1 from the specific 
activity of the enzyme in crude lysates (Brozek and Raetz, 1990), much as was 
conducted for LpxK. The LpxM Km value was also estimated from data presented in 
Fig. 6 of Clementz et al. (1997). To do this, it was necessary to simulate Clementz et 
al.’s experiment using COPASI (Mendes et al., 2009), with the same enzyme and 
substrate concentrations that they used (0.1 µg/mL and 25 µM for protein and Kdo2-
lipid IVA respectively in a 20 µL reaction mixture), from which the Km value that 
corresponded to their figure results at a time of 30 minutes was identified. (iii) The 
MsbA catalysed translocation of Kdo2-lipid A across the inner membrane was modelled 
as another Michaelis-Menten process, setting its Km value to 0.021 mM and its kcat value 
to 166 s-1 based on data provided in Fig. 6 of Doerrler and Raetz (2002). 
Single-substrate Michaelis-Menten kinetics with inhibition was employed for the LpxH 
enzyme. In this case, the metabolite flux is 
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d P[ ]
dt
= -
d S[ ]
dt
=
kcat E[ ] S[ ]
Km + S[ ]( ) 1+
P[ ]
Ki
æ
èç
ö
ø÷
 (2) 
where Ki is the inhibition constant and the other parameters are the same as in eq. 1. 
Assays conducted on LpxH purified to 60% homogeneity displayed a specific activity 
of 63.2 µmol/min/mg (Babinski et al., 2002). This implies that the pure enzyme specific 
activity is about 105 µmol/min/mg, which is combined with the LpxH molecular weight 
of 26.8 kDa (Babinski et al., 2002) to yield its kcat as about 47 s
-1. The estimation of the 
Ki value is discussed below. 
Bi-substrate Michaelis-Menten kinetics was used for the forward LpxA, reverse LpxA, 
LpxB, and WaaA catalysis of Kdo2-lipid A steps. Treating the forward and reverse 
LpxA reactions as independent irreversible reactions is legitimate in non-spatial models, 
such as this, because doing so does not introduce any new approximations (although, 
this is not true for spatial models (Andrews and Bray, 2004)). Most bi-substrate 
enzymatic reactions follow either a sequential or ping-pong mechanism (Marangoni, 
2003). In the sequential mechanism, the enzyme forms a ternary complex with both 
substrates before catalysing the reaction. In the ping-pong mechanism, the enzyme 
binds one substrate, forms one product, and then binds the second substrate and forms 
the second product. The only bi-substrate reactions in the lipid A pathway that have 
been investigated in sufficient detail to determine mechanisms are the steps catalysed by 
LpxA (Wyckoff and Raetz, 1999) and LpxD (Bartling and Raetz, 2008), both of which 
were found to follow the sequential mechanism. Lacking further experimental evidence, 
the model assumed sequential mechanisms for the other bi-substrate reactions in the 
lipid A pathway as well. The sequential mechanism metabolite flux is 
 
d P[ ]
dt
= -
d S1[ ]
dt
= -
d S2[ ]
dt
=
kcat E[ ] S1[ ] S2[ ]
Km1 + S1[ ]( ) Km2 + S2[ ]( )
  (3)  
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where [S1] and [S2] are the two substrate concentrations with respective Michaelis-
Menten constants Km1 and Km2. In some cases, these parameters needed to be estimated. 
(i) The LpxA kinetic parameters were determined previously for the forward reaction 
(Anderson et al., 1993; Wyckoff and Raetz, 1999), but not for the reverse reaction. 
Thus, the model assumed the same Km values for the reverse reaction as for the forward 
reaction (the Km of ACP was set to that for β-hydroxymyristoyl-ACP, and Km of UDP-
3-O-[β-hydroxymyristoyl]-NAc to that for UDP-GlcNAc) based upon the likelihood 
that the enzyme binding affinities are not substantially affected by the acyl group 
transfer. However, the reverse reaction kcat value was set to 100 times that of the 
forward reaction to account for the reaction’s unfavourable equilibrium constant of 
approximately 0.01 (Anderson et al., 1993). (ii) The LpxB kcat value was estimated from 
the specific activity of LpxB purified to near homogeneity (Metzger and Raetz, 2009) 
much as was done for LpxH, which resulted in a kcat value of 129 s
-1. (iii) The WaaA 
specificity for Kdo2-lipid A is 8.7 fold lower than for lipid IVA (Belunis and Raetz, 
1992). To account for this, the kcat value for the former reaction was reduced by 8.7 fold 
while keeping other reaction constants the same. 
Finally, the model utilized bi-substrate Michaelis-Menten kinetics with inhibition for 
the LpxD and WaaA steps. Assuming the sequential mechanism again, which was the 
correct mechanism for LpxD, the metabolite flux is 
 
d P[ ]
dt
= -
d S1[ ]
dt
= -
d S2[ ]
dt
=
kcat E[ ] S1[ ] S2[ ]
Km1 + S1[ ]( ) Km2 + S2[ ]( ) 1+
P[ ]
Ki
æ
èç
ö
ø÷
 (4) 
The WaaA kcat value was computed as 16.7 s
-1 from the specific activity of the purified 
protein much as was done for LpxH (Belunis and Raetz, 1992). The WaaA inhibition 
constant was computed from results by Belunis and Raetz (1992) which indicated that 
100 µM of lipid A inhibited the WaaA reaction by 24.1% in vitro. Their experimental 
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conditions involved purified enzyme and substrates, thus excluding the possibility of 
FtsH playing a role in the inhibition. Whilst assuming a non-competitive inhibition (eq. 
4), in which case Km is constant, it was derived that at 100 µM of inhibitor and excess 
CMP-Kdo, a 24.1% reduction in the reaction rate implies that Ki is about 0.315 mM. 
 
2.3.4  LpxC and WaaA synthesis and degradation 
The model included translation and degradation reactions for LpxC and WaaA in order 
to explore the effects of their regulation via FtsH proteolysis. As in the rest of the 
model, the model accounted for degradative protein turnover within cells, but not 
protein loss through sequestration into daughter cells or the translation that is required 
to replace those proteins. 
LpxC and WaaA synthesis were modelled with zero order reaction kinetics in which the 
production rate is constant. This approach combines transcription, translation, and any 
translocation into a single reaction step. The degradation of these proteins were also 
modelled with a first order reaction for degradation that is not catalysed by FtsH, and 
also an independent reaction obeying mass action kinetics for degradation that is 
catalysed by FtsH (Michaelis-Menten kinetics might be more appropriate, but those 
parameters cannot be computed from available data). Together, these processes combine 
to give the net production rate for each of these proteins as 
 
d P[ ]
dt
= ktranslate - kdegrade P[ ]- kFtsH FtsH*[ ] P[ ]   (5) 
where [P] is the concentration of the LpxC or WaaA protein, ktranslate is the production 
rate constant, kdegrade is the rate constant for uncatalysed degradation, and kFtsH is the rate 
constant for FtsH degradation. 
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To determine the production and degradation parameters for LpxC, initial analyses were 
conducted on results presented in Schakermann et al (2013) which indicated that LpxC 
in wild-type E. coli can have a half-life of 120 minutes under nutrient and temperature 
conditions that lead to rapid growth. Thus, it was assumed that the long LpxC half-life 
arose because FtsH was essentially inactive under these conditions. This implies that the 
uncatalysed LpxC degradation has a half-life of about 120 minutes and kdegrade is about 
9.62×10-5 s-1. Separately, it has been reported that cells with inhibited FtsH activity 
using a temperature sensitive mutant, exhibit 4-fold elevated LpxC concentrations 
(Ogura et al., 1999) thus, increasing LpxC counts from about 385 molecules to about 
1540 molecules. Combining this molecule count with the kdegrade value and the 
assumption that [FtsH*LpxC] equals zero in this mutant, enables eq. 5 to be solved for 
steady-state conditions to give a ktranslate value of about 0.148 molecules/s. Next, 
combining the kdegrade, ktranslate, and the wild-type LpxC count of 385 molecules enables 
eq. 5 to solved for steady-state to give that kFtsH[FtsH*LpxC] is 2.89×10
-4 s-1. It is 
impossible to solve for kFtsH by itself from the available information, but the rationale 
for its estimation are presented below. 
The WaaA synthesis and degradation parameters were computed similarly. First, a 
mutant without FtsH maintained about 72% of its WaaA concentration after 30 minutes 
(Katz and Ron, 2008), from which it was derived that kdegrade is about 1.8×10
-4 s-1. Next, 
the half-life of WaaA in wild-type cells under optimal growth conditions is about 10 
minutes (Katz and Ron, 2008). This gives the combined degradation rate constant, 
kdegrade + kFtsH[FtsH*WaaA], as approximately 1.15×10
-3 s-1, implying that the catalysed 
degradation rate constant is about 9.8×10-4 s-1. Combining the total degradation rate 
with the wild-type WaaA abundance of 153 molecules per cell gives the protein 
translation rate, ktranslate, as 0.176 molecules/s. 
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2.3.5  FtsH activation and inactivation 
The model treats FtsH activation in a substrate-specific manner, but with the constraint 
that the total FtsH count per cell is conserved at 579 molecules (Ishihama et al., 2008). 
Furthermore, the model did not account for FtsH sequestration through activation for 
other degradation targets, such as RpoH or misfolded proteins. FtsH activation and 
inactivation were modelled with mass action kinetics, meaning that net FtsH activation 
towards a specific substrate was modelled according to 
 
d FtsH*[ ]
dt
= kactive activator[ ] FtsH[ ]- kinactive FtsH*[ ]  (6) 
where [FtsH*] represents the concentration of a substrate-specific active form of FtsH, 
[activator] represents the concentration of the substrate-specific activator (lipid A 
disaccharide for the LpxC substrate and Kdo2-lipid A for the WaaA substrate), and 
[FtsH] represents the concentration of inactive FtsH. The first term on the right hand 
side represents the activation rate and the second represents the inactivation rate. 
The FtsH proteolysis rate, for either LpxC or WaaA, depends on three parameters, 
kactive, kinactive, and kFtsH. However, the available experimental data only enabled the 
quantification of the product kFtsH[FtsH*], for each substrate, with values given above. 
Thus, the system is underdetermined, with multiple possible combinations of 
parameters that are each equally good at agreeing with the available data. This was 
addressed by making a few assumptions. First, it was assumed that during growth on 
rich media, 10% of the total FtsH is activated for degradation of LpxC, 10% is activated 
for degradation of WaaA, and 80% is inactive (i.e. there are 58 copies of FtsH*LpxC, 58 
copies of FtsH*WaaA, and 463 copies of inactive FtsH). This is intuitively sensible 
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because it assumes a reasonably large reservoir of inactive FtsH to allow for strong 
regulatory control and other proteolysis tasks. Combining this assumption with the prior 
values for the kFtsH[FtsH*] products yield kFtsH of 2.0 mM
-1s-1 for LpxC and kFtsH of 6.8 
mM-1s-1 for WaaA. Secondly, it was assumed that both kinactive values equal 0.1 s
-1. This 
gives the active states a 10 s lifetime, which is fast enough to enable rapid control. Next, 
the kactive was derived from the steady-state version of eq. 6, while substituting in this 
inactivation rate constant, the assumed FtsH* and FtsH concentrations, and the steady-
state activator concentrations that arose from simulations in which the LpxC and WaaA 
enzyme counts were fixed to the values listed in Table 2.1 (activator counts were 35,600 
and 155 molecules, respectively). The results are that kactive is 0.14 mM
-1s-1 for LpxC 
and 32.3 mM-1s-1 for WaaA. It should be noted that the assumptions made here do not 
affect the model’s steady-state condition at all. In other words, the estimates are 
necessary for running simulations but do not affect the results that are presented below. 
 
2.4  METHODS 
2.4.1  Simulations 
Simulations were performed with non-spatial deterministic methods using the COPASI 
software (Mendes et al., 2009). This level of detail was determined to be adequate 
because preliminary simulations using spatial stochastic simulations (with Smoldyn 
(Andrews et al., 2010) and non-spatial stochastic simulations (with StochKit (Sanft et 
al., 2011) yielded essentially identical results. It was assumed that the volume of a cell 
is 6.7×10-16 litres (Cayley et al., 1991) and a cell generation time equal 30 min. 
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2.4.2  Experimental procedures 
2.4.2.1  Bacterial strain and growth conditions 
An E. coli K-12 strain AG1 (recA1, endA1, gyrA96, thi-1, hsdR17(rK
- mK
+), supE44, 
relA1) containing a plasmid (pCA24N) (Kitagawa et al., 2005) bearing E. coli LpxK-
GFP gene fusion (to the C-terminus) was obtained from the National BioResource 
Project (NIG) Japan. Cells were grown at 30°C in Luria-Bertani (LB) (10 g tryptone, 5 
g yeast extract, 5 g NaCl per litre) containing 20 µg/ml of chloramphenicol and when 
required, protein expression was induced using varying concentrations of IPTG (Sigma, 
UK).  
 
2.4.2.2  Preparation of cell extracts 
Cell extracts were prepared as described previously (Sorensen et al., 1996; Zeng et al., 
2013). Briefly, an overnight culture was inoculated into fresh LB containing different 
concentrations of IPTG at an OD600 of 0.05 and grown to mid-log phase (OD600 = 0.5). 
The respective cultures were normalized to the same OD600 of 0.5. 3 ml of normalized 
culture was centrifuged using a benchtop centrifuge at maximum speed (13,000 rpm) 
for 1 min, and the cell pellets re-suspended in 100 µl of 2x Laemmli sample buffer 
(Sigma, UK). The samples were heated at 99°C for 10 min prior to centrifugation for 5 
min. The supernatants were collected for Western blot analysis.  
 
2.4.2.3  Western blot 
20 µl of each sample were loaded onto a 10% SDS-polyacrylamide gel. Following 
electrophoresis, proteins were transferred to a PVDF membrane using the Bio-Rad 
Trans-Blot Turbo system. An LpxC antiserum generated in rabbit (a generous gift from 
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Prof. Franz Narberhaus) and a secondary anti-rabbit peroxidase-linked antibody (Sigma, 
UK) were used for immunodetection at dilutions of 1:20000 and 1:10000 respectively. 
Blots were developed using the ECL chemiluminiscent reagents (Bio-Rad) and the 
signals detected using the ChemiDoc MP system (Bio-Rad). 
 
2.5  MODEL RESULTS 
2.5.1  Model adjustment 
The initial model, defined using literature parameter values where available, exhibited a 
lipid A production rate that was too low. Also, several internal metabolite 
concentrations accumulated to very high levels. These problems were addressed with 
two model adjustments. 
 
2.5.1.1  LpxM enzyme count 
Initial model simulations only produced about 20% of the 1 million lipid A molecules 
that E. coli cells actually produce per generation. This did not change even if the FtsH 
degradation of LpxC and WaaA and all negative feedbacks were removed. This slow 
production rate arose from LpxM acting as a bottleneck in the pathway as seen by its 
substrate increasing linearly over time, rather than stabilizing at a steady-state level. 
This may indicate that cells have more than the 186 LpxM proteins that proteomic 
research on the cell cytoplasm indicated (Ishihama et al., 2008), which would not be 
surprising because LpxM is an integral membrane protein. Alternatively, it may be that 
other enzymes acylate LpxM’s substrate in parallel to LpxM; in particular, LpxL and 
LpxP can catalyse essentially the same lipid A synthesis reaction (Clementz et al., 1997; 
Vorachek-Warren et al., 2002b). Whilst assuming the former explanation, the LpxM 
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molecule count in the model was increased by 20 fold, from 186 to 3720. This removed 
substrate accumulation upstream of LpxM and caused the model to produce lipid A at 
about 1 million molecules per generation. 
 
2.5.1.2  LpxH product inhibition 
Initial simulations also resulted in high lipid X concentrations which rose over the 
course of several cell generations and stabilized at about 400,000 copies. In contrast, 
2000 copies were observed in vivo (Takayama et al., 1983). From observations, this 
accumulation arose because LpxH rapidly diverted UDP-2,3-bis(β-hydroxymyristoyl)-
D-glucosamine towards lipid X, while LpxB only consumed lipid X in a 1:1 ratio with 
UDP-2,3-bis(β-hydroxymyristoyl)-D-glucosamine. For this reason, it was assumed that 
LpxH is regulated through product inhibition, as described above. The experimental 
lipid X count was reproduced when the Ki value was set to 0.2 µM; however, this value 
is unusually small and it created a bottleneck in the pathway resulting in an 
accumulation of the LpxC product and decreased lipid A production (negative feedback 
at LpxD prevents accumulation of its product, backing the accumulation up to the LpxC 
product instead). Thus, it was imperative to decrease the LpxH inhibition by increasing 
Ki.  
As mentioned above, mutants with inactive FtsH exhibit 4-fold increased LpxC 
concentrations (Ogura et al., 1999); they were also reported to produce 32% more lipid 
A (Table 1 of Ogura et al. (1999), comparing their AR3317 at 30°C vs. 42°C, or their 
AR3289 vs. AR3291). The LpxH inhibition constant was set so that the model would 
reproduce this result, which turned out to be a Ki value of 0.015 mM. This value was 
large enough that it did not cause the LpxC product to accumulate in wild-type cells. 
However, the LpxC product still accumulated in cells without FtsH due to the higher 
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metabolite flux through the LpxC step and the lack of product inhibition at this step. 
This Ki value caused the steady-state lipid X concentration to be about 22,000 
molecules in either wild-type or FtsH mutant cells, which is much larger than the 2000 
that were observed experimentally (Takayama et al., 1983). Further investigation 
indicated that this difference cannot be eliminated simply by adjusting enzyme kinetic 
parameters without creating large metabolite accumulations, which suggests that this 
region of the biosynthesis pathway includes dynamics that are not in the model. For 
example, the difference could arise from metabolic channelling between the LpxH and 
LpxB enzymes. 
 
2.5.2  Comparison of model with experiment 
2.5.2.1  Mutant with defective LpxA 
Anderson et al. (1993) reported that cells with defective LpxA, which have at least 150-
fold lower LpxA specific activities, have 5- to 10-fold increased LpxC concentrations 
and an LPS content that is reduced by approximately 30% (their strain SM101 at 30°C). 
This perturbation was simulated with the model by decreasing the LpxA kcat value by 
150 fold to 0.048 s-1. The simulation resulted in a 3.9 fold increase in LpxC levels, in 
reasonably close agreement with experiment. This is essentially the maximum LpxC 
increase that the model can produce under any condition, arising from model 
assumption that cells with completely inactive FtsH exhibit 4-fold higher LpxC 
concentrations (Ogura et al., 1999). However, the model only produced 24,000 lipid A 
molecules per generation rather than the 1.1 million molecules that it produces with the 
standard parameters (Table 2.1), which is a reduction of 98%. These results were 
unaffected irrespective of a decrement in the LpxA reverse reaction kcat value or not, or 
even if the reverse reaction was removed altogether. This limitation is clarified by 
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noting that the reaction velocity of the LpxA step is simply kcat[LpxA] in these 
conditions from eq. 1, which works out to 57,000 product molecules per generation; 
these need to dimerize to form lipid A, meaning that the LpxA step limits lipid A 
production to only 29,000 molecules per generation, in close agreement with the model 
result. Thus, Anderson et al.’s observation that LpxA in the SM101 strain exhibits a 
150-fold reduced kcat value but reduces the lipid A production rate by only 30%, is not 
compatible with the model. This is because their results cannot arise from the assumed 
LpxA protein count or kcat parameters. The disagreement implies that these parameters 
are incorrect by more than an order of magnitude which seems unlikely, or potentially, 
there is an alternate biosynthetic pathway; for example, perhaps LpxD can catalyse what 
is normally the LpxA step since they both utilize β-hydroxymyristoyl-ACP as substrate. 
 
2.5.2.2  Inhibition of LpxC 
CHIR-090 is a powerful antibiotic that controls E. coli and P. aeruginosa growth with 
efficacy that is similar to the clinically-relevant drug ciprofloxacin (Barb and Zhou, 
2008). Its minimum inhibitory concentration (MIC) on E. coli, meaning the lowest drug 
concentration required to inhibit visible growth, is between 0.20 and 0.25 µg/ml (Barb 
et al., 2007; Zeng et al., 2013). Barb et al. reported that CHIR-090 acts by inhibiting 
LpxC through the two-step mechanism (Barb et al., 2007) 
    (7) 
where LpxC-I represents a complex between LpxC and the CHIR-090 inhibitor, and I* 
represents an enzyme/inhibitor isomer. They reported the reaction parameters as k4/k3 = 
4 nM, k5 = 1.9 min
-1, and k6 = 0.18 min
-1 (Barb et al., 2007). They did not report 
separate parameters for k3 and k4, but their results only becomes logical if this 
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complexation reaction comes to equilibrium reasonably quickly. Thus, it was assumed 
here that k4 = 0.1 s
-1, from which k3 was computed as 25000 mM
-1s-1. This mechanism 
was added to the model to see if it would exhibit the same inhibitory effect. Firstly, it 
was observed that fixing the free inhibitor concentration to a constant value does not 
affect the steady-state biosynthesis pathway at all. This seems reasonable because the 
LpxC count is not fixed in the model, but arises from the LpxC translation and 
degradation rates, which the inhibitor does not affect (the reversibility of inhibitor 
binding implies that, at steady-state, LpxC is sequestered into and released from 
complexes at the same rate). On the other hand, the inhibitor induces a very strong 
transient effect. Fig. 2.3A represents the amount of lipid A produced by the model over 
the course of 30 minutes, in which all metabolite concentrations started at steady-state 
and then CHIR-090 was added at time 0. The CHIR-090 MIC was assumed to 
correspond to the inhibitor concentration that reduces lipid A production by 50%, based 
on results that reported that this is when cells become non-viable (Onishi et al., 1996). 
From the data presented in Fig. 2.3A, model cells became non-viable when the free 
intracellular CHIR-090 concentration exceeds 0.31 molecules/cell, which is 0.76 nM. 
Clearly, molecule counts are discrete, implying that these are time-averaged quantities. 
This MIC corresponds closely with the in vitro inhibition constant of CHIR-090 (Ki*) 
which is 0.5 nM (Barb et al., 2007). Taking the in vivo MIC as 0.25 µg/ml, and using 
the CHIR-090 molecular weight of 437.4 g/mol, indicates that the MIC is 570 nM of 
extracellular CHIR-090. Combining this with the intracellular MIC suggests that the 
intracellular CHIR-090 concentration is about 1000 fold lower than the extracellular 
concentration. 
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Figure 2.3. Comparison of model with experiment. The figure herein is displayed on 
the next page. (A) Effect of CHIR-090 antibiotic on lipid A production. The model (Fig. 
2.1 plus eq. 7) was started with all metabolites at their steady-state concentrations 
without CHIR-090. Then, antibiotic was added and the total amount of lipid A produced 
over the following 30 minutes was quantified, indicated with the solid black line. The 
free antibiotic concentration, quantified as the average number of uncomplexed CHIR-
090 molecules/cell was kept constant. The black dashed line represents model estimate 
of the MIC for the intracellular antibiotic concentration and the red dashed line 
represents the antibiotic inhibition constant (Barb et al., 2007) (B) Correlation between 
LpxC half-life and cell generation time. The experimental data (red circles) are from 
Schakermann et al. (2013), who varied generation times using different growth 
conditions and then quantified LpxC half-lives. The model data (black diamonds) were 
collected by varying the LpxC half-lives (and LpxC kcat) and then quantifying the 
generation times, defined here as the time required to produce 1 million lipid A 
molecules. Lines are least-difference best-fits to the data using the function y = c1/x + c2, 
primarily to guide the eye. (C) Effect of overexpressing LpxC on the LpxC half-life 
(black curve, left axis) and on the lipid A production rate, measured relative to the wild-
type production rate (blue curve, right axis). The dashed line represents the wild-type 
condition using the LpxC translation rate from Table 2.1.  
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2.5.2.3  Correlation between LpxC half-life and cell generation time 
Schakermann et al. (2013) reported that faster growing cells, such as those grown in 
rich media and/or at higher temperatures, stabilize LpxC more rapidly than slow-
growing cells. These experiments were simulated as a way of validating the model. 
Schakermann et al.’s results for rich medium were only considered because all of the 
model parameters were estimated from experiments performed with rich medium. For 
each LpxC half-life value from Table 2 of Schakermann et al. (2013), eq. 5 was used to 
compute the concentration of FtsH*LpxC that would produce it (here, ktranslate was 0, and 
kdegrade and kFtsH were the values from Table 2.1). Next, the standard model was changed  
in two ways: the LpxC kcat value was adjusted to account for the given growth 
temperature according to data presented in Fig. 2 of Jackman et al. (2000), and the rate 
of FtsH activation for LpxC degradation, kactive, was adjusted until the model exhibited 
the desired FtsH*LpxC concentration. The rationale for the latter change is that cells 
might regulate LpxC half-lives by altering the FtsH activation rate. Finally, the cell 
generation time was computed from the steady-state lipid A production rate in this 
adjusted model, under the assumption that a generation time is determined by how long 
a cell requires to produce 1 million lipid A molecules. Fig. 2.3B indicate that the model 
results agree reasonably well with the experimental results, which supports the model. It 
is suspected that the model underestimates cell generation times with long LpxC half-
lives because it does not account for other cell processes which may limit cell division 
rates at these fast growth rates. 
 
2.5.2.4  Overexpression of lpxC 
Fuhrer and co-workers cloned the lpxC gene into an inducible expression vector and 
then induced with 0.01% or 0.1% arabinose, which overexpressed the LpxC enzyme 
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(Fuhrer et al., 2006; Fuhrer et al., 2007). They did not quantify the extent of 
overexpression, but comparable cells increased protein expression by 100 to 200 fold 
with 0.01% arabinose induction (Guzman et al., 1995). Fuhrer et al. found that LpxC 
overexpression increased LPS amounts by about 1.27 fold and 1.7 fold in cells induced 
with 0.01% and 0.1% arabinose respectively (this was estimated from Fig. 4 of Fuhrer 
et al. (2007)). They also found that overexpressing LpxC with 0.01% arabinose resulted 
in a protein half-life of about 11 minutes (Fuhrer et al., 2006). 
This arabinose induction was simulated by increasing the model’s LpxC translation rate 
constant and observing its effect on the lipid A production rate and LpxC half-life (Fig. 
2.3C). As in the experiment, overexpressing LpxC led to increased lipid A production 
and shorter LpxC half-lives. However, these effects stopped changing once LpxC was 
overexpressed about 4-fold, in contrast to the 100 to 200 fold overexpression that the 
experiments may have produced. At higher than 4-fold overexpression, the LpxC 
product accumulated in the model because LpxD became a bottleneck; this prevented 
further changes to the LpxC lifetime and lipid A production rate. Nevertheless, if one 
assumes a more modest experimental overexpression, then the model results agree well 
with the 0.01% arabinose induction experiment. In particular, at 2.8 fold 
overexpression, the model observed a 1.27 fold increase of lipid A production and a 14 
minute LpxC half-life, which is reasonably close to the 11 minutes that Fuhrer et al. 
observed (Fuhrer et al., 2006). The 0.1% arabinose induction experiment is harder to 
match because this resulted in 1.7 fold more LPS, whereas LpxC overexpression could 
not produce more than 1.36 fold more lipid A in the model due to LpxD acting as a 
bottleneck. A possible explanation for this difference is that Fuhrer et al. found that 
LpxC overexpression led to longer cell generation times (Fuhrer et al., 2006) in addition 
to the effects mentioned above. Thus, it may be that cells produce lipid A only 36% 
faster than normal, but they take twice as long to divide, leading to 1.7 fold more LPS in 
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cells. Together, these results indicate that the model agrees qualitatively with Fuhrer et 
al.’s LpxC overexpression experiments, and it could agree quantitatively as well; but 
this cannot be assessed currently with the available experimental data. 
 
2.5.2.5  Substrate limitation 
It is well known that organisms grow more slowly when nutrients are limited. For 
example, Taniguchi et al. (2010) observed that E. coli grown on minimal medium had a 
150 minute generation time. Replicating this in the model was straightforward. As 
above, it was assumed that a cell generation is the time that the model takes to produce 
1 million lipid A molecules. The model reproduces the 150 minute generation time 
when any one substrate limits the lipid A production rate with 16,000 UDP-GlcNAc 
molecules, or 43 β-hydroxymyristoyl-ACP molecules, or 510 CMP-Kdo molecules. It 
also reproduces the 150 minute generation time when all three substrates are partially 
limiting with 80,000 UDP-GlcNAc, 210 β-hydroxymyristoyl-ACP, and 2400 CMP-Kdo 
molecules (about 5 times the prior numbers). Thus, substrate limitation does increase 
generation times in the model as expected. 
However, these results disagree with those of Schakermann et al. (2013) in that the low 
substrate concentrations in the model led to decreased lipid A disaccharide counts which 
caused slower LpxC degradation whereas, Schakermann et al. reported that substrate 
limitation leads to a more rapid LpxC degradation. They found that growth in minimal 
medium leads to an LpxC half-life of about 10 minutes. This appears to occur because 
substrate limiting conditions lead to increased (p)ppGpp alarmone concentrations, 
which increase FtsH expression (Slominska et al., 1980). The model could agree with 
these data as well, but only if the total FtsH count was increased roughly 25-fold to 
about 14,000 molecules (the model also used 250,000 UDP-GlcNAc, 650 β-
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hydroxymyristoyl-ACP, and 7600 CMP-Kdo molecules, which are about 15 times 
higher than the single-substrate limitation values presented above). This modified model 
exhibited a 10 minute LpxC half-life and a 160 minute generation time, in close 
agreement with results presented in Schakermann et al. The cost of achieving this 
agreement was that the high FtsH concentration led to fast WaaA degradation which 
made WaaA catalysis of CMP-Kdo the rate-limiting step as observed by the fact that 
lipid IVA accumulated rapidly. The large FtsH expression increase and the lipid IVA 
accumulation suggest that this model is incorrect for substrate limiting conditions. In 
particular, achieving the combination of rapid LpxC degradation and relatively low lipid 
A disaccharide concentrations, without increasing the FtsH concentration 25-fold, 
requires additional LpxC degradation regulation. 
 
2.5.2.6  Overexpression of lpxK stabilizes LpxC 
As mentioned above, a preliminary model that did not include FtsH feedback regulation 
exhibited lipid A disaccharide accumulation (Fig. 2.2), which led to the proposition that 
this metabolite is the feedback source for LpxC degradation. If this is the case, then it 
follows that lpxK overexpression should reduce lipid A disaccharide concentration, 
which would down-regulate LpxC degradation and lead to higher LpxC levels. This 
hypothesis was tested experimentally. Fig. 2.4A indicates that this is indeed the case. 
LpxC levels increased substantially with lpxK overexpression, even under modest IPTG 
induction. This same perturbation was tested in the model, finding exactly the same 
results (Fig. 2.4B). These results are consistent with the assignment of lipid A 
disaccharide as the feedback source. In contrast, the opposite correlation between LpxC 
levels and lpxK overexpression would be expected if the feedback source were 
downstream of LpxK, so the experiments provide strong evidence against that  
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Figure 2.4. Overexpression of lpxK increases LpxC concentration. (A) Lower row 
represents LpxK bands on an SDS-PAGE gel, arising from overexpression induced with 
the amount of IPTG shown at the top of each column. The upper row represents the 
resultant LpxC bands on a Western blot for the same induction levels. (B) Model 
prediction of LpxC overexpression arising from lpxK overexpression. The model was 
that which was presented in Fig. 2.1 but with different LpxK enzyme counts at steady-
state. 
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possibility. Similarly, only a very weak correlation would be expected if the feedback 
source were further upstream of LpxK, meaning at or before the lipid X metabolite, due 
to the near irreversibility of the LpxB enzyme, so the experiments provide strong 
evidence against those possibilities as well. Thus, the experiments presented here 
strongly indicate that lipid A disaccharide is the feedback source for activating FtsH for 
LpxC degradation. 
 
2.5.3  Model predictions 
2.5.3.1  Lipid A synthesis sensitivity on enzyme concentration 
The sensitivity of lipid A synthesis on enzyme counts were investigated in several ways. 
First, the effect of small enzyme concentration variations were analyzed. Using the 
methods of metabolic control analysis (Fell and Sauro, 1985; Fell, 1992), flux control 
coefficient is defined as 
 
 Ci =
¶ln J
¶lnEi
×100%  (8) 
where i represents one of the 10 pathway enzymes, J represents the biosynthesis rate of 
lipid A at the outer membrane, and Ei represents the count of enzyme i. The flux control 
coefficients were quantified by starting the model at steady-state, varying an enzyme 
count by 5%, and observing the effect on the lipid A production rate. 
When the three pathway substrates were set to saturating concentrations and used the 
“open-loop”, in which case, negative feedback through FtsH was removed but the wild-
type enzyme counts were kept to values from Table 2.1, the pathway flux was solely 
controlled by LpxC (Fig. 2.5A black bars). This is consistent with the view that LpxC is 
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the rate-limiting step of lipid A synthesis (Fuhrer et al., 2006; Mahalakshmi et al., 
2014). However, the “closed-loop” case, in which the feedbacks through FtsH were 
replaced and thus returned to a better model for the wild-type pathway, the model 
exhibited no sensitivity to LpxC concentration perturbations (Fig. 2.5A red bars). 
Instead, the feedback caused the LpxC enzyme count to return to its steady-state level, 
which meant that the perturbation did not affect the lipid A production rate. LpxK was 
the sole enzyme that controlled pathway flux in the closed-loop case. 
Yet different enzymes controlled pathway flux when substrate concentrations were 
reduced. For each substrate, the concentration was set to the value that led to about 0.5 
million lipid A molecules produced per generation and then computed flux control 
coefficients for each enzyme. Limiting UDP-GlcNAc shifted control to LpxA (Fig. 
2.5B). This contrasts the view that LpxA does not affect pathway flux simply because it 
is reversible and has an unfavourable equilibrium constant (Anderson et al., 1993). 
Limiting β-hydroxymyristoyl-ACP shifted control to LpxD, LpxH, and LpxB (60%, 
20%, and 20%, respectively) (Fig. 2.5C). Finally, limiting CMP-Kdo shifted control to 
WaaA in the open-loop case (Fig. 2.5D black bars), and to MsbA in the closed-loop 
case (Fig. 2.5D red bars). These results suggest that control of pathway flux is typically 
localized to relatively few enzymes, but those which depend on the substrate 
concentrations. 
Next, lipid A biosynthesis on enzyme counts for the case of large perturbations, 
assuming saturating substrate concentrations were examined. For each enzyme, the 
fraction of the wild-type count (Table 2.1) that would lead to 0.5 million lipid A 
molecules produced in 30 minutes was determined. In the open-loop case, the  
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Figure 2.5. Sensitivity of lipid A production rate on enzyme abundance. (A) Black 
bars represents enzyme control coefficients for the open-loop case, in which wild-type 
enzyme counts were assumed but FtsH regulation was disabled. Red bars represents 
enzyme control coefficients for the closed-loop case, in which FtsH regulation was 
enabled. (B) The UDP-GlcNAc count was set to 50,000 molecules which represented 
substrate limiting conditions that led to approximately 0.5 million lipid A molecules 
produced per generation. As in ‘A’ above, black and red bars represent enzyme control 
coefficient for the open-loop and close-loop case respectively. (C) Enzyme control 
coefficient when β-hydroxymyristoyl-ACP count were limited at 200 molecules. 
Denotation for black and red bars are same as in ‘A’. (D) Enzyme control coefficient 
when the CMP-Kdo count were limited at 5000 molecules. Black and red bars are same 
as in ‘A’. (E) Enzyme abundance reductions that led the model to produce 0.5 million 
lipid A molecules per cell generation for the open-loop (black bars) and closed-loop 
(red bars) cases.  
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production rate was most sensitive to the LpxC and LpxK enzyme counts (Fig. 2.5E 
black bars). In the closed-loop case, as before, LpxC perturbations were ineffectual 
because its concentration was regulated through feedback. As a result, the pathway was 
most sensitive to LpxK (Fig. 2.5E red bars). 
 
2.5.3.2  WaaA Regulation 
Katz and Ron’s finding that the concentration of WaaA is regulated through degradation 
by FtsH (Katz and Ron, 2008) leads to the obvious question of why it is regulated in 
addition to LpxC. From sensitivity analysis presented below, one answer may be that 
WaaA regulation is used to control pathway flux when the CMP-Kdo concentration is 
limiting (Fig. 2.6A). In this situation, the lipid A synthesis rate is insensitive to small 
changes in the LpxC concentration, making that less useful for regulation, but is 
controlled by the WaaA concentration instead. Also, reducing lipid A production when 
CMP-Kdo is limiting would conserve Kdo for other uses. For example, Kdo can be 
catalysed by Kdo aldolase to produce D-arabinose and pyruvate (Ghalambor and Heath, 
1966). Although it has been suggested that CMP-Kdo synthesis is the rate-limiting step 
to lipid A synthesis (Ray et al., 1981), the strong effects of LpxC and the other upstream 
enzymes discussed above, indicate that this is not the normal case. Additionally, the 
model observed that CMP-Kdo limitation leads to rapid lipid IVA accumulation with no 
apparent correction mechanism. Together, these results point to the likelihood that 
WaaA regulation helps control the lipid A production rate when the CMP-Kdo 
concentration is low, but probably not so low as to be rate-limiting. 
A second possible explanation for WaaA’s regulation is that it might decrease reactions 
with undesirable substrates (Katz and Ron, 2008) due to the fact that WaaA has a low 
substrate specificity. As mentioned previously above, WaaA can glycosylate a wide  
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Figure 2.6. WaaA regulation. (A) The flux control coefficient of WaaA as a function 
of the CMP-Kdo substrate concentration. This is for the open-loop case, in which wild-
type enzyme counts were assumed but FtsH regulation was disabled. (B) The ratio of 
alternate lipid A to normal lipid A (Kdo2-lipid A) as a function of the number of WaaA 
proteins. All parameters are the same as in Table 2.1, except that the WaaA proteolysis 
rate constant was changed in order to alter the WaaA degradation rate and hence the 
WaaA steady-state copy number. The maximum enzyme count displayed arose from no 
FtsH mediated proteolysis. The dashed line indicates the wild-type count, from Table 
2.1.  
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range of lipid acceptors, including Kdo2-lipid A in particular (Brozek et al., 1989; 
Belunis and Raetz, 1992), which was included in the model architecture as production 
of alternate lipid A. Simulations were run with different rate constants for WaaA 
degradation by FtsH. It was observed that slower WaaA degradation led to higher 
steady-state enzyme counts, which then led to higher relative amounts of alternate lipid 
A (Fig. 2.6B). Thus, the model agrees with suggestions that WaaA regulation might 
help regulate the lipid A molecule composition (Katz and Ron, 2008). This mechanism 
functions even if CMP-Kdo is in excess. 
 
2.6  SUMMARY 
A quantitative model of the nine enzyme-catalysed steps of E. coli lipid A biosynthesis 
has been developed, drawing parameters from the experimental literature. The model 
accounts for biosynthesis regulation, which occurs through regulated degradation of the 
LpxC and WaaA (also called KdtA) enzymes. The LpxC degradation signal appears to 
arise from the lipid A disaccharide concentration which was deduced from prior results, 
model results, and new lpxK overexpression results. The model agrees reasonably well 
with many experimental findings including the lipid A production rate, the behaviours 
of mutants with defective LpxA enzymes, correlations between LpxC half-lives and cell 
generation times, and the effects of lpxK overexpression on LpxC concentrations. Its 
predictions also differ from some experimental results which suggest modifications to 
the current understanding of the lipid A pathway, such as the possibility that LpxD can 
replace LpxA and that there may be metabolic channeling between LpxH and LpxB. 
The model results indicate that WaaA regulation may serve to regulate the lipid A 
production rate when the Kdo concentration is low and/or to control the number of Kdo 
residues that get attached to lipid A. Computation of flux control coefficients suggests 
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that LpxC is the rate-limiting enzyme if pathway regulation is ignored, but that LpxK is 
the rate-limiting enzyme if pathway regulation is present, as it is in real cells. Control 
also shifts to other enzymes if the pathway substrate concentrations are not in excess. 
Based on these results, LpxK may be a much better drug target than LpxC, which has 
been pursued most often. 
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Chapter  3 
An integrated biosynthesis model for lipid A and 
phospholipids during outer membrane biogenesis in  
E. coli 
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3.1  OVERVIEW 
This chapter builds upon the previous chapter which investigated the lipid A 
biosynthesis pathway. Although a large amount of research has been conducted on 
either LPS or phospholipids synthesis, our current understanding on the cross-talk 
between both pathways is limited at the moment. Since both pathways are synchronised 
in order to ensure a proper balance of membrane components, studies underpinning the 
underlying mechanisms would be invaluable. There are a number of experimental 
findings which indicate the existence of strong links between both biosynthetic 
pathways. Firstly, E. coli mutants which are resistant to an LpxC inhibitor (CHIR-090) 
harbour essential mutations in a gene involved in phospholipids synthesis called fabZ 
(Zeng et al., 2013). In a similar manner, inactivation of the ftsH gene render cells non-
viable apparently due to lack of controlled LPS synthesis (Narberhaus et al., 2009). 
However, ftsH knockout mutants are viable when a suppressor mutation is present in the 
fabZ gene, making its protein product hyperactive (Ogura et al., 1999; Schakermann et 
al., 2013). The fact that these two enzymes (i.e. LpxC and FabZ) in principle compete 
for a common substrate (the activity of LpxA is highly unfavourable), and sometimes 
harbour compensatory mutations underline a close regulatory relationship between both 
pathways. Secondly, the catalytic activity of LpxK is entirely dependent on the presence 
of phospholipids indicating there is a substrate level interaction between the two 
pathways (Ray and Raetz, 1987). Therefore, in the context of outer membrane 
biogenesis, the role of phospholipids cannot be ignored in the study of LPS biosynthesis 
and regulation. 
Furthermore, during membrane synthesis, approximately 20 million molecules of fatty 
acids are synthesized in E. coli through the action of a series of enzymes as discussed 
earlier (Raetz et al., 2009). Yu et al. (2011) reconstituted an in vitro steady state kinetic 
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system of fatty acid biosynthesis using purified enzymes and they observed that the 
maximum fatty acid production rate obtainable was 100 µM/min. This production rate 
falls way below the required amount of fatty acids required by a cell in vivo (if one 
assumes a cell volume of 6.7 x 10-16 L (Cayley et al., 1991) and a generation time of 30 
min (Mackie, 2013)). Thus, in order to test the consistency of reported in vitro 
parameters, and investigate the role of the biosynthetic enzymes on fatty acids turnover 
rate, a ‘systems’ approach is necessary.    
The aim of this chapter is to provide a first detailed integrated computational model of 
the LPS and phospholipids biosynthetic pathways. The model would examine 
interactions of all major enzymic components at the transcriptional, proteomic and 
metabolome level of detail. Such model would provide new insights into the complex 
biogenesis of the E. coli outer membrane. 
 
3.2  MODEL ARCHITECTURE 
Initiation of fatty acid biosynthesis begins with the condensation of malonyl-ACP with 
acetyl-CoA and this reaction is conducted exclusively by FabH (Heath and Rock, 
1996a). Subsequent reaction steps are carried out by FabG, FabA/FabZ, and FabI 
respectively which ultimately completes a single cycle. At the expense of FabH, further 
elongation cycles begin with FabB and/or FabF by the condensation of malonyl-ACP to 
the growing fatty acyl chain. Yet again, FabG, FabA/FabZ, and FabI catalyse 
subsequent steps to complete the cycle (Fig. 1.6).  
A schematic representation of the model is depicted in Fig. 3.1. The model commences 
at fatty acid initiation step with the FabH reaction (reaction involves 2-carbon substrate) 
which then leads to the formation β-hydroxydecenoyl-ACP (a 10-carbon substrate). 
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This meant that reaction intermediate steps between the actual product of FabH and β-
hydroxydecenoyl-ACP were ignored (i.e. the 4-, 6-, and 8-carbon steps). Ignoring these 
steps were valid since β-hydroxydecenoyl-ACP is a direct substrate for trans-2-
decenoyl-ACP production. Trans-2-decenoyl-ACP in turn, represents a key substrate in 
the metabolic junction of UFAs and SFAs synthesis. The distribution of SFAs and 
UFAs in membrane phospholipids is the most crucial aspect of phospholipids synthesis 
(Magnuson et al., 1993). Amongt the components of phospholipids, fatty acids 
represent the only variable constituents. Furthermore, the relative distribution of SFAs 
and UFAs represent the key player in phospholipids and membrane regulation 
(Magnuson et al., 1993; Zhu et al., 2009). The consequence of ignoring these steps 
would have no significant effect on the model output since in reality, perturbation of 
steps prior to the formation of β-hydroxydecenoyl-ACP would directly affect the pool 
of trans-2-decenoyl-ACP which in turn, would affect both SFAs and UFAs levels 
proportionately. 
The catalytic activity of FabH is regulated at the post-translational level (Heath and 
Rock, 1996a). This enzyme is known to be inhibited by acyl-ACPs especially 
palmitoyl-ACP (C16:0) and cis-vaccenoyl-ACP (C18:1) (Heath and Rock, 1996a).  
FabA and FabZ dehydrates β-hydroxydecenoyl-ACP to produce trans-2-decenoyl-ACP. 
Under physiological conditions, this reaction step is unfavourable (Heath and Rock, 
1996b). The trans-2-decenoyl-ACP synthesized can either be reduced to decanoyl-ACP 
(a SFA) by the action of FabI in an essentially irreversible reaction (Heath and Rock, 
1995), or further isomerized by FabA to produce cis-3-decenoyl-ACP which is the first 
step in UFAs biosynthesis (Kass et al., 1967). Thus, competition for trans-2-decenoyl-
ACP between FabA and FabI influences the relative ratios of SFAs and UFAs. 
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Figure 3.1. Model of the E. coli LPS and phospholipids biosynthesis pathway. The 
figure herein is displayed on the next page. Enzymes and metabolites are displayed with 
three text styles: upright bold indicates that these concentrations are fixed, upright plain 
indicates that these concentrations vary, and italics indicates that these species are not 
included in the model explicitly. Black arrows with barbed heads represent chemical 
reactions in which reactants are converted to products. Red arrows with closed heads 
represent enzymatic influences on chemical reaction rates, and red arrows with T-bar 
heads represent inhibitory influences. Variables represent model parameters. Numbers 
next to black arrows for bi-substrate reactions indicate which substrate is designated 
number 1 and number 2. Blue arrows represents pathway interactions that are novel and 
derived from this work. The top right corner represents the transcriptional activation and 
repression of fabA and fabB genes. Both genes consist of two separate promoters; one 
which is constitutively expressed, and another which is activated by FadR and repressed 
by FabR. 
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However, overexpression of FabA does not increase UFAs yield because FabB limits 
UFAs synthesis in this case. In fact, FabA overexpression conditions increased the total 
cellular SFAs whilst the UFAs level remained the same (Clark et al., 1983). This is 
because, overexpression would increase the concentration of trans-2-decenoyl-ACP, 
and subsequently result in faster production of SFAs; but UFAs synthesis rate remain 
unchanged. Unsurprisingly, overexpression of both FabA and FabB increased the total 
amount of cellular UFAs (Cao et al., 2010). Decanoyl-ACP and cis-3-decenoyl-ACP 
are both utilized as substrates for further rounds of fatty acyl elongation catalysed by 
FabB/FabF, FabG, FabA/FabZ, and FabI respectively. 
FabB and FabF differ only in some catalysed reactions. Both enzymes are capable of 
catalysing the elongation of saturated fatty acyl-ACP of chain length C6 to C14 (Janßen 
et al., 2014). In the synthesis of UFA, FabB catalyses the condensation of cis-3-
decenoyl-ACP and cis-5-dodecenoyl-ACP. Both FabB and FabF catalyses cis-7-
tetradecenoyl-ACP, and the reaction involving palmitoleoyl-ACP is carried out 
exclusively by FabF (Edwards et al., 1997). Deletion of FabB results in cells that are 
auxotrophic for UFAs (Cronan et al., 1969). On the other hand, overexpression results 
in increased levels of UFAs (Cao et al., 2010). FabF is not essential for growth in E. 
coli; however, FabF knockout mutants result in cells that are temperature-sensitive 
(Garwin et al., 1980a). This is because cis-vaccenic acid produced from the 
condensation of palmitoleoyl-ACP is essential at maintaining membrane fluidity under 
low temperature conditions (Janßen et al., 2014). Overexpression on the other hand, has 
been reported to be lethal to the cell (Subrahmanyam and Cronan, 1998). 
One of the key regulation of fatty acid synthesis in E. coli is the transcriptional 
regulation of fabA and fabB genes (Nunn et al., 1983; Zhang et al., 2002; Feng and 
Cronan, 2012). Both genes have two set of promoters; one which is constitutively 
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expressed, and another which is activated by FadR and repressed by FabR (Campbell 
and Cronan, 2001; Zhang et al., 2002; Feng and Cronan, 2009; Feng and Cronan, 2011). 
Transcription is repressed in the presence of sufficient UFAs which further highlights 
the dual role of FabA and FabB in UFAs synthesis (Zhu et al., 2009). In addition to the 
activation of fabA and fabB, FadR is also a repressor of all genes that code for proteins 
involved in the β-oxidation cycle (Simons et al., 1980).     
The products of FabB and FabF are reduced by FabG which leads to the formation of a 
3-hydroxyacyl ACP. Both unsaturated and saturated fatty acyl substrates1 of varying 
chain-lengths are suitable substrates (Toomey and Wakil, 1966). Under physiological 
conditions, the reactions are readily reversible (Toomey and Wakil, 1966). Cells are 
non-viable under FabG knockout conditions which indicate its role cannot be 
substituted by other enzymes (Lai and Cronan, 2004). 
Next, the 3-hydroxyacyl ACPs are dehydrated by the action of FabA and FabZ 
although, their substrate preferences differ. This reaction step is unfavourable under 
physiological conditions as well (Heath and Rock, 1996b). FabZ prefers fatty acyl 
substrates of short chain length whereas, FabA has a higher affinity for substrates of 
medium chain length (Heath and Rock, 1996b). Unlike FabZ, FabA is incapable of 
dehydrating fatty acyl-substrates with a cis configuration (i.e. UFAs substrates) (Heath 
and Rock, 1996b). One of the reaction substrates of FabA/FabZ, β-hydroxymyristoyl-
ACP is also an essential precursor molecule in the biosynthesis of LPS (Ogura et al., 
1999) thus, phospholipids and LPS synthesis are regulated in response to perturbation in 
                                                          
1 “saturated acyl substrate” was mentioned a number of times in this report for certain reactions of FabG, 
FabB, FabF, FabZ and FabA. Although, only substrates of FabF and FabB can be truly saturated, since all 
other acyl substrates catalysed by the enzymes mentioned above always contain at least a double-bond, 
the term “saturated acyl substrate” was utilized for simplicity to represent substrates that are consumed 
exclusively for SFAs synthesis.    
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this common substrate pool (Ogura et al., 1999; Schakermann et al., 2013). Co-
ordinated regulation of both pathways is achieved through controlled FtsH-mediated 
proteolysis of LpxC, the second enzyme involved in LPS synthesis (Ogura et al., 1999; 
Fuhrer et al., 2006). Due to the highly unfavourable equilibrium constant of the first 
enzyme (LpxA), degradation of LpxC would increase the substrate pool of β-
hydroxymyristoyl-ACP. As stated previously in Chapter 2 (Figs. 2.2 and 2.4), the 
feedback regulatory signal appear to arise from levels of lipid A disaccharide, a 
metabolite downstream of LpxC in the LPS pathway. Since compensatory mutations in 
the fabZ gene are crucial under ftsH inactivation (Ogura et al., 1999) or LpxC inhibition 
conditions (Zeng et al., 2013), this suggests that the activities of LpxC and FabZ are co-
regulated in order to maintain an appropriate ratio of LPS and phospholipids. 
The last step catalysed by FabI, is essentially the only irreversible step in fatty acyl 
elongation cycle. This enzyme is inhibited by one of its product, palmitoyl-ACP, 
presumably to prevent an unnecessary accumulation of acyl-ACPs due to the high 
energy requirement involved in fatty acid synthesis (Heath and Rock, 1996c). Inhibition 
of FabI is lethal to the cell (Egan and Russell, 1973); however, overexpression does not 
result in any growth defect (Xu et al., 2006). 
Fatty acid biosynthesis in E. coli usually ends when the acyl chain contains 16 or 18 
carbon atoms which then serve as substrates for the synthesis of phospholipids (Heath et 
al., 2002). The first step in the biosynthesis of phospholipids involves the transfer of 
two acyl moieties derived from acyl-ACPs to a single molecule of glycerol-3-phosphate 
(G3P). These acyl groups are attached to G3P by inner membrane proteins PlsB and 
PlsC (Goelz and Cronan, 1980; Rock et al., 1981). Subsequent enzymic reaction steps 
occur leading to the formation of membrane phospholipids (Heath et al., 2002). In the 
model, it was assumed that the reaction products of PlsB and PlsC would ultimately be 
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utilized for phospholipids synthesis so the model ignored subsequent steps. This is 
intuitively reasonable given that fatty acids of 16 and 18 carbon carbons are exclusively 
used in the production of phospholipids under optimum conditions (Heath et al., 2002). 
Thus, the model focuses on the quantification of fatty acyl chains that are transferred to 
G3P. This was important to effectively study the SFAs/UFAs distribution in the 
membrane, rather than studying the phospholipid as a whole single molecule. 
Understanding the relative distributions of SFAs/UFAs is invaluable because as 
mentioned earlier, fatty acids are the only dynamic and variable component of 
phospholipids. Also, regulation of the fatty acid composition is crucial under varying 
environmental conditions.  
PlsB attaches fatty acids to position-1 of G3P whereas, fatty acids found in position-2 
result from reactions with PlsC (Goelz and Cronan, 1980; Rock et al., 1981). Fatty acids 
located in position-2 are primarily UFAs while SFAs and cis-vaccenic acid are present 
in position-1 (Goelz and Cronan, 1980; Rock et al., 1981). Although, myristic (C14:0) 
and stearic acids (C18:0) can also be detected at significant levels in some E. coli 
strains, the major fatty acids found in E. coli membranes are palmitic acid (C16:0), 
palmitoleic acid (C16:1), and cis-vaccenic acids (C18:1) and their ratios vary depending 
on the bacterial strain and growth conditions (Raetz, 1978).     
The LPS pathway arm of the integrated model is similar to that which was described in 
Chapter 2 with some minor modifications. A brief summary is provided here. 
Biosynthesis of lipid A, the sole essential component of LPS involves nine enzyme 
catalysed reaction steps (Reatz et al., 2009). The first enzyme LpxA, is characterized 
with an unfavourable equilibrium constant of approximately 0.01 which means that 
LpxC, the second enzyme catalyses the pathway committed step (Anderson et al., 
1993). Pathway regulation occurs through FtsH-mediated degradation of LpxC and 
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WaaA (Ogura et al., 1999; Katz and Ron, 2008). In addition, the catalytic activity of 
LpxK is entirely dependent on the presence of phospholipids especially cardiolipins 
(Ray and Raetz, 1987). However, subsequent model findings indicated that the catalytic 
activation of LpxK is solely dependent on the abundance of UFAs moiety present in 
phospholipids as described below.    
 
3.3  MODEL EQUATIONS AND PARAMETERS 
The interactions between substrates and enzymes were modelled under steady-state 
conditions for an E. coli cell. A cell volume of 6.7 x 10-16 L and a doubling time of 30 
min was assumed in the same manner as the lipid A model presented in Chapter 2. With 
the exceptions of FabA, FabB, LpxC and WaaA (whose regulation was being studied in 
the model), the concentration for other proteins were fixed. Thus, the model ignored 
protein synthesis and degradation, and cell volume growth. Such assumptions are 
adequate because enzyme concentrations remain relatively constant over the course of 
the cell cycle. Table 3.1 lists all parameters employed in the model.
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Table 3.1: Abundance and kinetic parameters of integrated lipid A and phospholipids biosynthesis model. 
Species 
Species 
abundance 
(molec./cell) 
Substrate 
Substrate 
identity in 
COPASI file 
Kms or Km  
   (mM) 
Kmp 
(mM) 
kcat or 
kcatf (s-1) 
 
kcatr 
       (s-1) 
Notes and other 
parameters 
UDP-
GlcNAc 
2,000,000      
 
excess concentration 
CMP-Kdo 2,000,000       excess concentration 
G3P 1,000,000       excess concentration 
Acetyl-CoA 2,000,000       excess concentration 
ACP 1,024a       actual concentration 
FabH 1,320a   0.04g  12  Ki = 0.1 mM 
        Ki* = 0.067mM 
FabB 14,300a Decanoyl-ACP C10 0.022 0.022 3.4 0.38 K1 = 7.945 s-1 
  Dodecanoyl-ACP C12 0.022c 0.022 3.4 0.38 Kactive = 1.0 x 10-3 s-1 
  Myristoyl-ACP C14 0.071c 0.071 2.1 0.23 Kinactive = 0.1 s-1 
  cis-3-decenoyl-ACP C10:1 0.012 d 0.012 0.31 1.6 K3 = 11.12 s-1 
  cis-5-dodecenoyl-ACP C12:1 0.028c 0.028 3.9 0.43 K-4 = 2 s-1 
  cis-7-tetradecenoyl-ACP C14:1 0.027c 0.027 4.14 0.46 K-5 = 2 s-1 
        Kdegrade = 5.556 x 10-4 s-1 
FabF 1,280a Decanoyl-ACP  0.068 0.068 3 1.6  
  Dodecanoyl-ACP  0.068 0.068 2.7 1.45  
  Myristoyl-ACP  0.068c 0.068 0.83 0.45  
  cis-7-tetradecenoyl-ACP  0.06c 0.06 2.49 1.34  
  Palmitoleoyl-ACP C16:1 0.017d 0.017 6.74d 3.6  
FabG 13,800a 3-oxo-dodecenoyl-ACP Ketoacyl-12 0.01 0.01 1232 536  
  3-oxo tetradecenoyl-ACP Ketoacyl-14 0.01 0.01 1232 536  
  3-oxo hexadecenoyl-ACP Ketoacyl-16 0.01 0.01 1232 536  
  3-oxo-cis-5-dodecenoyl-ACP Ketoacyl-12:1 0.01 0.01 1232 536  
  3-oxo-cis-7-tetradecenoyl-ACP Ketoacyl-14:1 0.01 0.01 1232 536  
  3-oxo-cis-9-hexadecenoyl-ACP Ketoacyl-16:1 0.01 0.01 1232 536  
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  3-oxo-cis-vacc-11-enoyl-ACP Ketoacyl-18:1 0.01 0.01 1232 536  
FabZ 3,330a β-hydroxydecenoyl-ACP B-OH-10 5.5 x 10-5 5.5 x 10-5 2.65 9.14  
  β-hydroxydodecenoyl-ACP B-OH-12 5.5 x 10-5 5.5 x 10-5 1.59 1.59  
  β-hydroxymyristoyl-ACP 
Βeta-
hydroxymyrist
oylACP 
5.5 x 10-5 5.5 x 10-5 0.53 
0.53 
 
  β-hydroxypalmitoyl-ACP B-OH-16 5.5 x 10-5 5.5 x 10-5 1.06 1.06  
  β-hydroxy-cis-5-dodecenoyl-ACP B-OH-12:1 5.5 x 10-5 5.5 x 10-5 1.59 1.59  
  β-hydroxy-cis-7-tetradecenoyl-ACP B-OH-14:1 5.5 x 10-5 5.5 x 10-5 1.59 1.59  
  β-hydroxy-cis-9-hexadecenoyl-ACP B-OH-16:1 5.5 x 10-5 5.5 x 10-5 3.18 3.18  
  β-hydroxy-cis-vacc-11-enoyl-ACP B-OH-18:1 5.5 x 10-5 5.5 x 10-5 3.18 3.18  
FabA 23,400a β-hydroxydecenoyl-ACP  1.7e 1.7 5.4 18.6 K1 = 5.2 s-1 
  β-hydroxydodecenoyl-ACP  1.7 1.7 4 4 Kactivate = 1.4 x 10-3 s-1 
  β-hydroxymyristoyl-ACP  1.7 1.7 0.53 0.53 Kinactivate = 0.1 s-1 
  β-hydroxypalmitoyl-ACP  1.7 1.7 0.53 0.53 K3 = 31.2 s-1 
  trans-2-decenoyl-ACP trans-10 1.0 x 10-4 0.5e 1.65 11.75 K-4 = 90 s-1 
        K-5 = 90 s-1 
        Kdegrade = 5.556 x 10-4 s-1 
FabI 12,500a trans-2-decenoyl-ACP  0.01  20.6  Ki = 0.035 mM 
  trans-2-dodecenoyl-ACP trans-12 0.0033h  15h   
  trans-2-tetradecenoyl-ACP trans-14 0.0033  15   
  trans-2-hexadecenoyl-ACP trans-16 0.0033  15   
  trans-3-cis-5-dodecenoyl-ACP trans-12:1 0.0033  15   
  trans-3-cis-7-tetradecenoyl-ACP trans-14:1 0.0033  15   
  trans-3-cis-9-hexadecenoyl-ACP trans-16:1 0.0033  15   
  (2-trans-11-cis)-vaccen-2-enoyl-ACP trans-18:1 0.0033  15   
FadR 295a       K2 = 0.054 s-1 
        K-2 = 0.1 s-1 
FabR 295        
PlsB 1,400b Palmitoyl-ACP C16 0.015b  13.2  Km2 for G3P substrate is 
0.14 mM estimated from 
(b)  
  cis-vaccenoyl-ACP 
C18:1 
0.025b  11.76 
 
PlsC 4,200 Palmitoleoyl-ACP C16:1 0.012  4.4  Km2 for G3P substrate is 
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  cis-vaccenoyl-ACP  0.025  7.6  0.7 mM estimated from (f) 
         
         
LpxK        k = 0.0064 s-1 
        ka = 0.0094 s-1 
        Kinact = 0.0034 s-1 
  (a)   Ishihama et al. (2008), (b) Green et al. (1981), (c) Garwin et al. (1980b), (d) D’Agnolo et al. (1975), (e) Kass et al. (1967),  
(f) Rock et al. (1981), (g) Heath and Rock (1996a), (h) Rafi et al. (2006) Parameters that do not have citations are discussed  
in the main text.
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3.3.1  Substrate and enzyme abundance 
The levels of UDP-GlcNAc and CMP-Kdo were kept constant at 2 million molecules (5 
mM). The levels of acetyl-CoA and G3P were also maintained at 2 million and 1 
million molecules respectively. This led to substrate saturation conditions throughout 
the simulations. 
The FabA, FabB, FabF, FabG, FabH, FabI, FabZ, and FadR protein copy numbers were 
derived from mass spectrometry proteomic data collected on E. coli cytosolic fractions 
(Ishihama et al., 2008). On the other hand, the PlsC count was estimated as 4200 
molecules per cell from the reported PlsB count (Green et al., 1981) as described below.    
 
3.3.2  Enzyme kinetics 
Most of the enzymes involved in fatty acid biosynthesis are involved in multiple 
reaction steps. This therefore suggests that accounting explicitly for enzyme-substrate 
complexation is essential. Unfortunately, accounting for complexation requires precise 
enzyme association/dissociation constant parameters; whereas, available information in 
the literature indicates the pathway is poorly parameterized. On the other hand, 
complexation in the model may not be crucial because acyl-ACPs could barely be 
detected experimentally in E. coli cells which indicate their levels are too low (Fig. 8 in 
Jiang and Cronan, 1994). Furthermore, there are a number of thioesterases in E. coli 
which cleave acyl-ACPs and thus, regulate their concentration; although the 
thioesterases are non-essential (Jiang and Cronan, 1994; Heath et al., 2002). Finally, 
acyl-ACPs in the cytoplasm are toxic to the cell and they induce a strong inhibitory 
effect on a number of enzymes involved in fatty acid synthesis (Bergler et al., 1996; 
Heath and Rock, 1996a; Heath and Rock, 1996c). All these indicate that substrate levels 
are extremely low and are likely below the Km value for enzymes. Although, acetyl-
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CoA which is a substrate for FabH is highly abundant in the cell, modelling 
complexation is unnecessary because FabH is involved in a single-reaction step as 
mentioned above.  
All kinetic parameters for enzymes involved in the LPS biosynthesis arm of the model 
have been described previously in Chapter 2. The phospholipids pathway reactions were 
modelled using either single-substrate or bi-substrate Michaelis-Menten mechanisms. 
The integrated LPS/phospholipids model includes reversibility of reactions and several 
feedback loops which are essential for models to attain a steady-state (Cornish-Bowden 
and Cardenas, 2001). 
A single-substrate reversible Michaelis-Menten kinetics was employed for FabG, FabB, 
FabF, FabZ, and FabA (Mendes et al., 2009). Here the metabolic flux is 
d[P]
dt
= −
d[S]
dt
= (
kcatf 
[E][S]
Kms 
-
kcatr [E][P]
Kmp 
)(
1
1 + 
[S]
Kms
 + 
[P]
Kmp
)  (9) 
where [S] is the substrate concentration, [P] is the product concentration, [E] is the total 
enzyme concentration, kcatf is the enzyme catalytic rate constant for the forward 
reaction, kcatr is the enzyme catalytic rate constant for the reverse reaction, Kms  and Kmp 
are the Michaelis constants for substrate and product respectively. The Kmp values were 
unavailable so the model assumes same values for Kms and Kmp in all reversible 
reactions. This meant that the equilibrium constant for each reaction was implemented 
by adjusting the kcatr parameter as described below.      
There were no specific FabG parameters with substrates of carbon chain lengths C10 to 
C18 so it was essential to make calculations. The specific activity of FabG whilst 
utilizing a 4-carbon ketoacyl substrate was reported as 2.9 µmol/min/µg (Zhang et al., 
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2003) from which a kcat value of 1232 s
-1 was estimated assuming the MW of a FabG 
protein is 25.5 kDa (Sun et al., 2008). This value was assigned to kcatf for all chain 
lengths in the model. Furthermore, a Km value of 0.01 mM was utilized which is the Km 
parameter for its second substrate (NADPH) (Sun et al., 2008). The absence of specific 
FabG parameters for any of its substrates studied in the model suggests that the model 
may be inadequate at investigating the effect of FabG perturbations on E. coli fatty 
acids profile. In Toomey and Wakil (1966), the FabG reaction led to 40% of product 
formation at a pH of 9.0 in comparison to its optimum pH in which all substrates were 
converted to product. The low product formation was as a result of the reaction 
becoming unfavourable at a pH of 9.0. However, the physiological pH of E. coli is 
about 7.5 (Wilks and Slonczewski, 2007), and this led to 70% of products being formed. 
This suggests that under physiological conditions, the reaction equilibrium constant is 
2.3. Since the model assumes Kms and Kmp to be same, this meant that the equilibrium 
constant equals the kcatf / kcatr ratio. Thus, kcatr was derived as 536 s
-1. 
The Km values for FabB with respect to dodecanoyl-ACP (C12:0), myristoyl-ACP 
(C14:0), cis-5-dodecenoyl-ACP (C12:1) and cis-7-tetradecenoyl-ACP (C14:1) 
substrates were derived from Table IV in Garwin et al (1980b). From the same source, 
the authors estimated the specific activity of FabB for myristoyl-ACP as 2.9 
µmol/min/mg from which a kcatf value of 2.1 s
-1 was estimated. The kcatf values for 
dodecanoyl-ACP, cis-5-dodecenoyl-ACP and cis-7-tetradecenoyl-ACP were further 
derived relative to the specific activity for myristoyl-ACP as reported in Garwin et al. 
(1980b). On the other hand, the catalytic activity of FabB with decanoyl-ACP (C10:0) 
and dodecanoyl-ACP substrates are similar (Edwards et al., 1997) so the model uses 
same Km and kcatf for both substrates. Although, a FabB kcat value of 14.5 s
-1 towards cis-
3-decenoyl-ACP was initially estimated from the reported specific activity in D’Agnolo 
et al. (1975), this had to be modified to a kcat of 0.31 s
-1 as described below.    
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The FabF parameters for myristoyl-ACP and cis-7-tetradecenoyl-ACP were obtained 
from Table IV in Garwin et al (1980b) much as was done for FabB. According to Fig. 3 
in Edwards et al. (1997), the catalytic activity of FabF whilst utilizing decanoyl-ACP 
and dodecanoyl-ACP substrates was 3.6 and 3.25 folds higher respectively relative to 
myristoyl-ACP. This fold increase was implemented in the model by adjusting the kcatf 
values relative to those of myristoyl-ACP while maintaining same Km values. 
Furthermore, the equilibrium constants of the FabB and FabF reactions were derived as 
9 and 1.86 respectively from Fig. 3 in D’Agnolo et al (1975) much as was done for 
FabG, which enabled the kcatr parameters to be estimated.  
A kcatf value of 0.53 s
-1 was estimated from the reported specific activity of FabZ 
towards β-hydroxymyristoyl-ACP (C14:0) (Zeng et al., 2013). There were no available 
Km parameters for FabZ thus, had to be estimated. In Zeng et al (2013), the authors 
found that in a 40 µl reaction volume, varying the concentration of FabZ from 12.75 to 
25.5 nM resulted in a specific activity of 1.87 µmol/min/mg when the concentration of 
β-hydroxymyristoyl-ACP was 50 µM. Since the specific activity of a reaction equals the 
rate of reaction multiplied by reaction volume, divided by the mass of total protein, it is 
possible to estimate the reaction rate in their experiments and subsequently derive Km. If 
one assumes an enzyme concentration of 12.75 nM, this amounts to 8.67 x 10-6 mg in 
40 µl (the MW of FabZ is 17 kDa) thus, the reaction rate R, can be calculated as 6.75 x 
10-3 µM/s. The Km constant can then be derived from 𝐑 =
𝑘𝑐𝑎𝑡 [E][S]
𝐾𝑚 + [S]
. By inputting the 
necessary parameters ([E] = 12.75 nM, kcat = 0.53 s
-1, [S] = 50 µM), a Km value of 5.5 x 
10-5 mM can be derived. This Km value was utilized for all substrates of FabZ. 
Furthermore, the kcatf values for β-hydroxydecenoyl-ACP (C10:0), β-
hydroxydodecenoyl-ACP (C12:0) and β-hydroxypalmitoyl-ACP (C16:0) were derived 
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relative to that of β-hydroxymyristoyl-ACP according to Fig. 5 in Heath and Rock 
(1996b).  
The specific activity of FabZ whilst catalysing β-hydroxy-cis-7-tetradecenoyl-ACP 
(C14:1) is similar to that of β-hydroxymyristoyl-ACP (Fig. 6 in Heath and Rock, 
1996b). Consequently, the parameters for FabZ were same for both substrates in the 
model (although this was modified as described below). There were no available 
information in the literature to estimate parameters for other unsaturated fatty acyl 
substrates of FabZ. Thus, the model assumed similar catalytic rates for both saturated 
and unsaturated fatty acyl substrates of the same chain length. This meant that 
parameters for 12-carbon and 16-carbon saturated substrates were assigned to 12-carbon 
and 16-carbon unsaturated substrates respectively. 
The reaction affinity of FabA and FabZ towards β-hydroxymyristoyl-ACP is also 
similar (Heath and Rock, 1996b). Since they both have similar molecular weight, this 
indicates they also share similar kcatf values as well. The FabA kcatf values for β-
hydroxydecanoyl-ACP, β-hydroxydodecenoyl-ACP and β-hydroxypalmitoyl-ACP 
relative to β-hydroxymyristoyl-ACP were calculated according to Fig. 5 in Heath and 
Rock (1996b). A FabA Km value of 1.7 mM was obtained for β-hydroxydecenoyl-ACP 
from Kass et al (1967). This Km value was assigned to other β-hydroxy substrates of 
FabA. 
The equilibrium constant for the dehydratase activity (i.e both FabZ and FabA) has been 
reported to vary with substrate chain length. Under reactions involving short chain 
substrates (4-carbon chain), the ratio of substrates to products was 1:9 indicating the 
reverse reaction is more favourable (Heath and Rock, 1995). However, the ratio of 
substrates to product becomes 75:22 (the unaccounted 3% is the cis-product from the 
FabA isomerase reaction which indicates the equilibrium constant for the isomerase 
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reaction is 0.14) when utilizing β-hydroxydecenoyl-ACP as substrate indicating an 
equilibrium constant of 0.29 (Heath and Rock, 1996b). Therefore, the kcatr values of 
FabA and FabZ for this substrate can be calculated. Furthermore, the substrate/product 
ratio becomes 1:1 under reactions involving long chain substrates (Heath and Rock, 
1995). This meant that kcatf  equals kcatr for all other dehydratase reactions.    
For the isomerase activity of FabA, the kcatr was estimated as 11.7 s
-1 (i.e. cis-3-
decenoyl-ACP was substrate) from Fig. 7 in Helmkamp and Bloch (1968) and the Kmp 
parameter obtained from Kass et al. (1967). The reaction equilibrium constant of 0.14 
as mentioned above enabled kcatf to be derived. Although, the same values for Kms and 
Kmp were initially assumed, the Kms value was changed to 0.0001 mM as described 
below.  
Bi-substrate Michaelis-Menten kinetics was used to model the transfer of fatty-acyl 
moieties to G3P by PlsB and PlsC. Here, the metabolic flux is  
d[P]
dt
= −
d[S1]
dt
= −
d[S2]
dt
 = 
kcat[E][S1][S2]
(Km1 + [S1])(Km2 + [S2])
   (10) 
where [S1] and [S2] are the two substrate concentrations with respective Michaelis-
Menten constants Km1 and Km2. The phospholipids fatty acid composition in the model 
only includes the major fatty acids found in E. coli membranes (i.e. palmitic, 
palmitoleic, and cis-vaccenic acids). This is because, other minor fatty acids vary from 
strain-to-strain and sometimes, non-existent in some E. coli strains. As mentioned 
above, PlsB and PlsC attaches fatty acids to positions-1 and -2 of G3P respectively. 
Fatty acids found in position-1 are palmitic and cis-vaccenic acids while palmitoleic 
acids and, again, cis-vaccenic acids are present in position-2. Hence, PlsB and PlsC both 
utilize cis-vaccenoyl-ACP substrate. 
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The PlsB kcat values were derived from the reported specific activities of 9.5 and 8.5 
µmol/min/mg for palmitoyl-ACP and cis-vaccenoyl-ACP substrates respectively (Green 
et al., 1981). 
There were no available specific kcat and Km values for PlsC so estimates had to be made 
as well. Rock et al. (1981) reported a Km value of 0.012 mM for the incorporation of 
palmitoleoyl-ACP into G3P whilst using inner membrane enzymic fractions. Since 
incorporation of palmitoleoyl-ACP is conducted exclusively by PlsC, one can assign 
this Km value to PlsC with the assumption that there was no competition for this 
substrate with other membrane proteins. The authors also reported similar specific 
activities for the incorporation of palmitoyl-ACP and palmitoleoyl-ACP. The 
incorporation of palmitoyl-ACP is also performed exclusively by PlsB. This therefore 
suggests that 1 mg of inner membrane fraction (which contains PlsB) whilst utilizing 
palmitoyl-ACP would result in the same reaction rate as 1 mg of inner membrane 
fraction (containing PlsC) when catalysing palmitoleoyl-ACP. Since the molecular 
weight of PlsB is 3 times that of PlsC (Green et al., 1981; Coleman, 1992), this 
indicates PlsC copy number in membrane extract is 3 times that of PlsB (hence, PlsC 
count per cell is about 4200 molecules). This also suggests that the kcat value for PlsC 
towards palmitoleoyl-ACP would be 3 times less that for PlsB with palmitoyl-ACP 
substrate. 
 Additionally, Goelz and Cronan (1980) observed that 32% of fatty acids attached to 
position-1 of G3P were cis-vaccenic acids (i.e. by PlsB). A preliminary simulation for 
PlsB was run using COPASI (1400 copies per cell (Green et al., 1981) with saturated 
levels of palmitoyl-ACP and cis-vaccenoyl-ACP. It was observed that when there were 
no competition for cis-vaccenoyl-ACP (i.e. absence of PlsC), 37% of fatty acids 
attached to position-1 were cis-vaccenic acid instead of 32%. However, when 
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competition was included (i.e. presence of PlsC), it was observed the Vmax for PlsC 
required to attain 32% of cis-vaccenic acid in position-1 was 1.94 folds greater than that 
of PlsB. Thus, with the knowledge of the PlsB kcat value for cis-vaccenoyl-ACP, and 
protein counts for both PlsB and PlsC, the kcat of PlsC towards cis-vaccenoyl-ACP 
substrate can be derived as 7.6 s-1.   
A single-substrate Michaelis-Menten kinetics with inhibition was used for the FabI 
enzyme for all substrates. In this case, the metabolite flux is 
d[P]
dt
= −
d[S]
dt
 = 
kcat[E][S]
(Km + [S])(1 + 
[P]
Ki
 )
    (11) 
where Ki is the inhibition constant, [P] is the concentration of palmitoyl-ACP, and the 
other parameters are the same as in eq. 10.  
The model used same parameters for trans-2-tetradecenoyl-ACP (C14:0) and trans-2-
dodecenoyl-ACP (C12:0) since they both had similar affinities with FabI (Weeks and 
Wakil, 1968). There was no information available in the literature regarding FabI 
reactions with trans-2-hexadecenoyl-ACP (C16:0). The model assumed that the FabI 
reaction rate would not increase with increasing carbon-chain length for saturated 
substrates since the affinities of trans-2-dodecenoyl-ACP and trans-2-tetradecenoyl-
ACP were same. Furthermore, in the absence of FabI parameters with unsaturated 
substrates, same parameters for saturated 12-carbon, 14-carbon and 16-carbon 
substrates were assigned to 12-carbon, 14-carbon and 16-carbon unsaturated substrates 
respectively. The FabI kcat value for trans-2-decenoyl-ACP was estimated from Fig. 7 in 
Weeks and Wakil (1968) relative to that reported for trans-2-dodecenoyl-ACP (Rafi et 
al., 2006) and its Km parameter was derived from Fig. 6 of Weeks and Wakil (1968). 
Finally, Heath and Rock (1996c) observed that at a palmitoyl-ACP concentration of 400 
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µM, the FabI reaction rate was inhibited by 92%. If one assumes non-competitive 
inhibition and excess substrate conditions, a Ki value of 0.035 mM can be derived. 
The FabH reaction step was modelled using an irreversible single-substrate Michaelis 
kinetics with dual acyl-ACP (palmitoyl-ACP and cis-vaccenoyl-ACP) inhibition. Here, 
the metabolite flux is 
d[P]
dt
= −
d[S]
dt
 = 
kcat[E][S]
(Km + [S])(1 + 
[P]
Ki
 )(1 + 
[P*]
Ki*
 )
    (12) 
where Ki* is inhibition constant arising from cis-vaccenoyl-ACP ([P*]) and other 
parameters are same as eq. 11.  
Although, an initial FabH kcat value of 3.28 s
-1 was derived from the reported specific 
activity (Heath and Rock, 1996a), it was apparent that this parameter would be 
insufficient to produce the appropriate amount β-hydroxydecenoyl-ACP required for 
SFAs and UFAs synthesis (the FabH molecule count is 1320 per cell (Ishihama et al., 
2008) which suggests a maximum production of 8 million products whereas 
approximately 20 million fatty acids are generated in vivo). This is unsurprising as it has 
been suggested previously that there are other enzymes capable of replacing FabH (Yao 
et al., 2012). Consequently, the kcat value was increased to 12 s
-1. The inhibition 
constants for palmitoyl-ACP and cis-vaccenoyl-ACP inhibitors were estimated as 0.1 
mM and 0.067 mM respectively from Heath and Rock (1996a) much as was done for 
FabI above.     
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3.3.2.1  LpxK catalytic activation and inactivation 
The activation of LpxK from an inactive to an active state was modelled using mass 
action kinetics according to 
d[LpxK*]
dt
= k (1+
[activator]
Ka
) [LpxK] − Kinact[LpxK*]   (13) 
where k is the phospholipids-independent activation constant, Ka is the phospholipids-
dependent activation constant,  Kinact is the inactivation constant, [activator] is the 
phospholipids concentration (i.e. fatty acids), [LpxK*] and [LpxK] represent the 
concentrations of the activate and inactive forms of LpxK.  
In Ray and Raetz (1987), the absence of phospholipids resulted in a maximum reaction 
rate which was 94% less than those with phospholipids stimulation. Since there are 432 
copies of LpxK per cell, this means the absence of phospholipids would result in 406 
copies of inactive LpxK, and 26 copies of active LpxK. By assuming Kinact as 0.1 s
-1,  k 
value of 0.0064 s-1 can be derived.  
When cells newly divide, LpxK would most likely be maximally activated quickly due 
to the essential need for LPS production. The model assumes that this maximal 
activation (which was arbitrarily defined as 95% of active proteins) would occur within 
100 s. It was also assumed that about 1.1 x 106 fatty acids would have been produced in 
100 s. This is because, there are approximately 1 million LPS in E. coli (Raetz et al., 
2009), and the LPS/phospholipids ratio is approximately 0.1 (Galloway and Raetz, 
1990; Raetz et al., 2009). Since 2 molecules of fatty acids make up a phospholipid 
molecule (with the exception of cardiolipins which occupy about 5% of total 
phospholipids), this suggest approximately 20 million fatty acids are produced for 
phospholipid biosynthesis per generation time. Thus, in 100 s, approximately 1.1 x 106 
fatty acids would be synthesized given a cell generation time of 30 min. By Inputting 
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LpxK and LpxK* counts as 22 and 410 molecules respectively, coupled with the 
activator count, the Ka value can be calculated as 0.0094 mM. 
 
3.3.2.2  Transcriptional regulation of fabA and fabB 
The expression of fabA and fabB genes occur from two different promoters. One of 
them, which is usually regarded as the ‘weak promoter’ is constitutive while the 
dominant promoter is regulated through mediated transcriptional activation and 
repression by FadR and FabR proteins respectively. 
Protein synthesis from the constitutive promoter was modelled according to the zeroth 
order reaction 
 promoterconst  
          𝐾1           
→        promoterconst + protein    (14)
  
where promoterconst represents the constitutive promoter and K1 is the resulting protein 
translation rate constant. This approach combines transcription and translation into a 
single reaction step.  
When fadR and fabR are inactivated, protein expression would occur solely from the 
constitutive promoter. Feng and Cronan (2011) observed that mRNA levels of fabA 
were 40% those of wild-type cells while those for fabB remained the same in a fadR and 
fabR double mutant. In the model, it was assumed that the relative fold-reduction in 
mRNA levels would result in a similar fold-reduction in protein levels. This is a 
reasonable assumption since neither FabA nor FabB are regulated at the post-
transcription or post-translation level. Therefore, the transcript half-lives, protein 
translation and degradation rates would remain constant under fabR and fadR 
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inactivation conditions. In wild-type E. coli, the FabA count is 23,400 (Ishihama et al., 
2008) which indicates a fadR/fabR double mutant contains approximately 9,360 FabA 
proteins. Thus, the translation rate can be derived as the production of 9,360 proteins 
over the course of a cell generation which gives a K1 of 5.2 molecules/s (assuming a 
generation time of 30 min). On the other hand, there are 14,300 FabB proteins per cell 
which enabled the K1 to be calculated as 7.945 molecules/s.     
In order to induce fabA and fabB expression, FadR is likely to be activated. The 
activation of FadR from an inactive to an active state was modelled using first order 
reaction kinetics 
[FadR] 
            𝐾−2         
←            
              𝐾2           
→            [FadR∗]      (15) 
where [FadR] and [FadR*] are the inactive and active forms of FadR , K2 and K-2 are the 
resultant activation and inactivation constants respectively. The cellular count of FadR 
is about 295 (Ishihama et al., 2008). The model assumes 100 copies of these would be 
used in the regulation of fabA and fabB (in which case, [FadR*] = 100) thereby leaving 
a reasonable FadR reservoir for other regulatory processes. This estimate may be 
inaccurate; however, they do not affect the model results at all. Thus, the estimate is 
only necessary to capture the activation of FadR. The model also assumed K-2 as 0.1 s
-1 
which then gave a K2 value of 0.054 s
-1. Again, the accuracy of the K2 and K-2 values are 
inconsequential provided their ratio is accurate.  
The activated form of FadR can bind reversibly to a DNA sequence downstream the 
regulated promoter and induce protein expression.  
promoterreg 
            𝐾inactive      
←                
  𝐾active[FadR
∗]   
→                 promoteractive     (16) 
promoteractive  
          𝐾3           
→        promoteractive + protein   (17) 
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where promoterreg is the regulated promoter, promoteractive is the active promoter 
resulting from FadR binding to DNA sequence, Kactive and Kinactive are the resultant 
activation and inactivation constants. K3 is the translation rate constant from the 
activated promoter. 
As mentioned above, there are 23,400 FabA proteins in wild-type E. coli. This means 
that the sum of K1 (i.e. from eq. 14) and K3[promoteractive] equals the synthesis of 23,400 
proteins per cell generation time. There are four different states the regulated promoter 
can assume; (i) an inactive state resulting from lack of DNA binding by FadR or FabR; 
(ii) an active state from DNA binding by FadR; (iii) an inactive state arising from FabR 
bound to DNA; and (iv) an inactive state arising from DNA binding by FabR in addition 
to a bound FadR. Irrespective of FadR bound to DNA, binding of FabR would prevent 
expression (Zhu et al., 2009). The FabR and FadR concentrations are likely to be 
optimized for precise control, so it was assumed that their concentrations are about half 
of the binding constant values. This implies that the probability is 0.25 for each of the 4 
states. This meant that [promoteractive] count equals 0.25. Inputting this value with prior 
estimate of K1 resulted in a K3 value of 31.2 s
-1.  
Furthermore, the transcript levels for fabA were increased by 1.8 folds in a fabR mutant 
which was estimated would result in 42,120 proteins. This indicates that there was 
continuous expression from the regulated promoter which meant the promoter can 
achieve only two possible states. Again, with prior knowledge of K1 and K3, a steady-
state estimate for [promoteractive] can be calculated as 0.583 molecules in a fabR mutant 
and subsequently derive [promoterreg] as 0.417 molecules. Next, by assuming Kinactive as 
0.1 s-1, coupled with the [FadR*], [promoterreg], and [promoteractive] values, one can 
derive Kactive as 1.4 x 10
-3 s-1. 
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On the other hand, the expression rates of fabB were similar in both wild-type and fadR 
mutant (Feng and Cronan, 2011) which suggest FabR is the dominant regulator of fabB 
in agreement with prior propositions (Feng and Cronan, 2011). This indicates that in 
wild-type cell, expression occurs mainly from the constitutive promoter which gives the 
[promoteractive] count as approximately zero. However, in a fabR mutant, the mRNA 
levels were increased by 1.7 folds in comparison to wild-type which was calculated 
would lead to 24,310 FabB proteins. Yet again, only two possible promoter states exists 
under fabR inactivation conditions and the model assumes a steady state count for 
[promoterreg] and [promoteractive] as both 0.5 molecules each. This enabled Kactive to be 
derived as 1.0 x 10-3 s-1 much as was done for fabA. 
The activation of FabR from an inactive to an active state is stimulated by the presence 
of UFAs (Zhu et al., 2009). It is believed that the cell is able to detect the relative ratio 
of SFAs and UFAs which then determines if FabR is activated (Zhu et al., 2009). The 
activated form of FabR then binds to an overlapping DNA sequence downstream of 
FadR (Zhu et al., 2009). Prior binding of FadR does not prevent the binding of FabR. 
Therefore, an active form of FabR can bind to DNA with different promoter states of 
[promoterreg] and [promoteractive] to give two different promoter inactive states. 
[FabR] 
              [SFA]            
←               
              [UFA]           
→               [FabR∗]       (18) 
promoterreg 
            𝐾−4      
←          
        [FabR∗]   
→            [inactive_promoter1]    (19) 
promoteractive 
            𝐾−5      
←          
        [FabR∗]   
→            [inactive_promoter2]    (20) 
where [FabR] and [FabR*] are the inactive and active forms of FabR, [UFA] and [SFA] 
are the concentrations of UFAs and SFAs respectively, [inactive_promoter1] and 
[inactive_promoter2] are the different inactive promoter states, K-4 and K-5 are the FabR 
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dissociation rate constants from DNA of [inactive_promoter1] and [inactive_promoter2] 
respectively. There were no specific estimates of the FabR cellular count in the 
literature so the model assumed same count as FadR. Again, this estimate is 
inconsequential since K-4 and K-5 parameters were fitted as described below. It was also 
assumed that the affinity of active FabR for promoterreg and promoteractive are similar 
which meant that the FabR dissociation constant is same irrespective of the promoter 
state. The K-4 and K-5 parameters were derived during model fitting.  
Protein degradation was modelled with first order kinetics as well, with Kdegrade as the 
degradation rate constant. The steady-state protein abundance in a cell is (K1 + 
[promoteractive]*K3)/Kdegrade. The Kdegrade value was calculated as 5.556 x 10
-4 s-1 for 
FabA and FabB using [promoteractive], K1 and K3 parameters described above.   
protein 
          𝐾degrade           
→              ⊘       (21) 
 
3.4  SIMULATIONS 
The integrated LPS and phospholipids synthesis model was simulated using 
deterministic methods using the COPASI software (Mendes et al., 2009). Simulations 
represented an E. coli cell generation under optimal growth conditions which is 1800 s. 
As mentioned previously in Chapter 2, using stochastic simulations and accounting for 
stochasticity had negligible effect on the results due to the high copy numbers of all 
model components which justified the use of deterministic simulations. The COPASI 
file is available as a supplementary information. 
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3.5  MODEL ADJUSTMENT 
Initial model parameters described above were unable to either achieve the appropriate 
SFAs/UFAs ratio or replicate some published experimental findings. This was as a 
result of limitations in the following areas; 
 
3.5.1  FabA isomerase and FabZ kinetics  
Initial simulations resulted in excess SFAs and little or no UFAs. This was solely due to 
FabI outcompeting FabA isomerase for trans-2-decenoyl-ACP substrate which led to an 
accumulation of SFAs substrates. This problem was solved in the model by reducing the 
Kms value of FabA isomerase towards trans-2-decenoyl-ACP to 0.0001 mM which 
resulted in SFAs occupying 50% of total fatty acids. Indeed, there were no reported Km 
parameters for the isomerization of trans-2-decenoyl-ACP in the literature as mentioned 
earlier; so it is unsurprising that the initial estimate was inadequate.  
Although the model had obtained 50% SFAs yield, a bottleneck in the UFA arm of the 
pathway ensured an insufficient production of UFAs resulting from accumulation of 
substrates of FabZ. Again, this is understandable given there were also no reported 
parameters for unsaturated substrates of FabZ in the literature as mentioned earlier. This 
was resolved by increasing both the kcatf and kcatr parameters (so the equilibrium 
constant remained the same) for the 14, 16 and 18-carbon unsaturated substrates by 3 
folds. 
 
3.5.2  FabB activity towards cis-3-decenoyl-ACP 
Initial parameters were unable to reproduce the roles of FabA and FabB in the synthesis 
and regulation of UFAs. For instance, overexpressing fabA in the model resulted in 
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increased levels of UFAs rather than the opposite effect. This was solely due to the high 
affinity of FabB for cis-3-decenoyl-ACP. This then suggests that the specific activity of 
FabB in vivo is far less than those reported in vitro by D’Agnolo et al. (1975). There are 
several pieces of evidence that supports the claim of FabB being the rate-limiting step in 
UFAs synthesis. Firstly, overexpression of FabA (which will theoretically increase the 
isomerisation of cis-3-decenoyl-ACP) does not increase nor decrease UFAs yield, 
although SFAs level are elevated (Clark et al., 1993). Secondly, overexpression of FabB 
enhances UFAs yield (Cao et al., 2010). In order to ensure FabB was the rate limiting 
step in UFAs synthesis, the kcatf parameter for cis-3-decenoyl-ACP substrate was chosen 
to be decreased. The proportion of SFAs in wild-type E. coli under optimum conditions 
can range from 50 – 70% of the total fatty acids (Zhu et al., 2009; Oursel et al., 2007). 
Whilst the levels of FabA and FabB were fixed to their steady-state counts, the kcatf 
value was reduced so that the model would produce 60% SFAs, which turned out to be 
a value of 0.31 s-1. 
 
3.5.3  LpxK catalytic activation   
At first, when the role of fatty acid biosynthetic enzymes on LpxC regulation was 
investigated, the model results deviated from published datasets. For instance, model 
inhibition of FabZ did not result in LpxC degradation in contrast to experimental 
findings by Zeng et al. (2013). This was because, the model had sufficient amount of 
fatty acids (especially SFAs) to catalytically activate LpxK, which ensured that lipid A 
disaccharide (the feedback source for LpxC degradation) did not accumulate. However, 
when the catalytic activation of LpxK arose solely from UFAs, the model replicated the 
results in Zeng et al. (2013) and other published results. Thus, the activation of LpxK is 
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most likely sensitive to the SFAs/UFAs ratio. Eq. 13 was modified to ensure LpxK was 
catalytically activated by UFAs and inactivated by SFAs 
d[LpxK*]
dt
= k (1+
[UFA]
Ka
) [LpxK] − Kinact[SFA][LpxK*]             (22) 
where [UFA] and [SFA] are the concentrations of the activator and deactivators 
respectively and other parameters are same as in eq. 13. Here, it is assumed Kinact[SFA] 
equals 0.1 s-1. As mentioned above, wild-type cells contain about 20 million fatty acids 
and 60% of these comprise of SFAs which is 12 million copies (29.7 mM). Using this 
concentration, Kinact can be derived as 0.0034 mM
-1s-1.      
Indeed, it was reported in Ray and Raetz (1987) that of all phospholipids species tested, 
cardiolipins had the most effect at activating LpxK. Although the authors did not 
provide a rationale for their observation, their use of bovine heart cardiolipins which are 
known to contain at least 94% UFAs of the total fatty acids, may have been implicated 
(Schlame et al., 1993). Similarly, cardiolipins of E. coli are characterized with more 
UFAs relative to other phospholipids moieties (Yokota et al., 1980). In this regard, the 
model strongly proposes that the activity of LpxK is dependent on the presence of UFA.  
Finally the K-4 and K-5 values were fitted as 90 s
-1 for fabA, and 2 s-1 for fabB which 
resulted in a protein steady-state count. 
 
3.6  MODEL RESULTS 
3.6.1  FabZ inhibition and overexpression 
Zeng at al. (2013) isolated FabZ mutants with decreased specific activities that had low 
levels of LpxC. The authors also observed that overexpression of FabZ increased levels 
of LpxC in wild-type cells. Although, there were no specific LpxC fold-changes in 
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either case from Zeng et al to quantitatively make comparison, both perturbations were 
tested in the refined model by decreasing or increasing the FabZ counts by 100 folds. 
As seen in Fig. 3.2A, LpxC levels were decreased by 40% when FabZ was inhibited and 
consequently, the amount of LPS being produced was also reduced by 40%. It was 
observed the LpxK catalytic activation rate was reduced by 50% which enabled lipid A 
disaccharide to accumulate and negatively feedback on LpxC degradation. The model 
produced excess SFAs and could barely synthesize UFAs due to the absence of an 
essential FabZ role at dehydrating cis-containing β-hydroxyacyl-substrates. Despite this, 
it was also observed that no accumulation of FabZ substrates occurred due to the readily 
reversible nature of the FabZ reactions. The production of SFAs occurred from the 
activities of the bi-functional FabA enzyme. In contrast, the dehydratase role of FabZ in 
UFAs synthesis cannot be complemented by FabA (Heath and Rock, 1996b) hence the 
absence of UFAs. An upregulation in FabA and FabB concentrations were observed but 
these had no effect at elevating the concentrations of UFAs because FabZ became the 
rate-limiting step in UFAs synthesis. 
On the other hand, the steady-state concentration of LpxC was increased by 2.6 fold 
when FabZ was overexpressed in the model (Fig. 3.2A). However, LPS levels were 
reduced by 70%. Since cells become non-viable when LPS amounts are reduced by 
more than 50% (Onishi et al., 1996), overexpression of FabZ would result in a lethal 
effect to the cell in agreement with data presented in Zeng et al. (2013). Regarding the 
fatty acid profile, the production of SFAs was slightly enhanced while UFAs amounts 
remained the same. Although, Lee et al. (2013) had reported that overexpression of 
FabZ increases the proportion of UFAs, their data exhibited this phenomenon only after 
prolonged growth (i.e. stationary phase) whereas, the model represents the exponential 
or steady-state growth phase of E. coli. In fact, their results indicated that when the cells 
were harvested early, SFAs were increased and UFAs decreased. Thus, in this respect, 
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the FabZ model is compatible with their experiments. Despite the slight increase in 
SFAs amount in the model, an up-regulation in FabA or FabB was not observed.  
 
3.6.2  The role of FabA and FabB in UFAs biosynthesis 
As mentioned above, cellular requirement for UFAs result in an upregulation of both 
fabA and fabB genes which enhances UFAs yield. However, sole overexpression of 
FabA increases SFAs synthesis rather than UFAs synthesis (Clark et al., 1983; Cao et 
al., 2010). This phenomenon was tested in the model as presented in Fig. 3.2B. Model 
results agree qualitatively with experimental evidence presented in Clark et al (1983). 
The slight quantitative disparity may arise since the experimental results used for 
comparison were carried out at 42°C whereas the model parameters represent optimum 
conditions.   
 
3.6.3  Overexpression of fabH 
In Tsay et al. (1992), it was reported that overexpression of fabH increased the cellular 
concentration of SFAs by 16%. Testing this perturbation in the model was relatively 
straightforward. A 10% increase in SFAs level was observed when the FabH count was 
increased by 100 folds in close agreement with the experiments. Furthermore, the model 
displayed an increase in the expression levels of FabA and FabB; however, expression 
of the latter was not as pronounced as FabA. 
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Figure 3.2. Model results. Model conditions were those depicted in Fig. 3.1 using 
paramters presented in Table 3.1. (A) Effect of FabZ inhibition and overexpression on 
LpxC and LPS levels. The FabZ molecule count were increased or decreased by 100 
folds to represent FabZ overexpression and inhibition respectively. (B) The role of 
FabA and FabB on SFAs/UFAs ratio. The FabA and FabB counts were kept constant 
and increased by 100 folds to represent overexpression conditions. This meant that 
FadR/FabR regulation was disabled.    
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3.7  SUMMARY 
A biosynthesis computational model of the outer membrane of E. coli was developed, 
drawing parameters from the literature, and making estimates when necessary. The 
model agrees qualitatively with experimental data and to some extent, quantitatively. 
The model findings indicate that the fatty acid enzymes have sufficient catalytic 
properties to produce approximately 20 million molecules required in vivo.   
However, the model may be inadequate for testing certain pathway perturbations. For 
instance, there were no specific parameters for FabG involving any of the substrates 
studied in the model. Therefore, the estimates made may only be adequate under wild-
type conditions where FabG does not limit pathway flux. Also, as stated above, FadR is 
a global regulator of certain genes involved in fatty acid biosynthesis and degradation. 
Apart from the transcriptional activation of fabA and fabB, the other roles of FadR are 
outside the scope of this work hence, the model may be inappropriate at studying the 
effect of FadR dynamics on fatty acid synthesis.  
One of the interesting findings from the model was the observation that the catalytic 
activity of LpxK may be reliant on the concentration of UFAs. The significance of this 
finding suggest that LpxK plays a crucial role in outer membrane homeostasis than was 
previously envisaged. The resultant effect of a decrement in LpxK activity would lead 
to the accumulation of lipid A disaccharide which in turn will enhance the degradation 
of LpxC. In other words, LpxC is expected to be less stable under low UFAs conditions 
according to the model findings.  
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Chapter  4 
Experimental methodology 
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4.1  OVERVIEW 
The last two Chapters have discussed the development of an integrated biosynthetic 
pathway model of lipid A and phospholipids. Although, there are a number of published 
experimental datasets which could be used to further validate the model, they however, 
focus mainly on one arm of the integrated pathway. For instance, there is little available 
information to test the effects of perturbation of one synthetic pathway on the regulation 
of the other. This would appear important given both lipid A and phospholipids are 
synchronously produced as discussed previously. Furthermore, model reliability would 
be improved if its prediction can be validated experimentally. 
This Chapter describes the experimental methodological approach aimed at model 
validation, and testing of its predictions.       
 
4.2  PROCEDURES 
4.2.1  Bacterial strains and growth conditions 
The E. coli strains and plasmids used for these experiments along with their relevant 
characteristics are presented in Table 4.1. E. coli strains JP1111, CY53, CY288 and 
DC170 were obtained from the E. coli Genetic Stock Center (CGSC) at Yale, USA 
while strain AG1 was purchased from the National BioResource Project (NIG) Japan. 
Strains W3110, ΔftsH, and plasmid pBO110 were gifts from Prof. Franz Narberhaus. 
Unless stated otherwise, cells were grown in LB medium (10 g tryptone, 5 g yeast 
extract, 5 g NaCl per litre). When required, antibiotics were used at the following 
concentrations for selective pressure; 20 µg/ml chloramphenicol, 30 µg/ml kanamycin 
and 100 µg/ml ampicillin. Protein expression was induced with either L-arabinose (for 
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cells containing the pBAD plasmid), or IPTG (for cells containing plasmid with the lac 
operator) as appropriate when required. 
 
4.2.2  Plasmid extraction 
An overnight culture of strain AG1 containing the pCA24N plasmid bearing the waaA 
gene was centrifuged (1 ml) using a microcentrifuge at maximum speed (13,000 rpm) 
for 1 min. The pellets were washed with phosphate buffered saline (PBS) and re-
suspended in 100 µl of a resuspension buffer (50 mM Tris-HCl, pH 7.5; 10 mM EDTA; 
100 µg/ml RNase). 200 µl of lysis buffer (0.2 M NaOH; 1% SDS) was added and mixed 
by gently inverting the tube and immediately, 200 µl of Potassium acetate solution was 
added to precipitate the genomic DNA. After 5 min, the suspension was centrifuged at 
maximum speed for 5 min and the supernatant-containing plasmid DNA (about 400 µl) 
collected and transferred onto a fresh tube. Plasmid DNA was precipitated by adding 1 
ml of absolute ethanol and placed in -20°C for 30 min prior to centrifugation. The 
pelleted plasmid DNA was air-dried and re-suspended in 30 µl of TE buffer (10 mM 
Tris-HCl pH 8.0, 1 mM EDTA) and subsequently used for bacteria transformation.    
 
4.2.3  Preparation of chemically-competent cells and bacterial 
transformation 
An overnight culture was grown in LB broth to mid-log phase (OD600 = 0.5). 1 ml of 
culture was aliquoted into Eppendorf tubes placed on ice, and harvested by 
centrifugation for 10 min at 3,000 rpm at 4°C. The pellets were re-suspended in 100 µl 
of ice-cold Transformation Storage Solution (TSS) buffer (Chung et al., 1989) (5 g 
polyethylene glycol 8000 (PEG); 1.5 ml 1 M MgCl2; 2.5 ml dimethyl sulfoxide 
(DMSO); LB broth added to 50 ml) and placed on ice. 
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Table 4.1:      E. coli strains and plasmids used in this study and their relevant 
characteristics 
Strains   Relevant characteristics1     Reference 
W3110 (wild-type) λ-, IN(rrnD-rrnE)1, rph-1              Bachmann (1972) 
JP1111  galE45(GalS), λ-, fabI392(ts), relA1, spoT1, thiE1      Egan and Russel (1973) 
CY53  λ-, fabA2(ts), relA1, rpsL118(strR), malT1(λR),  
               xyl-7, mtlA2, thiE1             Cronan et al. (1972) 
CY288  fhuA22, fabF200, zcf 229::Tn10, gyrA220(NalR),  
                              fabB15(ts), relA1, rpsL146(strR), pitA10, spoT1, T2R      Garwin et al. (1980b) 
ΔFtsH  W3110 zad220::Tn10 sfhC21ΔftsH3::kan           Tatsuta et al. (1998) 
DC170  F-, fabA203(p), fadR16, tyrT58(AS), mel-1             Clark et al. (1983) 
AG1   recA1, endA1, gyrA96, thi-1, hsdR17(rK- mK+),  
               supE44, relA1          Kitagawa et al. (2005) 
Plasmids 
pBO110   PBAD, araC, rrnBT, Ampr, lpxC            Fuhrer et al. (2006) 
pCA24N-waaA  lacIq, T-rrnB, cat, waaA        Kitagawa et al. (2005) 
1. Gene mutations highlighted in bold represent genes involved in fatty acid 
production/regulation. sfhC is a synonym for fabZ. The mutation fabA203(p) leads to the 
creation of a novel fabA promoter.  
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2 µl of plasmid DNA was added to the TSS cells and allowed to sit on ice. After 30 min, 
the cells were heat-shocked by incubating at 42°C for 30 s and immediately incubated 
on ice for 2 min. 1 ml of SOB (Super Optimal Broth) (0.5% yeast extract; 2% tryptone; 
10 mM NaCl; 2.5 mM KCl; 20 mM MgSO4; 20 mM glucose (Hanahan, 1983)) was 
added to the cells and incubated at 37°C for 1 h. 100 µl was spread onto LB agar plates 
with the appropriate antibiotics as selective marker and incubated overnight at 30 or 
37°C. 
 
4.2.4  Minimum inhibitory concentration (MIC) determination 
The minimal inhibitory concentration was defined as the lowest antibiotic concentration 
at which no measurable bacterial growth was observed in LB medium. Cultures were 
inoculated at a starting OD600 of 0.01 and incubated overnight at 30°C in the presence of 
varying concentrations of antibiotics. 
    
4.2.5  Preparation of cell extracts 
In the case of the temperature-sensitive mutants, isogenic strains were harvested and re-
suspended in TE buffer containing 1 mM of phenylmethanesulfonylfluoride (PMSF). 
The cells were lysed by sonication, centrifuged at maximum speed in a microcentrifuge  
for 1 min, and the protein concentration in the supernatant was determined using the 
Bradford assay and bovine serum albumin (BSA) as standard (Bradford, 1976). 1x 
Laemmli sample buffer was added to the supernatant and heated at 99°C for 5 min prior 
to Western blot analysis. 
Unless specified otherwise, cell extracts for other strains were prepared as described 
previously (Sorenson et al., 1996; Zeng et al., 2013). Briefly, an overnight culture was 
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inoculated into fresh LB grown to mid-log phase (OD600 = 0.5). The respective cultures 
were normalized to the same OD600 of 0.5. 3 ml of normalized culture was centrifuged at 
maximum speed for 1 min and the cell pellets re-suspended in 100 µl of TE buffer 
containing 1x Laemmli sample buffer (Bio-Rad). The samples were heated for 10 min 
prior to centrifugation for 5 min. The supernatants were collected for Western blot 
analysis.  
 
4.2.6  Western blot 
20 µl of each normalized sample were loaded onto a 10% SDS-polyacrylamide gel. For 
samples subjected to the Bradford assay, equal amounts of protein were loaded onto 
each well. Following electrophoresis, proteins were transferred to a PVDF membrane 
using the Bio-Rad Trans-Blot Turbo system. An LpxC antiserum generated in rabbit (a 
kind gift from Prof. Franz Narberhaus) and a secondary anti-rabbit peroxidase-linked 
antibody (Sigma, UK) were used for immunodetection at dilutions of 1:20000 and 
1:10000 respectively. The WaaA construct expressed from the plasmid contains a His-
tag attached to its N-terminus. Consequently, WaaA was immunoblotted using a 6x-His 
epitope tag primary antibody (Pierce) generated in mouse (1:6000) and a secondary 
anti-mouse alkaline phosphatse-linked (AP) antibody (1:8000). Blots were developed 
using the ECL chemiluminiscent reagents (Bio-Rad) or AP substrate kit (Bio-Rad) as 
appropriate. Signals were detected using the ChemiDoc MP system (Bio-Rad). 
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4.2.7  LPS analyses 
4.2.7.1 LPS extraction 
LPS was extracted from the membrane according to the method described by Henderson 
et al. (2013). Bacterial cultures (3 ml) were harvested and washed with PBS, and re-
suspended in 200 µl of PBS. 250 µl and 500 µl of chloroform and methanol were added 
respectively in order to form a single phase Bligh-Dyer mixture (chloroform, methanol, 
water, 1:2:0.8 v/v) (Bligh and Dyer, 1959). The tubes were mixed by inversion and 
incubated at room temperature for 30 min to ensure complete cell lysis. The mixture 
was thereafter centrifuged at 2,000 x g for 20 min and the supernatant which contains 
phospholipids and other lipids was discarded. The LPS containing pellet was washed 
with 1 ml of a single phase Bligh-Dyer mixture followed by centrifugation at 2,000 x g 
for 20 min. 
       
4.2.7.2  Kdo assay 
LPS was quantified by measuring the concentration of Kdo in the membrane as 
described by Karkhanis et al (1978). The respective cultures were grown and 
normalized to the same density prior to harvesting. Harvested cells were washed with 
PBS and re-suspended in TE buffer containing 1 mg/ml lysozyme. Cells were sonicated 
and centrifuged for 20 min at maximum speed. The membrane fractions were re-
suspended in 1 ml of 0.1 M H2SO4 and heated at 99°C for 30 min. After cooling and 
centrifugation for 5 min, 500 µl was pipetted into another test tube. 250 µl of 0.04M 
periodic acid was added, vortexed vigorously, and the mixture was left to stand at room 
temperature for 20 min. Next, 250 µl of 2.6% Sodium arsenate in 0.5M HCl was 
included in the mixture and vortexed vigorously. When the brown colouration that 
developed had disappeared, 500 µl of 0.6% thiobarbituric acid was added, vortexed and 
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heated for 15 min at 99°C. Whilst still hot, 1 ml of DMSO was added. The mixture was 
left to cool to room temperature and its optical density at 548 nm was read against a 
blank treated as above but without cell lysates.  
 
4.2.7.3  Heptose assay 
Heptose is a major constituent of the LPS core OS (Kneidinger et al., 2002). Heptose 
levels were determined by the method described in Wright and Rebers (1972). Bacterial 
culture were normalized prior to harvesting and washed with PBS. LPS was extracted 
from the membrane as described above and then placed in an ice water bath. 1.125 ml of 
H2SO4 (6 vol. of conc. H2SO4 and 1 vol. of H2O) was added, mixed vigorously, and left 
in the ice water bath for 3 min. Next, the tubes were transferred to a 25°C water bath for 
3 min prior to the addition of 25 µl of 3% cysteine-HCl. The mixture was heated at 
99°C for 20 min and absorbance readings were taken after 1 h at 505 nm and 545 nm. 
The difference in absorbance readings (A505 – A545) were used for quantitative analyses. 
The blank was treated as above but with the exclusion of cysteine-HCl. 
   
4.2.8  Phenotypic characterization on agar plates    
E. coli strains containing the plasmid bearing the waaA gene were grown to an OD600 of 
0.2 and serial dilutions from 10-1 to 10-4 were prepared. 2 µl of the dilutions were 
spotted on LB agar plates containing chloramphenicol and when required, IPTG was 
used to induce waaA expression. The plates were incubated at 30°C overnight. 
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4.2.9  Fatty acids analyses  
4.2.9.1  Fatty acids extraction 
Fatty acids extraction were performed essentially as described by Kurkiewicz et al 
(2003). 40 ml of bacteria cells harvested at an OD600 of approximately 0.5 were 
centrifuged and the pellets heated with 3M NaOH (1 ml) for 40 min at 90°C in a water 
bath. 2ml of 3.25M HCl was added and heated further for 10 min at the same 
temperature. After cooling, fatty acids were extracted 3 times using 1ml of hexane-
diethyl ether mixture (1:1). The organic layers were separated by centrifugation for 5 
min at 2400 x g. The obtained fatty acids were evapourated under vacuum prior to the 
derivation step. 
 
4.2.9.2  Preparation of 3-pyridylcarbinol (picolinyl) ester derivatives 
The derivatives were prepared as described previously (Harvey, 1998). The extracted 
fatty acids were heated with 20 µl of thionyl chloride for 10 min at 99°C. The residual 
thionyl chloride was evapourated under a stream of Nitrogen gas and a solution of 20% 
3-(hydroxymethyl) pyridine in acetonitrile (10 µl) was added. The mixture was heated 
for 1 min at 99°C. 500 µl of hexane was added prior to gas chromatography-mass 
spectrometry (GCMS) analysis.       
 
4.2.9.3  Gas chromatography-mass spectrometry 
GCMS analyses were performed using an Agilent GC 7890A and EI/CI MSD 5975C 
models. Chromatographic separations were performed using a capillary column (30 m, 
0.25 mm i.d., 0.25 µm film thickness) and helium was the carrier gas. The temperature 
program of the oven used were those previously described by Oursel et al. (2007); 
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initial temperature at 200°C, held for 1 min, raised to 240°C at 8°C min-1, then ramped 
to 300°C at 2°C min-1. 
Peak identities were confirmed from their electron ionization (EI) mass spectra, and 
comparison with retention times of known standards. 
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Chapter  5 
Experimental results 
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5.1  OVERVIEW 
Whilst the model presented in Chapters 2 and 3 have provided insight into the complex 
regulation of LPS synthesis during outer membrane biogenesis, a number of the model 
findings required experimental evidence. This would further enhance model reliability 
and in addition, the experimental findings could further be used to constrain the 
simulation parameters which would ensure a more accurate representation of the model. 
The regulation of fatty acids and phospholipids biosynthesis has been studied 
extensively; however, little information exists regarding the impact of fatty 
acids/phospholipids synthesis on LPS regulation in terms of metabolic cross-talk. 
Although, Ogura et al. (1999) had initially suggested that acyl-ACPs may affect the 
regulation pattern of LpxC, there are no studies to date to confirm or test this 
hypothesis. Similarly, since the regulation of WaaA by FtsH was first reported by Katz 
and Ron (2008), no study has investigated the underlying regulatory mechanism. This 
would appear important because WaaA catalyses the reaction step that provides lipid A 
with its antigenic properties (Meredith et al., 2006).  
Furthermore, because LPS is in direct contact with the external environment, it is 
intuitive that LPS synthesis and regulation would be sensitive to environmental and 
physiological changes. In addition to testing model predictions, this Chapter aims to 
investigate LPS regulation under varying environmental and physiological conditions, 
investigate the possible role of acyl-ACPs on LpxC stability, and underpin the possible 
rationale behind WaaA regulation using a range of experimental methods.   
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5.2  ROLE OF FATTY ACID BIOSYNTHESIS ENZYMES ON LPS 
REGULATION 
Although, the model presented in Chapters 2 and 3 indicated that lipid A disaccharide is 
the feedback source for FtsH-mediated LpxC degradation, there are additional 
information which suggests there may be other FtsH feedback signals arising from the 
fatty acids biosynthesis pathway. For example, it was observed in Ogura et al. (1999) 
that LpxC levels were elevated in a fabI (ts) mutant. In order to understand the role of 
fatty acids synthesis on LpxC regulation, it was essential to analyse a number of fatty 
acid biosynthetic mutants as described below. 
 
5.2.1 Excess substrate flux into the saturated fatty acid and LPS 
pathway stimulates LpxC degradation   
Four E. coli strains were used to investigate the role of fatty acid synthesis on LPS 
regulation. The first was strain JP1111 which possesses a mutation in the fabI gene and 
consequently resulting in a temperature-sensitive FabI protein. In other words, when the 
cells are grown at low temperatures (such as 30°C), the effect of the mutation is not 
apparent and the FabI protein functions normally. However, when grown at higher 
temperatures (such as 42°C), growth ceases due to an inactive FabI protein. Higher 
temperatures are usually referred to as the “non-permissive temperatures”. This 
phenomenon is the same for all temperature sensitive mutants in this study. The second 
strain CY288 possesses two relevant mutations; a mutation in the fabF gene which 
apparently reduces the FabF specific activity (this fabF mutation is active at all 
temperatures) (Garwin et al., 1980b); and another mutation in the fabB gene leading to a 
temperature-sensitive FabB protein. The third E. coli strain was CY53 with a 
temperature sensitive FabA protein. Finally, strain DC170 has a mutation in the fabA 
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gene leading to the creation of a novel fabA promoter and thus, overexpressing the 
FabA protein by 13 folds (Clark et al., 1983). The genetic characteristics of these strains 
are listed in Table 4.1.     
The levels of LpxC in these mutants were used as an indicator of pathway activity. 
When E. coli strains JP1111 (fabI (ts)) and CY288 (fabF200, fabB (ts)) were grown at 
the non-permissive temperature, LpxC was highly stabilized whereas LpxC was rapidly 
degraded in strain CY53 (fabA (ts)) mutant (Fig. 5.1).  
Next, the SFAs and UFAs distribution in these mutants were analysed to determine if 
the regulatory signal is driven by levels of lipid A disaccharide, or from sources outside 
of the LPS pathway. In other words, an increment of substrate flux into the SFAs 
pathway is an indirect indication of increased flux into the LPS pathway. This is 
because LPS substrates are derived from the SFAs pathway (i.e. β-hydroxymyristoyl-
ACP) (Fig. 3.1).   
When strain JP1111 (fabI (ts)) was grown at the non-permissive temperature, the 
proportion of UFAs were substantially increased (Fig. 5.2). Inhibition of FabI which 
catalyses the first committed step in SFAs synthesis (Heath and Rock, 1996b) enabled 
the isomerase activity of FabA to divert substrates towards UFAs synthesis (see 
pathway description in Fig. 3.1). This indicates a reduction of substrate influx into the 
SFAs synthesis arm and subsequently the LPS pathway. This was further confirmed 
using LPS quantification assay described below. Therefore, LpxC stability observed in 
strain JP1111 (fabI (ts)) at the non-permissive temperature is as a result of decreased 
levels of lipid A disaccharide.   
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Figure 5.1. Effect of fatty acid biosynthetic enzyme inhibition on LpxC stability. E. 
coli strain JP1111 (fabI (ts)) cells were grown at 30°C to an OD600 of 0.15. Part of the 
culture was transferred to 42°C and grown for 150 min. Growth ceased after 2 
generations at the non-permissive temperature. Strain CY288 (fabB200, fabB (ts)) cells 
were prepared as above except that cells were grown in a modified LB broth (5 g 
tryptone, 2.5 g yeast extract, 2.5 g NaCl). Growth ceased after 2 generations at 42°C. 
Overnight culture of strain CY53 (fabA (ts)) were grown directly either at 30°C or 42°C. 
At the latter temperature, growth ceased after 3 generations. Cell extracts and Western 
blotting were conducted as described in Chapter 4. Blue bars on the right represent 
computational simulations using the model described in Chapter 3 and parameters 
presented in Table 3.1. Here, model enzyme counts were reduced arbitrarily to mimic 
the non-permissive temperature because there were no available information in the 
literature on residual enzyme activity in these mutants. The FabF count was reduced by 
10 folds, FabI and FabB by 100 folds, and FabA by 500 folds. 
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Similarly, fatty acids distribution were analysed in strain CY288 (fabF200, fabB (ts)). 
This strain had a lesion in the fabF gene in addition to having a temperature-sensitive 
FabB protein. When grown at 30°C, the fatty acid profile of the cells were characterised 
with significant levels of medium chain-length fatty acids (Fig. 5.2). This partial 
inhibition of fatty acid elongation occurred due to the lesion in FabF (Garwin et al., 
1980b); although, cells remain viable due to a functional FabB. However, when grown 
at 42°C, a further increment in medium chain fatty acids (especially pentadecanoic acid, 
an odd chain fatty acid) and reduction in long chain fatty acid moieties were observed 
(Fig. 5.2). This clearly indicates that fatty acid elongation has been halted. Since LPS 
precursor molecules are derived from fatty acyl-ACPs, halting fatty acid elongation 
would repress levels of lipid A disaccharide and stabilize LpxC. Although, increased 
levels of SFAs were generally observed at 42°C, these were mainly odd-chain fatty 
acids. Odd-chain fatty acyl-ACPs are unsuitable substrates for LPS synthesis due to a 
strict requirement of LpxA for β-hydroxymyristoyl-ACP (Anderson et al., 1987) and 
therefore would not be expected to be shunted down the LPS pathway. Therefore LpxC 
stability in this strain can be attributed to low levels of the lipid A disaccharide. Again, 
this was confirmed by LPS quantification as described below.  
Furthermore, a concomitant decrease in both long-chain SFA and UFA (stearic and cis-
vaccenic acids) were observed in strain CY53 (fabA (ts)) when grown at the non-
permissive temperature (Fig. 5.2). The only reasonable explanation from the pathway 
schematic in Fig. 3.1 is that the rate of synthesis of trans-2-decenoyl-ACP was reduced 
given FabA is the major dehydratase involved in this step (Heath and Rock, 1996b). 
Subsequently, limited substrates would be diverted into both SFAs and UFAs arm of the 
pathway resulting in reduced palmitoyl-ACP and palmitoleoyl-ACP concentrations. An 
 
133 
 
 
 
 
 
 Figure 5.2. Effect of inhibiting fatty acid biosynthetic enzymes on fatty acid 
composition. Black and red bars represents growth conditions at 30°C and 42°C 
respectively. Cells were grown as described in Fig. 5.1 and their fatty acids content 
determined using GCMS analysis. Error bars represent standard error of mean. Fatty 
acids notation are C14, myristic acid; C15, pentadecanoic acid; C16:1, palmitoleic acid; 
C16, palmitic acid; C18:1, cis-vaccenic acid; C18, stearic acid.   
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increased competition for low levels of palmitoyl-ACP and palmitoleoyl-ACP by 
phospholipids acyltransferases (PlsB and PlsC) (Goelz and Cronan, 1980; Rock et al., 
1981) would further ensure that only a small proportion of these acyl pool are elongated 
to stearic and cis-vaccenic acids by FabB and FabF respectively (Edwards et al., 1997). 
Although, substrate flux into the SFAs pathway would generally be reduced, inhibition 
of FabA resulted in increased LpxC degradation as presented in Fig. 5.1 due to an 
accumulation of lipid A disaccharide. Accumulation of lipid A disaccharide would 
occur under this condition because FabA plays a major role in the dehydration of β-
hydroxymyristoyl-ACP due to a higher protein copy number (Ishihama et al., 2008) and 
similar catalytic activities with FabZ (Heath and Rock, 1996b). Therefore, a loss of 
FabA activity would increase the concentration of β-hydroxymyristoyl-ACP which is 
then shunted into the LPS pathway.   
As a confirmation that strain CY53 (fabA (ts)) grown at 42°C was characterized with 
sufficient substrate flux into the LPS pathway, the concentration of LPS were identical 
to those grown at 30°C (Fig. 5.3). In contrast, reduction in LPS levels were observed in 
both strains JP1111 (fabI (ts)) and CY288 (fabF200, fabB (ts)) when grown at the non-
permissive temperature which is indicative of low substrate availability (Fig. 5.3). 
Together, these findings indicate that the FtsH-mediated LpxC degradation signal arises 
solely from lipid A disaccharide under fatty acids inhibition conditions.   
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Figure 5.3. Quantification of LPS in fatty acid biosynthetic enzyme mutants. Black 
bars represents experimental results which were determined by measuring the amount of 
Kdo in the bacterial membrane. Error bars represent standard error of mean. The blue 
bars are simulations results using model conditions as described in Fig. 5.1 above. 
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5.2.1.1 Overexpression of FabA enhances LpxC degradation. 
Up until now, the effect of fatty acyl enzymic inhibition on LpxC regulation has been 
analysed. It was also important to test the effect of fatty acyl enzymic overexpression on 
LpxC stability. This would confirm if the inhibition and overexpression data are 
compatible with conclusions above.   
When strain DC170 (fabAup) which overexpresses fabA was grown at 30°C, there were 
no differences in LpxC levels relative to the control strain (W3110). However, at 42°C, 
LpxC was degraded more rapidly (Fig. 5.4A). Clark et al. (1983) had reported 
previously that strains overexpressing fabA at temperatures of 30°C or less, did not 
result in elevated level of SFAs whereas at optimum temperature, and especially 42°C, 
SFAs concentrations were significantly increased even though UFAs level remained 
constant. As stipulated above, excess flux of substrates into the SFA pathway arm and 
subsequently the LPS pathway enhances LpxC degradation which most likely explains 
the results presented in Fig. 5.4A. Furthermore, the amount of LPS synthesized at both 
temperatures were similar to those of wild-type (Fig. 5.4B). In particular, at 42°C in 
which pathway substrate flux was increased, an increment in LPS relative to wild-type 
(W3110) is not expected because LpxK becomes the rate-limiting step. Instead, lipid A 
disaccharide would accumulate leading to a rapid degradation of LpxC (Fig. 5.4A).      
Furthermore, overexpression of LpxC was observed to be toxic in strain DC170 
(fabAup) and under such condition, cells spend a significant length of time in the lag 
growth phase apparently to degrade excess LpxC prior to reproduction (Fig. 5.4C). This 
also supports the claim that LpxC levels must be lowered under FabA overexpression 
conditions. 
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Figure 5.4. Effect of fabA overexpression on LPS regulation. Both wild-type 
(W3110) and DC170 (fabAup) cells were grown in LB broth at the given temperatures 
until mid-log phase. Cells were normalized prior to harvesting. (A) LpxC levels in 
W3110 and DC170 (fabAup). (B) LPS quantification in both W3110 and DC170 
(fabAup) strains. Error bars represent standard error of mean. (C) Strains W3110 and 
DC170 (fabAup) were transformed with a plasmid bearing the lpxC gene (pBO110) and 
protein expression was induced using 0.1% L-arabinose overnight at 30°C. Overnight 
cells were transferred to fresh broth (without inducer) and incubated at 42°C. Growth 
rate was monitored (left) and after 90 min, part of the culture were harvested, and cell 
extracts subjected to the Bradford assay prior to Western blot analysis (right).   
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5.3  LPXC IS RAPIDLY DEGRADED UNDER TOXIC CELL CONDITIONS 
Having established from above that mutations in the fabI and fabF/fabB genes stabilize 
LpxC, a similar study was conducted to observe the impact of specific inhibitors of 
these gene products on LpxC levels. When wild type cells (W3110) were treated with 
sub-MIC levels of irgasan (also called triclosan, an inhibitor of FabI (Rafi et al., 2006)), 
LpxC was highly stabilized (Fig. 5.5A). A similar result was obtained in the presence of 
cerulenin, a specific inhibitor of FabF and FabB proteins (Price et al., 2001). Thus, 
these results corroborates with the gene mutation studies presented in Fig. 5.1. It should 
be noted that under the drug treatment conditions in Fig. 5.5A, there were no differences 
in growth rates. However, under drug treatment conditions that led to differential 
growth rates, the LpxC regulation pattern deviated from those of the gene mutation 
studies (Fig. 5.5B). This therefore suggests that LpxC is rapidly degraded under toxic 
conditions. 
Schakermann et al. (2013) had previously reported that FtsH-mediated LpxC 
degradation is correlated with growth rate under substrate limiting conditions resulting 
from an accumulation of the alarmone (p)ppGpp. This alarmone usually accumulates 
under amino acid starvation and/or environmental stress conditions (Janßen et al., 
2014). It is plausible that cellular toxicity induced by antibiotics leads to the 
accumulation of (p)ppGpp which activates LpxC degradation. Alternatively, (p)ppGpp 
accumulation is known to repress the expression of a wide range of genes including 
lpxK (Traxler et al., 2008). In the latter scenario, repression of lpxK would cause lipid A 
disaccharide to accumulate and subsequently facilitate the rapid degradation of LpxC.    
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Figure 5.5. Effect of antibiotics that inhibit fatty acid enzymes on LpxC stability. 
Cerulenin is an inhibitor of FabF and FabB, while irgasan inhibits FabI at low 
concentrations. The antibiotics were used at the following concentrations; cerulenin, 10 
µg/ml; irgasan, 0.01 µg/ml. (A) lpxC protein expression was induced in wild-type strain 
(W3110) overnight with 0.1% L-arabinose at 30°C. Overnight culture was inoculated 
into fresh broth (without inducer) at 42°C to an OD600 of about 0.1. The culture was 
split, antibiotics were added, and incubation was allowed to continue for another 90 
min. There were no differences in growth rates prior to harvesting. Bradford assay was 
performed on the cell extracts and equal amount of protein was loaded onto a 10% SDS-
PAGE gel for Western blot analysis. (B) Conditions were same as in ‘A’ above with the 
sole exclusion; lpxC expression was induced overnight with 0.2% arabinose. Cells 
treated with antibiotics grew more slowly than the control.       
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5.4  PROTEOLYTIC REGULATION  OF LPXC IN AN FTSH KNOCKOUT 
MUTANT 
Given that the results presented above indicate that excess flux of metabolites into the 
SFAs pathway enhances LpxC proteolysis, the next goal was to examine the likelihood 
of SFAs commonly found in membrane phospholipids to directly impact on LpxC 
instability. Under in vitro conditions, it was observed that the addition of excess 
palmitic acid to wild-type (W3110) cell lysates for 10 min resulted in an increased 
degradation rate of LpxC in a dose dependent manner (Fig. 5.6A). This phenomenon 
was not observed in the presence of myristic acid, a shorter chain fatty acid. Provided 
these findings are translatable in vivo, they prove interesting for a number of reasons. 
Firstly, and although highly unlikely, it points to a possibility of prior postulation of 
lipid A disaccharide being the feedback source for LpxC degradation as inaccurate. 
Secondly, and more plausible, it indicates the presence of an unidentified protease 
involved in the regulation of LpxC. In order to clarify these assumptions, further tests 
were required. 
Next, cell lysates of an ftsH knockout mutant were treated with palmitic acid and LpxC 
degradation was also observed in a dose-dependent manner (Fig. 5.6B). This therefore 
indicate that under these in vitro conditions, an unidentified protease was responsible 
for the degradation of LpxC. Furthermore, proteolysis under palmitic acid condition was 
inhibited in the presence of EDTA which indicates the protease belonged to the class of 
metalloprotease, similar to FtsH (Fig. 5.6C).  
 
 
 
141 
 
 
Figure 5.6. In vitro LpxC proteolysis in an ftsH knockout mutant. (A) Effect of fatty 
acids on LpxC stability in vitro. E. coli W3110 strain (wild-type) containing a plasmid 
bearing lpxC gene was grown at 30°C in the presence of 0.1% arabinose to induce 
protein expression. Cells were harvested at mid-log phase, re-suspended in Tris-HCl pH 
8.0 (without EDTA) and lysed via sonication. The lysates were added to tubes 
containing various concentrations of fatty acids and incubated for 10 min at 30°C. 
Sample buffer was added immediately after incubation and heated for 5 min prior to 
Western blot analysis. (B) Effect of palmitic acid on LpxC stability in ftsH knockout 
mutant cells in vitro. Cells (without plasmid) were treated as in ‘A’ above. (C) Palmitic 
acid-induced LpxC degradation occurs via a metalloprotease in vitro. E. coli W3110 
cells were prepared as in ‘A’ above but some samples contained EDTA and PMSF to 
inhibit metalloproteases and serine proteases respectively. 
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However, under normal physiological conditions, LpxC and palmitic acid are localized 
in separate cellular compartments (cytoplasm and outer membrane respectively) and 
may not be in direct contact with one another as it was in the in vitro assays. Since 
palmitic acid exists in the cytoplasm in the forms of palmitoyl-CoA and palmitoyl-ACP 
(Janßen et al., 2014), it was essential to investigate the effect of both forms of palmitic 
acid on LpxC stability.     
Palmitic acid is known to be actively transported across the membrane from the external 
environment by FadL (Kumar and Black, 1991) and immediately converted to 
palmitoyl-CoA by FadD (Weimar et al., 2002). Interestingly, when palmitic acid was 
added to the growth medium of wild-type E. coli (W3110), the levels of LpxC were 
elevated (Fig. 5.7A). This observation is readily explainable from prior experimental 
data, and earlier results presented in Fig. 5.1. Palmitoyl-CoA induces a strong inhibitory 
effect on FabI with a Ki value of about 3 µM (Bergler et al., 1996). Due to the inhibition 
of FabI, LpxC would be stabilized (Fig. 5.1). Thus, increment in cellular palmitoyl-CoA 
concentration has an opposite effect on LpxC stability than the free-form of palmitic 
acid.  
On the other hand, under in vivo conditions, inhibiting substrate flux into the LPS 
pathway will increase the cellular concentration of palmitoyl-ACP (Zhu et al., 2009). 
This is because when LPS substrate influx is inhibited, it leads to elevated levels of β-
hydroxymyristoyl-ACP which is subsequently dehydrated by FabZ and shunted towards 
the production of palmitoyl-ACP. Cells were treated with sub-lethal concentrations of 
an LpxC inhibitor (CHIR-090) in order to reduce substrate flux into the LPS pathway. 
Under this condition, LpxC stability was observed in wild-type (W3110) cells (Fig. 
5.7A). These results are also readily explainable; LpxC stability occurred due to 
decreased levels of lipid A disaccharide. Yet again, increment in cellular palmitoyl-ACP  
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Figure 5.7. In vivo LpxC proteolysis in an ftsH knockout mutant. (A) Effect of 
increased palmitoyl-ACP and palmitoyl-CoA concentrations on LpxC stability in vivo. 
E. coli W3110 and ftsH knockout mutant cells were grown in LB broth at 30°C to an 
OD600 of 0.1. The cultures were split and CHIR-090 and palmitic were added and 
incubation continued until the OD600 reached 0.5. The cultures were normalized 
according to their density prior to Western blot analysis. (B) LpxC is less degraded in 
vivo in ftsH knockout cells in the presence of antibiotics that affect membrane 
synthesis/stability. Cells were grown to an OD600 of 0.5 and cultures were split into 
different tubes. The respective antibiotics were added for 5 min prior to the addition of 
200 µg/ml of chloramphenicol to block protein expression. After 30 min, the cells were 
shock-frozen in liquid Nitrogen and thereafter, allowed to thaw on ice prior to Western 
blot analysis. Bands were quantified using the Chemi-Doc Imager software.   
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concentration has an opposite effect on LpxC stability than the free-form of palmitic 
acid. However, the presence of palmitic acid or sub-lethal concentration of CHIR-090 in 
the culture medium had no effect on LpxC stability in ftsH knockout mutant cells (Fig. 
5.7A). Together, these findings indicate that the direct interaction of LpxC with long 
chain free-fatty acids (i.e. fatty acids not bound to ACP or CoA) facilitated FtsH-
independent LpxC proteolysis as observed in the in vitro assays.      
Interestingly, when the in vivo LpxC degradation rate was monitored in ftsH knockout 
cells that were treated with a higher concentration of CHIR-090 or other antibiotics that 
affected the bacterial membrane, an increment in LpxC level was observed (Fig. 5.7B). 
This indicates that in untreated cells, residual LpxC proteolysis occurred which 
confirms the presence of an additional regulatory protease. Additionally, it also 
indicates that LpxC regulation is crucial to the bacterial cells which must maintain the 
desired protein levels irrespective of an accumulation of lipid A disaccharide, or 
presence/absence of a functional FtsH protease.    
 
5.5  WAAA REGULATION 
In addition to LpxC, WaaA is regulated via FtsH-mediated degradation (Katz and Ron, 
2008). The regulation of WaaA enzyme is poorly understood. In fact, only one study by 
Katz and Ron (2008) have investigated the regulatory role of WaaA to date. In Chapter 
2, different rationales for WaaA regulation were postulated. Briefly, the model 
suggested that regulation of WaaA may influence LPS synthesis rate when CMP-Kdo is 
limiting. Alternatively, WaaA regulation may help to prevent reactions with undesirable 
substrates. As a result, it was important to investigate the exact role of WaaA 
degradation during LPS synthesis.  
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Figure 5.8. Proteolytic degradation of WaaA. (A) E. coli (W3110) cells containing a 
plasmid bearing the 6x-His-waaA gene were grown at 37°C in LB broth with the 
addition of 20 µg/ml of chloramphenicol for selective pressure. At an OD600 of 0.5, 
waaA expression was induced using 1 mM of IPTG for 10 min prior to the addition of 
300 µg/ml of spectinomycin to block protein translation. 3 ml of culture were dispensed 
in various Eppendorf tubes and were shock frozen in liquid Nitrogen to stop all cellular 
processes. The indicated time points represent min after the addition of spectinomycin 
when the cells were frozen. The cells were allowed to thaw on ice and harvested prior to 
Western blot analysis. (B) The procedure was same as in ‘A’ above with the sole 
exclusion of waaA expression being induced with 0.1 mM IPTG.     
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An E. coli (W3110) strain was transformed with a plasmid bearing the waaA gene 
which had histidine (6x-His) tagged to its N-terminus region. Because gene fusions 
either to the N-or C- terminus region can prevent the proteolytic regulation of its protein 
product (Fuhrer et al., 2006; Fuhrer et al., 2007), it was crucial to ensure that the waaA 
plasmid construct was suitable for experimental investigations. In this regard, the WaaA 
half-life was monitored by inducing protein expression under different concentrations of 
IPTG. Under modest IPTG induction, the half-life of WaaA was approximately 10 min 
(Fig. 5.8B). This is in agreement with prior observations by Katz and Ron (2008) in 
which chromosomally expressed WaaA possessed a half-life of 10 min under optimum 
conditions. Therefore, the His-tag does not interfere with WaaA regulation. Although, 
under excessive IPTG induction, proteolysis of waaA was not observed after 30 min 
(i.e. half-life > 30 min) (Fig. 5.8A).  
 
5.5.1  Overexpression of waaA is toxic to cells 
When waaA was overexpressed, cell growth was inhibited (Fig. 5.9). A similar finding 
was observed previously for LpxC in studies by Fuhrer et al. in which overexpression of 
a functional lpxC gene resulted in cell toxicity (Fuhrer et al., 2006). The authors also 
observed that overexpression of non-functional lpxC did not result in cell toxicity. 
Therefore, it is plausible that under unregulated WaaA conditions, such as during 
overexpression, increased metabolic activity occurs which is undesirable to the cell. 
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Figure 5.9. Overexpression of waaA is toxic to cells. E. coli strain W3110 containing 
a plasmid bearing 6x-His-WaaA gene was grown to an OD600 of 0.2, serially diluted, 
and spotted on agar plates containing either no sugar or 1 mM IPTG to induce protein 
expression. Plates were incubated overnight at 30°C. 
 
 
 
Figure 5.10. waaA overexpression under reduced LPS pathway flux conditions. (A) 
Cell growth was severely inhibited even under pathway flux inhibition with CHIR-090. 
Conditions are similar to Fig. 5.9 above. The concentration of CHIR-090 used was 0.02 
µg/ml. (B) The combined toxicity resulting from waaA overexpression and CHIR-090 
treatment is additive. The growth curve was monitored in LB broth.    
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The next step would be to determine if such an increase in metabolic activity correlates 
with an increment in LPS biosynthesis. If indeed LPS is increased, then it indicates that 
WaaA exerts some degree of control on LPS synthesis rate in contrast to model 
assumptions. To clarify this, LPS pathway flux was reduced by inhibiting LpxC using 
sub-MIC concentrations of CHIR-090. Yet, overexpression of waaA under this 
condition did not prevent cellular toxicity (Fig. 5.10A). This provided a first indication 
that unregulated production of WaaA would also result in increased metabolic activity 
which may be independent on LPS production rate. In fact, the toxicity induced by 
waaA overexpression and LpxC inhibition were additive (Fig. 5.10B). These results do 
not conclusively exclude the possibility of WaaA at influencing LPS synthesis rate. 
Therefore, further detailed analyses were required as described below.    
          
5.5.2  Effect of waaA overexpression on LPS composition 
In order to clarify if LPS levels were increased when waaA is overexpressed, LPS was 
quantified in cells overexpressing waaA by quantifying the amount of Kdo in the 
bacterial membrane. Under this condition, Kdo levels were elevated by approximately 
20 % (Fig. 5.11). However, an increment in Kdo may not indicate increased LPS level 
under waaA overexpression. This is because, the role of WaaA is to add two Kdo 
residues to the LPS lipid precursor (lipid IVA); therefore, the possibility still exists that 
overproduction of WaaA may result in multiple additions of Kdo to lipid IVA (i.e. re-
glycosylation) or alternatively, Kdo may be added to other undesirable lipid acceptors 
(other than lipid IVA) (Brozek et al., 1989; Belunis and Raetz, 1992) in the membrane. 
This also indicates that quantification of LPS using the Kdo assay may be inappropriate 
under waaA overexpression conditions. To further clarify these possibilities, substrate 
flux into the LPS pathway was inhibited using ½ MIC of CHIR-090. The rationale for  
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Figure 5.11. Kdo concentration under waaA overexpression. Cells were grown at 
37°C to an OD600 of 0.1 and split. CHIR-090 was added to the appropriate culture for 30 
min prior to addition of IPTG. Growth was allowed to continue for 45 min and the 
cultures were normalized according to their density prior to harvesting. Kdo in the 
membrane extract was quantified as described in Chapter 4. Error bars represent 
standard error of mean.  
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this was that by reducing the influx of substrates, the LPS synthesis rate would be 
dependent on substrate availability and not WaaA concentration. Similarly, 
overexpression of WaaA under this condition led to a 20 % increase in Kdo levels in 
comparison to cells that were solely treated with CHIR-090 (Fig. 5.11). Again, these 
findings indicate that the rate of glycosylation by WaaA is independent on lipid IVA 
availability. 
Furthermore, it was essential to investigate if the re-glycosylated lipid IVA or other 
alternate lipids (i.e. lipids other than lipid IVA) that could be glycosylated by WaaA are 
being consumed for LPS synthesis. Consequently, LPS was extracted from the 
membrane and the concentration of heptose sugar was quantified. Heptose sugars are 
primarily used in the synthesis of core OS of LPS. They are attached directly to the Kdo 
residues (Fig. 5.12A). In other words, they provide an alternative means to quantify LPS 
indirectly. The results obtained differed from those of the Kdo quantification. When 
waaA was overexpressed, the concentration of heptose was decreased in comparison to 
uninduced cells (Fig. 5.12B) which indicate that LPS levels are also decreased under 
waaA overexpression. Additionally, when pathway flux was inhibited (using CHIR-
090) and waaA overexpressed, the concentration of heptose were slightly increased in 
comparison to cells solely treated with CHIR-090 (Fig. 5.12B). Altogether, these results 
indicate that unregulated waaA expression is undesirable under normal conditions.  
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Figure 5.12. Heptose concentration under waaA overexpression. (A) Structure of 
LPS depicting the attachment of heptose residues to kdo in the core OS. Source: 
http://lipidlibrary.aocs.org/Primer/content.cfm?ItemNumber=39339 [Accessed 17th 
September, 2015]. (B) Cells were prepared exactly as described in Fig. 5.11 above. LPS 
was extracted from the membrane prior to heptose quantification.  
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To further elucidate the effect of waaA overexpression on the structural stability of the 
bacterial outer membrane, the MICs of different antibiotics were determined for cells 
overexpressing waaA.   
When waaA was overexpressed, the cells were more susceptible to colistin in 
comparison to uninduced cells (Table 5.1). Colistin is an antimicrobial peptide that 
selectively targets bacterial LPS (Warren et al., 1985). Interestingly, at low levels of 
waaA overexpression, the MICs to erythromycin and kanamycin which are known to 
inhibit translation, were the same as uninduced cells. This indicate that overexpression 
of waaA results in cells with reduced LPS concentration or a defective LPS structure. 
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Table 5.1:  MIC of different antibiotics under waaA overexpression 
  
Cell preparation and growth conditions are same as in Fig. 5.11 with the exception; 
growth was allowed to continue for 2 h after IPTG induction. The cultures were 
normalized according to their density and MICs were determined as described in 
Chapter 4.  
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5.6  SUMMARY 
The regulation of LPS biosynthesis is crucial to cell viability. Two of the key regulatory 
points previously reported are LpxC and WaaA which are both degraded by FtsH. 
Earlier studies have indicated that enzymes involved in fatty acid biosynthesis affect the 
regulation of LpxC which suggests the possibility of a regulatory signal arising from the 
fatty acids biosynthetic pathway. However, the results presented in this Chapter 
involving the analysis of cellular fatty acids composition and LPS quantification 
strongly indicate there are no additional FtsH feedback sources separately from lipid A 
disaccharide. Instead, excessive flux of metabolites into the SFAs pathway results in 
increased concentration of β-hydroxymyristoyl-ACP which subsequently shunts through 
the LPS pathway leading to elevated levels of lipid A disaccharide. Nevertheless, LpxC 
regulation appears to be independent on lipid A disaccharide under toxic cellular 
conditions. Interestingly, further investigation acknowledged the presence of an 
unidentified metalloprotease involved in LpxC regulation in ftsH knockout mutant cells. 
In this case, LpxC degradation was observed to be repressed in vivo under conditions 
that promote membrane vulnerability.     
Although, overexpression of WaaA elevates the amount of Kdo in the bacterial 
membrane, this increment is independent of lipid IVA availability and do not elevate the 
total LPS concentration. In fact, overexpression conditions resulted in cells that were 
more susceptible to colistin which is known to directly interact with the LPS structure. 
An increased susceptibility was not observed with antibiotics that target protein 
synthesis. Altogether, these suggest that the regulation of WaaA during LPS synthesis 
are for qualitative purposes and not quantitative.  
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Chapter  6 
Discussion and conclusion 
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6.1  DISCUSSION 
6.1.1  The lipid A model 
This research began by constructing a model of the E. coli lipid A biosynthetic pathway, 
including its regulation, using parameters derived from published experimental data. 
After increasing the LpxM copy number and adding product inhibition to LpxH, the 
model agreed well with the observed lipid A production rate and exhibited steady-state 
metabolite concentrations. The model also agreed qualitatively with all published 
datasets that were tested, including ones in which LpxA was defective, LpxC was 
inhibited with an antibiotic, LpxC half-lives were compared with cell generation times, 
LpxC was overexpressed, and under substrate limiting conditions. The lipid A model 
also agreed well with experiments in which lpxK was overexpressed.  
Findings from the model indicate that the lipid A biosynthesis rate is controlled by 
LpxC, but only if substrates are in excess and if feedback regulation is ignored. 
However, LpxK becomes the controlling enzyme if feedback regulation is included, as 
it is in living cells, and other enzymes gain control if substrate concentrations are below 
saturation levels. The lipid A model also strongly indicated that WaaA may be regulated 
in order to control the lipid A production rate when the CMP-Kdo concentration is 
limiting, and/or to control the ratio of normal to alternate lipid A that is produced. 
Quantitative disagreements between metabolic models and experiments are particularly 
useful because they indicate which model assumptions are likely to be incorrect. These 
errors then enable new insights about the true system behaviour. Firstly, the initial lipid 
A model produced lipid A at 20% of the observed rate and exhibited LpxM substrate 
accumulation, which suggest that LpxM is actually present at a much higher 
concentration than was measured with proteomic methods (Ishihama et al., 2008). 
Alternatively, it could indicate that other enzymes are capable of catalysing the 
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substrate of LpxM in agreement with prior postulations (Clementz et al., 1997; 
Vorachek-Warren et al., 2002b). 
Secondly, high levels of lipid X during modelling suggest that the LpxH kinetics are 
regulated by product inhibition, and also that LpxH and LpxB may form a complex that 
performs metabolic channeling. The latter suggestion seems highly plausible because 
LpxB is immediately downstream of LpxH in the lipid A pathway, and both are 
peripheral membrane proteins. Since the LpxH substrate is localized in the cytoplasm, 
an absence of interaction between these proteins may result in a low LPS turnover rate 
because the catalytic product of LpxH may diffuse away from the membrane outside the 
reach of LpxB.  
Thirdly, the model exhibited 4-fold increased LpxC when LpxA was made defective, 
instead of the observed 5-10 fold increase (Anderson et al., 1993); this may arise from 
experimental differences, or due to unmodeled aspects of LpxC regulation, such as 
transcriptional regulation. There is recent evidence which suggests that LpxC could be 
regulated at the transcriptional level under sub-optimal conditions (Eraso et al., 2014). 
Fourthly, the model exhibited a 98% reduction in the lipid A synthesis rate when LpxA 
was defective, instead of the 30% that was observed experimentally (Anderson et al., 
1993). This large discrepancy between the model and experiment suggests the presence 
of alternate metabolic routes around LpxA, such as the possibility of LpxD at catalysing 
the LpxA step. This is because both LpxA and LpxD are acyltransferases that utilize β-
hydroxymyristoyl-ACP.  
Fifth, the model underestimated cell generation times when LpxC had a very long half-
life (Schakermann et al., 2014) which suggest that the growth rates of fast growing cells 
are not limited by the lipid A production rate. Finally, the model could exhibit the 
experimentally observed LpxC half-life and cell generation time when substrates were 
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limited (Schakermann et al., 2014), but only when the total FtsH concentration was 
increased 25-fold; this suggests that there are additional mechanisms that regulate LpxC 
degradation which was subsequently confirmed in this work. Not all of these 
speculations are proven by the model. Instead, they are possible solutions to situations 
in which the experiments that were used to create the model do not agree with 
experiments that were used to test the model. In this case, they provide hypotheses for 
further experimental investigation. 
The combination of prior published data, model results, and LpxK overexpression 
experiments provide strong evidence for lipid A disaccharide being a primary feedback 
source for LpxC degradation (Figs 2.2 and 2.4). Furthermore, these same sources of 
information suggest that this is the only feedback source among the chemical species 
that are known to be present.  
 
6.1.2  Integrated lipid A/phospholipids model 
An integrated model for both lipid A and phospholipids pathways was developed with 
major emphasis at the transcriptome, proteome and metabolome level of detail. The 
refined model comprises of 81 reactions involving 90 reacting species. Yet again, the 
initial parameters for the phospholipids pathway were unable to replicate a number of 
published datasets. For instance, the model initially produced excess SFAs and little or 
no UFAs. This may indicate that in addition to palmitoyl-ACP, the activity of FabI is 
further repressed by other acyl-ACPs; or more still, the isomerase activity of FabA is 
much higher in vivo. Furthermore, accumulation of cis-substrates of FabZ were 
observed indicating that FabZ possesses a higher affinity for its unsaturated acyl-
substrates than its saturated acyl substrates. The FabB activity for cis-3-decenoyl-ACP 
had to be reduced significantly which suggests that the first committed step in UFAs 
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synthesis may be regulated at the substrate level in vivo. Most importantly, the 
integrated model was able to replicate experimental results only when the catalytic 
activation of LpxK arose solely from UFAs.  
Although Ray and Raetz (1987) had reported that LpxK catalysis is stimulated by 
phospholipids, the model strongly suggests that such stimulation is driven by the UFAs 
moiety in phospholipids, and inhibited by SFAs. There are a number of published 
dataset that supports this notion. The phospholipids utilized in Ray and Raetz (1987) 
were bovine heart cardiolipins which are known to consist almost entirely of UFAs 
(Schlame et al., 1993). Furthermore, Roy and Coleman (1994) observed that when 
LpxD was inhibited, the specific activity of LpxK was decreased whereas the protein 
half-lives of LpxK were the same under normal and LpxD inhibition conditions. Further 
analysis by the authors indicated that overexpression of LpxD does not increase the 
specific activity of LpxK. This means that the decrease in LpxK activity is a secondary 
effect of the altered LpxD. These observations can readily be interpreted from the 
model. Because β-hydroxymyristoyl-ACP is a substrate utilized by LpxD, reduced 
LpxD activity would result in an accumulation of this substrate which is shunted 
towards SFAs production. This is because β-hydroxymyristoyl-ACP is derived from the 
SFAs pathway arm (Fig. 3.1). In return, excess SFAs would repress the catalytic 
activation of LpxK. 
Since the ratio of UFAs/SFAs influences the activation of LpxK, this suggests that LPS 
synthesis rate is correlated with membrane fluidity. This is due to the fact that UFAs in 
the membrane increases fluidity while SFAs decreases fluidity (Mansilla et al., 2004). It 
is also well documented that bacteria regulate their membrane composition in relation to 
fluidity (Mansilla et al., 2004). It is probable that under conditions of low membrane 
fluidity (such as under high SFAs condition), a reduced LpxK activity may be essential 
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in order to reduce the amount of LPS produced which potentially would add an extra 
permeability barrier, and subsequently reduce the influx of metabolites from the 
external environment. The opposite effect seems to occur under conditions of high 
membrane fluidity. It was reported in Wahl et al. (2011) that E. coli grown in 
environments that had increased membrane fluidity through degradation of LPS, led to 
an induction of PlsB transcription which would ultimately enhance the production of 
phospholipids.  
Nevertheless, more pathway regulation may take place around LpxK. Due to lipid A 
disaccharide being the feedback source for LpxC degradation, an increase in LpxK 
activity would lead to higher LpxC concentrations and hence faster lipid A production, 
which could help balance the phospholipid to LPS ratio. Thus, LpxK plays an essential 
role at maintaining LPS and phospholipids homeostasis. 
In addition, the model can help elucidate which lipid A pathway enzymes are likely to 
be good or poor antibacterial targets. Most of the best known inhibitors of the LPS 
pathway to date have been directed at LpxC (Onishi et al., 1996; McClerren et al., 
2005; Barb and Zhou, 2008), including the CHIR-090 antibiotic discussed above, 
presumably because most intracellular synthesis regulation takes place at LpxC. 
However, sensitivity analysis suggests that this intracellular regulation may actually 
make LpxC a poor drug target because it enables the cell to counteract external 
perturbations. Indeed, it was recently reported by Walsh and Wencewicz (2014) that the 
development of CHIR-090 has been hampered due to the ease of pathogen mutation to 
resistance. In contrast, the model suggests that LpxK would make a good target, as 
initially suggested by Emptage et al. (2012). LpxK is an essential enzyme without 
alternative synthetic routes, so strong inhibition would arrest lipid A production. More 
still, when the model accounted for feedback regulation, the lipid A production rate was 
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particularly sensitive to the LpxK concentration (Fig. 2.5A). Finally, inhibiting LpxK 
would lead to lipid A disaccharide accumulation. Lipid A disaccharide is cytotoxic 
(Garrett et al., 1998) and its accumulation would lead to LpxC down-regulation, which 
would further repress lipid A production. 
 
6.1.3  LpxC regulation 
It is well documented that an appropriate ratio of LPS and phospholipids is crucial for 
cell viability (Galloway and Raetz, 1990; Ogura et al., 1999) and this is achieved in part 
through controlled LpxC proteolysis by FtsH (Ogura et al., 1999). Model and 
experimental results strongly indicate there are no separate FtsH feedback sources aside 
from lipid A disaccharide mediated towards LpxC degradation. There has been some 
uncertainties as to the role of acyl-ACPs in the regulation of LpxC. In the first scenario, 
since LPS and phospholipids biosynthesis pathways both derive their precursor 
molecules from β-hydroxymyristoyl-ACP, it was accepted that competition for this 
common substrate influences the regulation of LpxC (Ogura et al., 1999). In other 
words, LpxC degradation would help conserve substrates for phospholipids synthesis. 
This initially seemed reasonable and is supported by the fact that FabZ inhibition 
enhances LpxC degradation (Zeng et al., 2013), and FabZ overexpression results in 
LpxC stability (Ogura et al., 1999). However, the model and experimental results 
disagree with this “competition model” regarding β-hydroxymyristoyl-ACP availability. 
As an example, LpxC would have been expected to be stabilized under conditions of 
FabA overexpression which invariably increases substrate flux into the SFAs pathway 
(Clark et al., 1983), and subsequently elevate the pool of β-hydroxymyristoyl-ACP. 
This should lead to a reduced competition between LpxC and FabZ for substrates. On 
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the contrary, increased LpxC degradation was observed under this condition (Fig. 
5.4A).  
In support of the model’s disagreement with the “competition model”, Ogura et al. 
(1999) also observed that LpxC levels were elevated in fabI (ts) mutants. Although, the 
authors had initially suggested that increased concentration of trans-2-tetradecenoyl-
ACP may enhance LpxC stability due to the observation that LpxC levels are also being 
elevated when FabZ is overexpressed, they also admitted the unlikelihood of trans-2-
tetradecenoyl-ACP accumulation under fabI (ts) conditions (Heath and Rock, 1995). 
Thus, they were unable to explain the rationale for LpxC stability under FabI inhibition 
conditions. Clearly, the results of this research indicate that the increased levels of LpxC 
in fabI (ts) mutant occurred due to decreased flux of substrates into the SFAs and LPS 
pathways (Figs. 5.2 and 5.3) which ultimately depreciated the lipid A disaccharide 
concentration.  
As mentioned above, a general contributing factor to the degradation of LpxC by FtsH 
is the excessive flux of substrates into the pathway arm of SFAs synthesis and 
subsequently the LPS pathway. The model presented in Chapter 3 provided a valuable 
tool at interpreting the observed cellular characteristics. There were two key factors 
from model interpretations which particularly influenced LpxC regulation; (i) 
competition between FabI and FabA isomerase for trans-2-decenoyl-ACP substrate. 
This competition determines substrate influx rate into SFAs and UFAs pathway arm; 
(ii) concentration of UFAs which is essential for the catalytic activation of LpxK. An 
increased concentration of UFAs would ensure lipid A disaccharide does not 
accumulate.  
On the other hand, LpxC stability is not solely attributable to an increased concentration 
of UFAs. For instance, UFAs were increased at the non-permissive temperature in strain 
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JP1111 (fabI (ts)), and decreased in strain CY288 (fabF200, fabB (ts)). Yet, LpxC was 
stabilized under both conditions (Figs 5.1 and 5.2). In the latter case however, cells 
were characterized with more medium-chained fatty acids and less long-chain fatty 
acids (Fig. 5.2). This implies that fatty acids synthesis and elongation proceeded at a 
slow rate which also indicate that levels of lipid A disaccharide would be decreased. 
Furthermore, it also implies that cellular membrane fatty acids composition are 
connected with LpxC regulation. The latter phenomenon has been observed previously 
in studies investigating membrane fluidity where it was found that the presence of 
UFAs or shorter-chain SFAs increase fluidity (Royce et al., 2013). Therefore, LpxC 
regulation may be correlated with membrane fluidity. Bacterial membrane fluidity is 
known to be increased at elevated temperatures (Mansilla et al., 2004) and non-
coincidentally, the half-life of LpxC is also increased under such conditions (although, 
it should be noted that the steady-state concentrations of LpxC are similar at both 30°C 
and 42°C) (Fig. S6 in Appendix)  
The observation of FtsH-dependent LpxC proteolysis occurring under toxic cellular 
conditions (Fig. 5.5) indicate an essential role of LpxC in general cell metabolism. 
Under these sub-optimal conditions, cells tend to shut down growth which also involves 
halting the synthesis of membrane components (Traxler et al., 2008). Schakermann et al 
(2013) observed that under stringent responses that led to the accumulation of the 
alarmone (p)ppGpp, the half-life of LpxC decreased and was dependent on FtsH. As 
mentioned earlier, their findings could be explained from the model based on prior 
results presented by Traxler et al (2008) in which the expression of lpxK is prominently 
deregulated under (p)ppGpp accumulation in comparison to other genes involved in 
LPS synthesis. This implies that LpxK would be present in low copies leading to 
increased concentration of lipid A disaccharide which enhances LpxC degradation. The 
correlation between LPS synthesis and growth rate is further supported by findings in 
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Zeng et al. (2013) whereby E. coli mutants resistant to CHIR-090 had decreased LpxC 
activity in addition to a suppressor mutation in the thrS gene. The mutation in the thrS 
gene leads to reduced protein production rate and slower cell growth (Zeng et al., 2013). 
Alternatively, FtsH degradation of LpxC may be activated via an unidentified 
metabolite under sub-optimal growth conditions. Together, these point to substantial 
signal processing taking place at FtsH, which then controls LPS synthesis through 
LpxC. 
The regulation of LpxC becomes more complicated by observations that an unidentified 
protease degrades LpxC. Although the in vitro results provided evidence that palmitic 
acid enhances LpxC proteolysis via another metalloprotease, this mechanism appears 
not to reflect the normal in vivo physiological setting (Fig. 5.6). In fact, an increase in 
the isoforms of palmitic acid usually found in the cytoplasm (i.e. palmitoyl-ACP and 
palmitoyl-CoA) stabilized LpxC levels (Fig. 5.7). Therefore, the observed in vitro 
results were possibly due to a direct interaction of the free-form of palmitic acid with 
LpxC. A possible implication is that during fatty acids biosynthesis, dissociation of the 
palmitic acid prosthetic group from its carrier protein (perhaps through the action of 
thioesterases) triggers LpxC proteolysis. Again, this mechanism may be linked to 
cellular toxicity as it is well documented that long chain free-fatty acids (i.e. fatty acids 
not bound to ACP or CoA) such as palmitic acid are toxic to cells (Lennen et al., 2011). 
An alternative explanation to the in vitro results could be due to palmitic acid binding to 
LpxC. Palmitic acid has also been reported to bind directly to the active site of LpxC in 
vitro (Barb and Zhou, 2008). Therefore, the actual LpxC substrate and excess palmitic 
acid possibly competes for the enzyme active site, in which case, palmitic acid may act 
as an inhibitor. Proteolysis under this condition could be directed at aberrant LpxC 
proteins. In support of this, Fuhrer et al. (2006) had initially suggested a possible 
involvement of other classes of proteases in the degradation of non-functional LpxC.  
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Irrespective of the in vitro results, residual degradation of LpxC still occurs under FtsH 
inactivation conditions (Fig. 5.7). Interestingly, treatment of bacterial cultures with 
compounds which reduced the levels of lipid A disaccharide and stabilized LpxC in 
wild-type cells, also led to LpxC stability in ftsH knockout mutants; although, much 
higher concentrations of those compounds were required. However, this does not 
indicate that lipid A disaccharide is the feedback source under those FtsH inactivation 
conditions since other antibiotics which directly targeted the membrane structure also 
resulted in LpxC stability (Fig. 5.7). Therefore, the regulatory signal for FtsH-
independent LpxC proteolysis arises from an unidentified metabolite or pathway. Due 
to LpxC being localized in the cytoplasm, this unidentified protease would most likely 
be localized in the cytoplasm or inner membrane. Thus, under conditions of direct LPS 
attack from the environment (i.e. outer membrane), it is highly plausible that this 
protease functions in parallel with a separate adapter protein which senses the 
vulnerability of the outer membrane and translates such information to the protease. 
Indeed, in a similar pattern, FtsH-mediated LpxC degradation has been reported to be 
dependent on an adapter protein YciM (Mahalakshmi et al., 2014). Due to LpxC being 
the first committed step in LPS synthesis, it is intuitively reasonable that when the 
bacterial membrane is under direct attack from the external environment, cells must 
attain the desired level of LPS through LpxC regulation irrespective of the 
concentration of lipid A disaccharide or presence of an active FtsH protein. It would be 
interesting to investigate whether the specific activity of LpxK are increased as well 
under such conditions.   
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6.1.4  WaaA regulation 
The lipid A biosynthesis pathway in E. coli comprises of only nine enzymic reaction 
steps; yet, two of those enzymes are regulated by the same FtsH protease. One of many 
puzzles surrounding LPS regulation has been to underpin the exact rationale for WaaA 
regulation in addition to LpxC. 
According to the model, there are several possible purposes for WaaA regulation. First, 
it may serve to regulate lipid A production, which the model proved is possible, but 
only if CMP-Kdo is at least partially limiting. Also, it may serve to regulate the relative 
production of lipid A and alternate lipid A, which the model also displayed is possible. 
This is because WaaA has a low substrate specificity (Katz and Ron, 2008).   
Further experimental investigations suggest that under optimum conditions, WaaA 
regulation is more correlated with LPS composition. Although, the levels of Kdo in the 
membrane were elevated under WaaA overexpression, the overall LPS concentration 
was not elevated which suggests that WaaA degradation functions as a means to prevent 
an uncontrolled addition of Kdo residues to lipid precursors. In support of this, some of 
the precursors for other substrates that can be glycosylated by WaaA could not be 
detected in wild-type E. coli (Takayama et al., 1983), suggesting that this step is tightly 
controlled. The situation changes at elevated temperatures where these alternate 
substrates accumulate (Nishijima and Raetz, 1979) and, probably not coincidentally, 
WaaA is degraded faster under these conditions (Katz and Ron, 2008). Furthermore, it 
is well established that the composition of lipids within bacterial membranes are altered 
as a response to temperature fluctuations and growth rate changes (de Mendoza et al., 
1983; Vigh et al., 1998; Mansilla et al., 2004), presumably to control membrane 
fluidity.  
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Nevertheless, since the alternate substrates that can be glycosylated by WaaA are absent 
under optimum conditions (Nishijima and Raetz, 1979; Takayama et al., 1983), this 
suggests that WaaA possibly re-glycosylates lipid IVA or alternatively, glycosylates 
other lipid A precursor molecules given that WaaA is rapidly degraded under optimum 
conditions. This also suggests that the activator is most likely downstream of LpxC 
within the LPS pathway.  
Interestingly, when WaaA was overexpressed under CHIR-090 treatment, an increment 
in LPS (using the heptose assay) was observed in comparison with cells that were solely 
treated with CHIR-090 (Fig. 5.12). This is in contrast to observations in wild-type and 
WaaA overexpressed cells in which the latter condition led to less LPS. A first intuitive 
analogy would be to assume that when bacterial cells are characterized with reduced 
LPS synthesis rate, multiple or re-glycosylation pattern by WaaA could help 
compensate for a fluid outer membrane. However, this seems unlikely since a 
combination of CHIR-090 treatment and WaaA overexpression induces a highly toxic 
effect to the cells in comparison to either CHIR-090 treatment or WaaA overexpression 
only (Fig. 5.10). This indicates that WaaA overexpression is highly undesirable even 
under limited LPS substrate conditions. 
From the arguments above, it can be concluded that WaaA does not control the rate of 
LPS synthesis under optimum conditions. Although, deletion of waaA has been reported 
to be lethal (Klein et al., 2009), Reynolds and Raetz (2009) have provided evidence to 
suggest that the importance of WaaA is mainly to provide the right substrates for LpxL 
which make its role more of a qualitative one. Furthermore, findings by Meredith et al. 
(2006) have indicated that WaaA is not essential for LPS synthesis and assembly. In the 
study, the authors generated a non-conditional E. coli strain that lacks Kdo and 
remained viable. In furtherance, the authors also observed that a second Kdo knockout 
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strain that was auxotrophic for arabinose-5-phosphate (A5P) became viable in the 
absence of A5P under MsbA overexpression conditions. This indicate that rates of non-
glycosylated lipid A transport can, in part, compensate for an absence of Kdo. Perhaps, 
previously observed correlation of cell viability and absence of Kdo arises due to a 
lethal pleiotropy resulting from the depletion of the carbohydrate, rather than an 
inherent need for the Kdo molecule itself as an indispensable component of LPS 
(Meredith et al., 2006).  
 
6.2  CONCLUSION 
A central theme of cell biology modeling method development is that non-spatial, non-
stochastic models are too simplistic (Ridgway et al., 2006; Andrews et al., 2009). In 
response, new software tools offer support for stochastic reaction dynamics and spatial 
localization of proteins. In this case, this research began by using the Smoldyn simulator 
(Andrews et al., 2010), which accurately addresses stochasticity and spatial detail, but 
found that simulations ran too slowly and the spatial detail did not affect the results. 
Thus, simulations were switched to StochKit (Sanft et al., 2011), which performs 
stochastic simulations but ignores spatial localization. Again though, the stochastic 
detail proved unnecessary (Fig. S8 in Appendix). Finally, the study settled on the use of 
non-spatial deterministic simulations. These simple simulations were appropriate in this 
case because the lipid A and phospholipids pathways are sufficiently poorly 
parameterized through experimental work. Therefore, including additional detail would 
have only complicated the model further. However, more detailed simulation methods 
will likely become useful as the lipid A and phospholipids syntheses become better 
characterized. For example, the model indicated that time-averaged intracellular CHIR-
090 antibiotic count in cells was about 0.3 molecules, implying that it is present in 
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extremely low copy numbers. This could lead to strong stochastic effects. Also, the 
results suggest the presence of interesting dynamics between LpxH and LpxB, such as 
metabolic channeling. These might be best modeled using spatial simulation methods. 
In conclusion, a first and comprehensive model for the biosynthesis of the outer 
membrane in E. coli was developed. The computational model agrees qualitatively with 
the presented experimental findings and to some degree, quantitatively. The regulatory 
elements presented in the model are largely new. The experimental results indicate a 
strong correlation between membrane fluidity and LpxC degradation. Furthermore, the 
results of this study indicate lipid A disaccharide is the sole feedback source for FtsH-
mediated LpxC degradation. Interestingly, FtsH-independent LpxC proteolysis was 
observed in vivo which was independent on lipid A disaccharide accumulation. The 
results presented above also imply that the catalytic activation of LpxK is entirely 
dependent on the presence of UFAs. Additionally, the regulation of WaaA is unintended 
to control the LPS synthesis rate but rather, to prevent undesirable lipid glycosylation 
patterns. 
The major points of control between LPS and phospholipid pathways lie with LpxC and 
LpxK. Both proteins sense interactions in the biosynthesis of phospholipids and co-
ordinately regulate the amount of LPS produced accordingly. The fact that LpxC 
regulation occurs through multiple channels highlight an important role in bacterial 
metabolism. Also, cells could potentially adapt to perturbations in LpxC levels through 
multiple sources which subsequently makes LpxC undesirable as a drug target. On the 
other hand, because LpxK is not known to be regulated through multiple channels, in 
addition to its important role at maintaining LPS and phospholipids homeostasis, drug 
design directed towards LpxK would result in potent therapeutic agents. Altogether, the 
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findings of this work provide new insights into the complex biogenesis of the E. coli 
outer membrane. 
 
6.3  FUTURE RECOMMENDATIONS 
The model presented in this research represents the most complete model for the 
biosynthesis of the outer membrane components of E. coli. An extension of the model 
incorporating peptidoglycan synthesis would effectively result in the creation of a 
model representing the entire bacterial membrane. Such information would be 
invaluable at interrogating membrane permeability and invariably guide drug 
development process. Further expansion of the model would represent a key step 
towards achieving a whole-cell model.  
Although the model agreed qualitatively with a wide range of experimental results, it 
also exhibited some quantitative differences. Thus, this model is not a final picture of 
lipid A and phospholipids biosynthesis, but instead represents the best understanding of 
the biosynthesis of the integrated pathway that is available to date. Nevertheless, the 
model present interesting findings which could not be validated in this research. For 
instance, a possibility that LpxH and LpxB could interact by forming a metabolic 
channel would be interesting for further investigation. The model also strongly indicates 
that the catalytic activity of LpxK is entirely dependent on the presence of UFAs. 
Again, this hypothesis would require further validation using in vitro enzyme kinetics 
assay. 
Additionally, characterization of the unidentified protease involved in LpxC degradation 
would be invaluable. This would further enhance our understanding on the essentiality 
of such protease, and perhaps, result in the assignment of a function if previously 
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unannotated. Likewise, further studies are necessary to investigate the structural 
composition of LPS under WaaA overexpression conditions.  
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APPENDIX 1 – GCMS chromatograms  
1.1  Fatty acids biosynthetic mutant strains 
 
 
 
Figure S1. Chromatograms of temperature-sensitive E. coli mutants. Fatty acid 
extraction and analysis were conducted as described in Fig. 5.2. These chromatograms 
presented herein also formed part of the data used to generate Fig. 5.2. Fatty acids 
notation are C14:0, myristic acid; C15:0, pentadecanoic acid; C16:1, palmitoleic acid; 
C16:0, palmitic acid; C18:1, cis-vaccenic acid; C18:0, stearic acid.  
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In the chromatograms presented in Fig. S1, the values on the Y-axis scale differ 
substantially between isogenic strains grown at 30°C and 42°C. This is understandable 
given that varying amount of sample would be expected to be lost during the fatty acid 
extraction process. In this regard, researchers usually include internal standards during 
sample preparations. Nevertheless, internal standards are particularly important when 
absolute quantification (such as in microgram or nanogram units) of the metabolites are 
essential. However, for semi-quantitative or qualitative studies such as this research, 
representing the data as relative percentages are commonly adopted. These may include 
representing peaks relative to a another peak (Yu et al., 2011), or representing a peak 
relative to the total peaks as was employed in this study (Goelz and Cronan, 1980; Clark 
et al., 1983; Kurkiewicz et al., 2003; Oursel et al., 2007). 
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1.2  ftsH knockout mutant 
 
Figure S2. Fatty acids chromatogram of wild-tpye and ftsH knockout mutants. 
Cells were grown at 30°C to mid-log phase prior to harvesting. Fatty acids extraction 
and GCMS analysis were performed as described in Chapter 4. Fatty acids notation are 
same as Fig. S1.    
 
 
As stated previously in the main text (section 3.1), ftsH knockout mutants are only 
viable when a suppressor mutation is present in the fabZ gene which subsequently leads 
to a hyperactive FabZ protein. Due to the lack of a functional FtsH protease, LpxC is 
stabilized. Results presented in Chapter 3 and Fig. 3.2 implies that when FabZ is 
overexpressed, SFAs are increased; however, the results in Fig. S2 above do not 
indicate a significant difference in SFAs level relative to wild-type (W3110). Thus, it is 
plausible that the increased concentration of LpxC effectively shunts β-
hydroxymyristoyl-ACP into the LPS pathway which otherwise would have been used 
for SFAs synthesis. In support of this, ftsH knockout mutants are characterized with 
20% increased LPS relative to wild-type (Ogura et al., 1999).  
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1.3 Electron Ionization (EI) mass spectra 
 
Figure S3. Mass spectra for myristic (C14:0) and palmitic acid (C16:0). This figure 
represents a typical spectra obtainable from picolinyl ester derivatives (Christie, 1989)†. 
The inset in the lower figure represents the points of cleavage in the picolinyl ester of 
palmitic acid that resulted in the ions of the spectra. In addition to identification using 
characteristic EI spectra, fatty acids were further confirmed using known standards.   
 
Table S1: Retention time of picolinyl esters of fatty acids 
Fatty acids    Retention time (min) 
Myristic acid (C14:0)    9.2 
Pentadecanoic acid (C15:0)   10.6 
Palmitoleic acid (C16:1)   12.2 
Palmitic acid (C16:0)    12.5 
cis-vaccenic acid (C18:1)   16.3 
stearic acid (C18:0)    16.6 
 
                                                          
† Christie, W.W. (1989) Gas Chromatography and Lipids. Oily Press Ltd., Ayr. 
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APPENDIX 2 – Lipid A regulation 
2.1  LpxC proteolysis 
As stated previously (Chapter 5, Fig. 5.6), LpxC was rapidly degraded when cell lysates 
were treated with palmitic acid. LpxC degradation did not occur when the reaction 
mixture contained 2.5 mM of EDTA which confirmed the protease responsible was a 
metalloprotease (Fig. 5.6). However, when the standard laboratory concentration of 
EDTA (1 mM) commonly used to inhibit metalloproteases was utilized, it had no effect 
on this protease under palmitic acid conditions (Fig. S4).  
 
   
 
Figure S4. In vitro LpxC proteolysis under palmitic acid conditions. E. coli W3110 
strain (wild-type) containing a plasmid bearing lpxC gene was grown at 30°C in the 
presence of 0.1% arabinose to induce protein expression. Cells were harvested at mid-
log phase, re-suspended in Tris-HCl pH 8.0 (without EDTA) and lysed via sonication. 
The lysates were added to tubes containing various concentrations of palmitic acid and 
EDTA and PMSF were included to inhibit metalloproteases and serine proteases 
respectively. Samples were incubated for 10 min at 30°C. Sample buffer was added 
immediately after incubation and heated for 5 min prior to Western blot analysis.  
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Additional characterization of this protease was conducted in vivo. E. coli ftsH knockout 
mutant cells treated with either PMSF or sodium arsenate had no effect on LpxC 
stability (Fig. S5). Whilst PMSF is known to inhibit serine proteases, sodium arsenate 
inhibits ATP-dependent proteases in vivo (Katz and Ron, 2008).    
 
 
 
Figure S5. LpxC proteolysis in an ftsH knockout mutant in vivo. Cells were grown 
in LB broth to an OD600 of 0.5 and cultures were split into different tubes. 2.5 mM 
PMSF and 20 mM sodium arsenate were added for 5 min prior to the addition of 200 
µg/ml of chloramphenicol to block protein expression. After 30 min, the cells were 
shock-frozen in liquid Nitrogen and thereafter, allowed to thaw on ice prior to Western 
blot analysis.  
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Although LpxC is rapidly degraded at lower temperatures (Schakermann et al., 2013), 
the steady state concentrations remain the same at both low and high temperatures (Fig. 
S6). This indicates that the LpxC synthesis and degradation ratio is crucial in the 
bacterial metabolism. 
 
 
 
 
Figure S6. The steady-state concentrations of wild-type LpxC are similar at 30 and 
42°C. Cells were prepared as described previously in Chapter 4.  
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2.1  WaaA regulation 
Light microscopy data of cells overexpressing waaA did not provide any qualitative 
information regarding the structural integrity of the membrane or cell (Fig. S7). This is 
in contrast to E. coli overexpressing lpxC in which the cells were characterized with 
elongated cell filament which was observable under the light microscope (Fuhrer et al., 
2007). Therefore, the effect of uncontrolled waaA synthesis on the bacterial membrane 
would be best visualized using an electron microscope. 
 
 
Figure S7. Microscopy of cells overexpressing waaA. Cells from an overnight culture 
were grown in fresh LB broth in the presence of 0.1 mM IPTG until an OD600 of 0.5. 
Cells were visualized using a Nikon microscope.  
 
 
205 
 
APPENDIX 3 – Model overview 
Initial model created using stochastic methods (with Stochkit) indicated that including 
‘noise’ in the simulations were unnecessary due to the high copies of lipid A molecules 
produced per generation time (Fig. S8). As a result, the use of deterministic simulation 
throughout this research was justified. 
 
 
Figure S8. Stochastic simulation for lipid A biosynthesis in E. coli using Stochkit 
software. Simulation parameters were same as those described in Table 2.1. This figure 
is representative of 100 realizations or runs.   
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Table S2: Annotation/definition of species nomenclature used in the COPASI file  
species name in COPASI file actual scientific notation and/or definitions 
acetyl-CoA acetyl-CoA 
ACP Acyl-carrier protein (ACP) 
Beta-hydroxymyristoylACP β-hydroxymyristoyl-ACP 
B-OH-10 β-hydroxydecenoyl-ACP 
B-OH-12 β-hydroxydodecenoyl-ACP 
B-OH-12:1 β-hydroxy-cis-5-dodecenoyl-ACP 
B-OH-14:1 β-hydroxy-cis-7-tetradecenoyl-ACP 
B-OH-16 β-hydroxypalmitoyl-ACP 
B-OH-16:1 β-hydroxy-cis-9-hexadecenoyl-ACP 
B-OH-18:1 β-hydroxy-cis-vacc-11-enoyl-ACP 
C10 decanoyl-ACP 
C10:1 cis-3-decenoyl-ACP 
C12 dodecanoyl-ACP 
C12:1 cis-5-dodecenoyl-ACP 
C14 myristoyl-ACP 
C14:1 cis-7-tetradecenoyl-ACP 
C16 palmitoyl-ACP 
C16:1 palmitoleoyl-ACP 
C18:1 cis-vaccenoyl-ACP 
CMP-KDO CMP-Kdo 
FabA FabA 
FabB FabB 
FabF FabF 
FabG FabG 
FabH FabH 
207 
 
FabI FabI 
FabR inactive FabR 
FabR* activated FabR 
FabZ FabZ 
FadR inactive FadR 
FadR* active FadR 
FadR/proA FadR that is bound to the fabA DNA i.e. active fabA 
promoter 
FadR/proB FadR that is bound to the fabB DNA i.e. active fabB 
promoter 
FtsH inactive FtsH 
FtsH_act_kdta activated FtsH for the degradation of WaaA 
FtsH_act_lpxc activated FtsH for the degradation of LpxC 
G3P glycerol-3-phosphate 
inact_proA1 inactive fabA promoter resulting from FabR binding to 
DNA 
inact_proA2 inactive fabA promoter resulting from FabR bound to 
DNA with prior FadR binding 
inact_proB1 inactive fabB promoter resulting from FabR binding to 
DNA 
inact_proB2 inactive fabB promoter resulting from FabR bound to 
DNA with prior FadR binding 
KdtA WaaA (formerly known as KdtA) 
ketoacyl-12 3-oxo-dodecenoyl-ACP 
ketoacyl-12:1 3-oxo-cis-5-dodecenoyl-ACP 
ketoacyl-14 3-oxo tetradecenoyl-ACP 
ketoacyl-14:1 3-oxo-cis-7-tetradecenoyl-ACP 
ketoacyl-16 3-oxo hexadecenoyl-ACP 
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ketoacyl-16:1 3-oxo-cis-9-hexadecenoyl-ACP 
ketoacyl-18:1 3-oxo-cis-vacc-11-enoyl-ACP 
lipidA Kdo2-Lipid A (Lipid A in the inner membrane prior to 
being translocated by MsbA) 
lipidA_OM lipid A in the outer membrane 
lipidA_un undesirable lipid A resulting from additional 
glycosylation of lipid A by WaaA 
lipidAdisaccharide lipid A disaccharide 
LpxA LpxA 
LpxB LpxB 
LpxC LpxC 
LpxD LpxD 
LpxH LpxH 
LpxK inactive LpxK 
LpxK_act LpxK that has been catalytically activated by UFAs 
LpxL LpxL 
LpxM LpxM 
MsbA MsbA 
P1 UDP-3-O-(β-hydroxymyristoyl)-Nac 
P2 UDP-3-O-(β-hydroxymyristoyl)-D-glucosamine 
P3 UDP-2,3-bis(β-hydroxymyristoyl)-D-glucosamine 
P4 lipid X 
P6 lipid IVA 
P7 Kdo2-Lipid IVA 
P8 lauroyl-Kdo2-Lipid IVA 
Palmitic palmitic acid in phospholipids 
Palmitoleic palmitoleic acid in phospholipids 
PlsB PlsB 
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PlsC PlsC 
proA regulated promoter of the fabA gene 
proA_unreg constitutive promoter of fabA gene 
proB regulated promoter of the fabB gene 
proB_unreg constitutive promoter of fabB gene 
promoter-KdtA the promoter of waaA 
promoter-LpxC the promoter of lpxC  
trans-10 trans-2-decenoyl-ACP 
trans-12 trans-2-dodecenoyl-ACP 
trans-12:1 trans-3-cis-5-dodecenoyl-ACP 
trans-14 trans-2-tetradecenoyl-ACP 
trans-14:1 trans-3-cis-7-tetradecenoyl-ACP 
trans-16 trans-2-hexadecenoyl-ACP 
trans-16:1 trans-3-cis-9-hexadecenoyl-ACP 
trans-18:1 (2-trans-11-cis)-vaccen-2-enoyl-ACP 
UDP-GlcNac UDP-N-acetylglucosamine 
Vaccenic cis-vaccenic acid in phospholipids 
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Table S3: Chemical reactions in the COPASI file and their definitions 
No Reaction name Reaction Definitions 
1 LpxA_forward UDP-GlcNac + Beta-
hydroxymyristoylACP -> P1 
+ ACP 
forward LpxA reaction 
2 LpxA_reverse P1 + ACP -> UDP-GlcNac + 
Beta-hydroxymyristoylACP   
reverse LpxA reaction 
3 LpxC P1 -> P2   LpxC catalysis step which represents the 
committed reaction in lipid A synthesis 
4 LpxC_translate promoter-LpxC -> 
 promoter-LpxC + LpxC 
translation of LpxC from the promoter. 
This approach combines transcription, 
translation, and any translocation into a 
single reaction step 
5 LpxC_degrade LpxC ->  The degradation of LpxC that is not 
catalysed by FtsH 
6 LpxH P3 -> P4   LpxH catalytic step 
7 LpxB P3 + P4 -> 
lipidAdisaccharide  
LpxB catalytic step 
8 LpxK lipidAdisaccharide -> P6   LpxK catalytic step 
9 KdtA_translate promoter-KdtA ->  
promoter-KdtA + KdtA 
translation of WaaA from the promoter. 
This approach also combines transcription, 
translation, and any translocation into a 
single reaction step 
10 KdtA_degrade KdtA ->  The degradation of WaaA that is not 
catalysed by FtsH 
11 KdtA CMP-KDO + P6 -> P7   WaaA catalytic step 
12 LpxL P7 -> P8 + ACP LpxL catalytic step 
13 LpxM P8 -> lipidA + ACP LpxM catalytic step 
14 MsbA lipidA -> lipidA_OM translocation of lipid A in the inner 
membrane by MsbA 
211 
 
15 LpxC_proteolysis LpxC + FtsH_act_lpxc -> 
FtsH_act_lpxc 
FtsH-dependent LpxC degradation 
16 FtsH_activate_LpxC FtsH + lipidAdisaccharide -> 
FtsH_act_lpxc + 
lipidAdisaccharide 
activation of FtsH by lipid A disaccaharide 
towards LpxC degradation 
17 FtsH_activate_KdtA FtsH + lipidA -> 
FtsH_act_kdta + lipidA 
activation of FtsH towards WaaA 
degradation. The activator is lipid A in the 
inner membrane prior to translocation by 
MsbA 
18 KdtA_proteolysis KdtA + FtsH_act_kdta -> 
FtsH_act_kdta 
FtsH-dependent WaaA degradation 
19 LpxD P2 + Beta-
hydroxymyristoylACP -> P3 
+ ACP 
LpxD catalytic step 
20 KdtA_alternate CMP-KDO + lipidA -> 
lipidA_un 
alternate glycosylation by WaaA of lipid 
A in the inner membrane prior to 
translocation by MsbA 
21 FtsH_inactive_LpxC FtsH_act_lpxc -> FtsH inactivation of FtsH-mediated LpxC 
degradation 
22 FtsH_inactive_KdtA FtsH_act_kdta -> FtsH inactivation of FtsH-mediated WaaA 
degradation 
23 FabA_C10 b-oh-10 = trans-10 FabA catalysis of its 10-carbon substrate. 
Reversible reaction 
24 FabZ_C10 b-oh-10 = trans-10 FabZ catalysis of its 10-carbon substrate. 
Reversible reaction 
25 FabA_isomerase trans-10 = C10:1 FabA isomerase reaction of trans-2-
decenoyl-ACP which represents the first 
step in UFAs synthesis. Reversible 
reaction 
26 FabI_C10 trans-10 -> C10 FabI catalysis of its 10-carbon substrate 
27 FabI_C14 trans-14 -> C14 FabI catalysis of its 14-carbon saturated 
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acyl substrate 
28 FabB_C12:1 C12:1 = ketoacyl-14:1 FabB catalysis of its 12-carbon cis-
unsaturated acyl substrate. Reversible 
reaction 
29 FabG_C14:1 ketoacyl-14:1 = B-OH-14:1 FabG catalysis of its 14-carbon cis-
unsaturated acyl substrate. Reversible 
reaction 
30 FabZ_C14:1 B-OH-14:1 = trans-14:1 FabZ catalysis of its 14-carbon cis-
unsaturated acyl substrate. Reversible 
reaction. 
31 FabI_C14:1 trans-14:1 -> C14:1 FabI catalysis of its 14-carbon cis-
unsaturated acyl substrate 
32 FabB_C10 C10 = ketoacyl-12 FabB catalysis of its 10-carbon saturated 
acyl substrate. Reversible reaction 
33 FabF_C10 C10 = ketoacyl-12 FabF catalysis of its 10-carbon saturated 
acyl substrate. Reversible reaction 
34 FabG_C12 ketoacyl-12 = B-OH-12 FabG catalysis of its 12-carbon saturated 
acyl substrate. Reversible reaction 
35 FabA_C12 B-OH-12 = trans-12 FabA catalysis of its 12-carbon saturated 
acyl substrate. Reversible reaction 
36 FabZ_C12 B-OH-12 = trans-12 FabZ catalysis of its 12-carbon saturated 
acyl substrate. Reversible reaction 
37 FabI_C12 trans-12 -> C12 FabI catalysis of its 12-carbon saturated 
acyl substrate 
38 FabB_C10:1 C10:1 = ketoacyl-12:1 FabB catalysis of cis-3-decenoyl-ACP. 
Reversible reaction 
39 FabG_C12:1 ketoacyl-12:1 = B-OH-12:1 FabG catalysis of its 12-carbon cis-
unsaturated acyl substrate. Reversible 
reaction 
40 FabZ_C12:1 B-OH-12:1 = trans-12:1 FabZ catalysis of its 12-carbon cis-
unsaturated acyl substrate. Reversible 
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reaction. 
41 FabI_C12:1 trans-12:1 -> C12:1 FabI catalysis of its 12-carbon cis-
unsaturated acyl substrate 
42 FabB_C12 C12 = ketoacyl-14 FabB catalysis of its 12-carbon saturated 
acyl substrate. Reversible reaction 
43 FabF_C12 C12 = ketoacyl-14 FabF catalysis of its 12-carbon saturated 
acyl substrate. Reversible reaction 
44 FabG_C14 ketoacyl-14 = Beta-
hydroxymyristoylACP 
FabG catalysis of its 14-carbon saturated 
acyl substrate. Reversible reaction 
45 FabA_C14 Beta-hydroxymyristoylACP 
= trans-14 
FabA catalysis of its 14-carbon saturated 
acyl substrate. Reversible reaction 
46 FabZ_C14 Beta-hydroxymyristoylACP 
= trans-14 
FabZ catalysis of its 14-carbon saturated 
acyl substrate. Reversible reaction 
47 FabB_C14 C14 = ketoacyl-16 FabB catalysis of its 14-carbon saturated 
acyl substrate. Reversible reaction 
48 FabA_C16 B-OH-16 = trans-16 FabA catalysis of its 16-carbon saturated 
acyl substrate. Reversible reaction 
49 FabZ_C16 B-OH-16 = trans-16 FabZ catalysis of its 16-carbon saturated 
acyl substrate. Reversible reaction 
50 FabI_C16 trans-16 -> C16 FabI catalysis of its 16-carbon saturated 
acyl substrate 
51 FabB_C14:1 C14:1 = ketoacyl-16:1 FabB catalysis of its 14-carbon cis-
unsaturated acyl substrate. Reversible 
reaction. 
52 FabF_C14:1 C14:1 = ketoacyl-16:1 FabF catalysis of its 14-carbon cis-
unsaturated acyl substrate. Reversible 
reaction. 
53 FabG_C16:1 ketoacyl-16:1 = B-OH-16:1 FabG catalysis of its 16-carbon cis-
unsaturated acyl substrate. Reversible 
reaction. 
54 FabZ_C16:1 B-OH-16:1 = trans-16:1 FabZ catalysis of its 16-carbon cis-
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unsaturated acyl substrate. Reversible 
reaction. 
55 FabI_C16:1 trans-16:1 -> C16:1 FabI catalysis of its 16-carbon cis-
unsaturated acyl substrate.  
56 FabF_C14 C14 = ketoacyl-16 FabF catalysis of its 14-carbon saturated 
acyl substrate. Reversible reaction. 
57 FabG_C16 ketoacyl-16 = B-OH-16 FabG catalysis of its 16-carbon saturated 
acyl substrate. Reversible reaction 
58 FabF_C16:1 C16:1 = ketoacyl-18:1 FabF catalysis of its 16-carbon cis-
unsaturated acyl substrate. Reversible 
reaction. 
59 FabG_C18:1 ketoacyl-18:1 = B-OH-18:1 FabG catalysis of its 18-carbon cis-
unsaturated acyl substrate. Reversible 
reaction. 
60 FabZ_C18:1 B-OH-18:1 = trans-18:1 FabZ catalysis of its 18-carbon cis-
unsaturated acyl substrate. Reversible 
reaction. 
61 FabI_C18:1 trans-18:1 -> C18:1 FabI catalysis of its 18-carbon cis-
unsaturated acyl substrate.  
62 PlsB_C16 C16 + G3P -> palmitic condensation of palmitoyl-ACP with 
glycerol-3-phosphate by PlsB 
63 PlsB_C18:1 C18:1 + G3P -> vaccenic condensation of cis-vaccenoyl-ACP with 
glycerol-3-phosphate by PlsB 
64 PlsC_C16:1 C16:1 + G3P -> palmitoleic condensation of palmitoleoyl-ACP with 
glycerol-3-phosphate by PlsC 
65 PlsC_C18:1 C18:1 + G3P -> vaccenic condensation of cis-vaccenoyl-ACP with 
glycerol-3-phosphate by PlsC 
66 ACTIVATION_LpxK LpxK = LpxK_act catalytic activation and inactivation of 
LpxK by UFAs (see screenshot in Fig. S9) 
67 FabA_constitutive_expression proA_unreg -> proA_unreg + 
FabA 
expresssion of fabA from the constitutive 
promoter 
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68 FabA_regulated_expression FadR/proA -> FabA + 
FadR/proA 
expresssion of fabA from the regulated 
promoter resulting from FadR binding to 
the DNA 
69 FabA_repression_by_FabR_1 proA = inact_proA1 inactivation of the regulated fabA 
promoter by FabR  
70 FabA_degradation FabA ->  degradation of FabA 
71 FabR_activation FabR = FabR* activation and inactivation of FabR  
72 FabA_promoter_activation proA = FadR/proA binding of FadR to the fabA DNA to 
activate expression (see screenshot in Fig. 
S10) 
73 FabA_repression_by_FabR_2 FadR/proA = inact_proA2 inactivation by FabR of the regulated fabA 
promoter already bound to FadR  
74 FabH acetyl-CoA -> b-oh-10 initiation of fatty acids synthesis by FabH 
75 FadR_activation FadR = FadR* activation and inactivation of FadR  
76 FabB_constitutive_expression proB_unreg -> proB_unreg + 
FabB 
expresssion of fabB from the constitutive 
promoter 
77 FabB_degradation FabB ->  degradation of FabB 
78 FabB_promoter_activation proB = FadR/proB binding of FadR to the fabB DNA to 
activate expression (see screenshot in Fig. 
S10) 
79 FabB_regulated_expression FadR/proB -> FabB + 
FadR/proB 
expresssion of fabB from the regulated 
promoter resulting from FadR binding to 
the DNA 
80 FabB_repression_by_FabR1 proB = inact_proB1 inactivation of the regulated fabB 
promoter by FabR  
81 FabB_repression_by_FabR_2 FadR/proB = inact_proB2 inactivation by FabR of the regulated fabB 
promoter already bound to FadR  
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Figure S9. Screenshots explaining reaction 66 in the COPASI file. (A) The catalytic 
activation of LpxK was modelled using reversible mass-action kinetics in which the 
forward and reverse rate constants represented the activation and inactivation rates 
respectively. The activation rate constant (B) and inactivation rate constant (C) were 
made pre-defined global quantities in COPASI using eq. 22 in Chapter 3. These global 
quantities were then recalled for use as rate constants as pictured in ‘A’.   
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Figure S10. Screenshots explaining reactions 72 and 78 in the COPASI file. The 
rationale is same as in Fig. S9 above. (A) The activation of fabA promoter by FadR was 
modelled using reversible mass-action kinetics in which the forward and reverse rate 
constants represented the activation and inactivation rates respectively. The FadR 
activation rate was made a pre-defined global quantity in COPASI using eq. 16 in 
Chapter 3. As in Fig. S9, the global quantity was recalled for use as rate constant. (B) 
Activation of fabB promoter. Conditions are same as ‘A’ above.  
 
 
 
 
